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general inTroducTion
Part of this chapter has been published as a review
Marco Benevento1, Marise van de Molengraft1, Rhode van Westen1, 
Hans van Bokhoven2, Nael Nadif Kasri3

ONE 
IntroductIon
The word “epigenetic” is derived from the ancient Greek prefix “ἐπί” (epi-), which means “on top 
of”, and the Greek word “γένος” (genos), which means “gene” or “race”. The term epigenetics 
generally refers to a set of heterogeneous cellular mechanisms that finely control gene expression 
at multiple levels. At the  biochemical level, these mechanisms include DNA  methylation of 
cytosine residues and post-translational modifications (PTMs) of histones. All modifications share 
the  same characteristic; they have the  capacity to reversibly modulate transcriptional activity 
while leaving the  DNA  sequence itself unaffected. This enables dynamic gene transcription 
patterns in the nucleus in response to environmental or developmental stimuli. 
Chromatin is a structure that consists of DNA and histones, whose function is to package 
DNA into a smaller volume within the nucleus and to control gene expression. Depending on 
the condensation state, chromatin can be distinguished into euchromatin and heterochromatin. 
Euchromatin is the  decondensed form, which is associated with genomic regions that are 
transcriptionally permissive, whereas heterochromatin is compacted and can exist in two 
forms; i) facultative, which is actively involved in gene expression and ii) constitutive, which 
is obligatorily silenced. The  histone protein is the  core structure of the  nucleosome. Each 
nucleosome consists of 147-164 base pairs of DNA  wrapped around an octamer of histone 
proteins, which includes two copies of histone H2A, H2B, H3 and H4 each (reviewed by 
Felsenfeld and Groudine, 2003). Of these proteins, histone 3 (H3) is the  most extensively 
studied. Histone tails protrude from the nucleosome to areas that are typically accessible for 
the  chemical modifications, such as acetylation, methylation, phosphorylation, and others 
(Figure 1.1) (Cedar and Bergman, 2009; Rose and Klose, 2014; Rothbart and Strahl, 2014).  
These modifications are installed by writer enzymes, such as histone acetyltransferases 
(HATs) and histone methyltransferases (HMTs); removed by eraser enzymes, such as histone 
deacetylases (HDACs) and histone demethylases (HDMs); and interpreted by reader enzymes, 
proteins that bind specific chromatin marks or are found in transcription repressor and activator 
complexes that regulate DNA accessibility by the basic transcription machinery (Kleefstra et al., 
2014; Ronan et al., 2013). Writer, eraser and reader enzymes specifically target one or a  few 
modifications. For example, the  writer enzyme Euchromatic histone methyltransferase-1 
(EHMT1) catalyses histone 3 lysine 9 (H3K9) mono-and dimethylation, but not trimethylation 
figure 1.1. Model figure depicting histone post-translational modifications (PTMs) and residues modified 
in histone H3.  
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(Figure 1.2) (Tachibana et al., 2005). The combinatorial nature of histone PTMs impact on gene 
expression has been postulated to generate a  histone code which cells use as “epigenetic 
“memory” of previous transcriptional states, yet this model is still under debate (Comoglio and 
Paro, 2014; de Pretis and Pelizzola, 2014; Lesne et al., 2015; Rando, 2012).
Recently, numerous studies have implicated dynamic changes in DNA  methylation and 
histone PTMs in the  formation or consolidation of long-term memories in specific memory-
related brain regions. In addition, pathways up and downstream of the chromatin modifying 
enzymes were found to be part of the signaling pathways governing synaptic plasticity and long-
term behavioral memory (Fonseca, 2016; Sweatt, 2016; Day and Sweatt, 2011b; 2011a; Kramer, 
2013; Levenson and Sweatt, 2005; Lipsky, 2013). Consequently, disturbances in epigenetic 
states can impede plasticity and underlie cognitive disorders (Benevento et al., 2016; Barco, 
2014; Kleefstra et al., 2014; Schaefer et al., 2011). Most of the studies on epigenetics in cognition 
have focused on DNA methylation and histone H3 (de)-acetylation and have been summarized 
in recent reviews (Gräff and Mansuy, 2008; Gräff et al., 2012b; Miller et al., 2010; Penney and 
Tsai, 2014; Zovkic et al., 2013). While DNA methylation is generally considered to inhibit gene 
transcription and histone acetylation is considered to be activating, histone methylation can 
achieve both gene activation and repression.
Histone methylation initially received less attention, because it was long assumed to be 
rigid and therefore of little interest to dynamic processes involved in cognition, such as learning 
and memory. Because the half-life of histone methylation is as long as the histone protein itself 
[reviewed by (Bannister et al., 2002), demethylation was thought to happen only passively 
through cell division. However the  discovery of an ‘eraser’ enzyme that removes histone 
methylation, histone demethylase LSD1 (Shi et al., 2004), suggested that histone methylation 
could also be dynamically regulated. In general, the outcome of histone methylation depends 
on (a) the  type of amino acid being modified, arginine (R) or lysine (K); (b) the  extent of 
methylation (mono-, di- or trimethylation), and (c) the  location of the  modified residue on 
the histone tail (Figure 1.1). In particular, histone H3 methylation has been shown to modulate 
enduring changes in gene expression to regulate memory formation and neural plasticity 
(Sharma  et al., 2016; Fischer et al., 2007; Gräff and Mansuy, 2008; Gupta  et al., 2010; Gupta-
Agarwal et al., 2012; 2014; Lubin et al., 2011; Parkel et al., 2013).
The repressive complex ehmT1/ehmT2
Dimethylation of lysine 9 of Histone H3 (H3K9me2) is a  PTM typically present in both 
euchromatin and heterochromatin at the  promoters of silenced genes. H3K9me2 in 
euchromatic regions is catalysed by the  heterodimerization of EHMT1 (KMT1D or GLP) with 
EHMT2 (KMT1C or G9a) (Figure 1.2) (Tachibana  et al., 2002). Indeed chemical inhibitors or 
genetic manipulations of either EHMT1 or EHMT2 has shown (in vivo and in vitro) to reduce 
H3K9me2 levels via specific EHMT1/EHMT2 inhibition of methyltransferase activity (Del Rio and 
Varchi, 2016; Qing and Wang, 2016; Chang et al., 2009; Kubicek et al., 2007; Vedadi et al., 2011). 
Biologically, the EHMT1/EHMT2 repressive complex is important for governing transcriptional 
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figure 1.2. Model depicting EHMT1/EHMT2 mediated mechanism of nucleosomal compaction when EHMT1 
(green stretched oval) and EHMT2 (light blue rounded rectangle) associate to a certain given stimulus. 
Nucleosomal compaction as showed in the figure represses gene transcription (red cross) by impeding 
transcription factors (orange triangle) binding to the promoter. Figure legend in the black-lined box. 
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output during development and cell differentiation (Tachibana et al., 2002, 2005; Fiszbein et 
al., 2016; Zhang et al., 2016; Cougot et al., 2016). This is best reflected by the  fact that both, 
Ehmt1-/- and Ehmt2-/- mice, show severe developmental delays and early embryonic lethality 
(Tachibana et al., 2008). At the level of gene regulation it has been suggested that the EHMT1/
EHMT2 complex prevents the re-expression of time locked developmental genes by interacting 
with Polycomb and REST/NSRF repressor complexes (Mozzetta  et al., 2014; Roopra  et al., 
2004). In terms of cellular maturation, the  EHMT1/EHMT2 repressor complex is required for 
the  commitment of human hematopoietic stem cells and brown adipose cells (Chen et al., 
2012; Schones et al., 2014). Specifically in the nervous system, loss of EHMT2 function led to 
increased cell proliferation and disorganized layering in the  retina  (Katoh et al., 2012), and 
also resulted in a switch of neuronal subtypes, from dopamine receptor D2 expressing (Drd2) 
neurons to Drd1 neurons in the mouse nucleus Accumbens (nAc) (Maze et al., 2014). Finally, 
EHMT1 and EHMT2 govern the heterochromatic silencing of olfactory receptor genes, which is 
essential for the diversification of olfactory neurons (Lyons et al., 2014). Overall these studies 
identified EHMT1 and EHMT2 as a crucial repressive complex during development and neuronal 
cell differentiation.
h3K9 meThylaTion in learning and memory
In recent years, numerous studies have provided evidence that changes in histone lysine 
methylation, leading to gene expression activation or repression, are also required for 
the  formation and consolidation of long-term memory (LTM) in particular brain regions. 
Specifically, the  expression of H3K4me3 and H3K9me2 marks were found to be transiently 
and dynamically regulated in rat CA1 hippocampus, entorhinal cortex (EC) and lateral 
amygdala (LA) following contextual fear-conditioning, a form of learning in which an aversive 
stimulus (e.g. an electrical shock) is associated with a particular neutral context (Gupta et al., 
2010; Gupta-Agarwal et al., 2012; 2014). H3K9me2 levels together with H3K4me3, an active 
mark for transcription (Akbarian and Huang, 2009; Schneider et al., 2004), are transiently 
increased in CA1 hippocampal neurons one hour after training rats in the  contextual fear-
conditioning paradigm, returning to baseline (H3K4me2) or even decreasing to levels below 
baseline (H3K9me2) twenty-four hours after training (Gupta et al., 2010). Of note, the novel 
context exposure alone was sufficient to trigger an increase in H3K9me2, but not H3K4me3, 
levels in CA1. Mice deficient in the  H3K4-specific histone methyltransferase, Mll, displayed 
deficits in contextual fear conditioning, suggesting that H3K4 methylation is required for 
proper long-term consolidation of contextual fear memories (Gupta et al., 2010). Interestingly, 
methylation dynamics of H3K9me2 and H3K4me3 were found to be different in the  EC and 
LA  (Gupta-Agarwal et al., 2012; 2014). While the  levels of both H3K9me2 and H3K4me3 
increased in the  EC one hour after contextual fear conditioning training, H3K9me2 protein 
levels were unaltered and H3K4me3 levels were reduced in the  EC twenty-four hours after 
training compared to naïve animals (Gupta-Agarwal et al., 2012). In the  LA, H3K9me2 levels 
were increased one hour following auditory fear conditioning and this increase persisted until 
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twenty-five hours following behavioral training. In contrast, H3K4me3 remained unchanged 
in the LA following training (Gupta-Agarwal et al., 2014). The differences observed in histone 
methylation dynamics in contextual and auditory fear conditioning hint towards a specific role 
for the  respective marks during memory formation and/or consolidation. Indeed, infusing 
a EHMT2 inhibitor, BIX-01924, in the CA1 impaired contextual fear memory twenty-four hours 
after training, whereas contextual fear memory was increased when BIX-01924 was delivered 
to the  EC (Gupta  et al., 2010; Gupta-Agarwal et al., 2012).  Moreover, EHMT2 inhibition in 
the EC had an effect on the contextual association as BIX-01924-infused rats displayed elevated 
freezing behavior twenty-four hours and seven days after training, compared to vehicle 
treated animals (Gupta-Agarwal et al., 2012). Inhibition of EHMT2 using the selective EHMT2 
inhibitor UNC0224 (Liu et al., 2009) in the LA also impaired fear memory, whereas inhibiting 
a  H3K9me2 demethylase LSD1, with trans-2-phenylcyclopropylamine (t-PCP) (Benelkebir 
et al., 2011; Binda  et al., 2010), enhanced fear memory. Collectively these data  indicate that 
bidirectional regulation of H3K9me2 in the LA is a regulator of fear memory. The differences 
observed between the  various brain regions suggest that methylation marks, in particular 
H3K9me2, could act as a molecular hub that underlies cellular connectivity between EC, CA1 
and LA. Interestingly, the  changes in methylation seen after behavioral training were very 
often accompanied with a  change in the  expression of the  respective enzymes mediating 
the methylation (e.g. EHMT2 or EHMT1), indicating that transcriptional regulation of EHMT1/
EHMT2 often precedes the changes in methylation.
The  importance of EHMT2 and EHMT1 in fear memory formation and consolidation has 
similarly been demonstrated using conditional knockout mice in which either EHMT1 or 
EHMT2 was removed in CamK2a  expressing neurons, in the  postnatal forebrain. Specifically, 
memory formation was impaired in Ehmt1fl/fl CamK2a-Cre mice twenty-four hours after training 
in the  contextual fear conditioning paradigm (Schaefer et al., 2009). Moreover, conditional 
knockdown of Ehmt1/Ehmt2 showed decreased explorative behavior, reduced sucrose 
preference and less anxiety-related behavior in the  elevated plus maze. Interestingly, these 
phenotypes partially overlapped with phenotypes observed in mice with haploinsufficiency in 
Ehmt1 (Ehmt1+/-), a mouse model for Kleefstra syndrome (KS) (Balemans et al., 2010; 2013). KS 
is caused, amongst others, by the  heterozygous loss of EHMT1/GLP (Willemsen et al., 2012). 
The syndrome is characterized by intellectual disability, general developmental delay, childhood 
hypotonia, cranio-facial abnormalities and autistic-like behavioral problems (Kleefstra  et al., 
2009; 2006; Nillesen et al., 2011; Willemsen et al., 2012). In contrast to the Ehmt1fl/fl CamK2a-Cre 
mice, Ehmt1+/- mice showed increased fear memory during acquisition and retention twenty-
four hours after contextual fear conditioning training, but impaired fear memory extinction 
when the  mice were re-exposed for five consecutive days after tone-stimuli association 
(Balemans et al., 2013). Furthermore Ehmt1+/- mice displayed typical autistic features such as 
reduced exploration, increased anxiety, altered social interaction (Balemans et al., 2010) and 
craniofacial abnormalities (Balemans et al., 2014).
Finally, a critical role for EHMT1/EHMT2 function in LTM was also found in Drosophila, in 
which the Drosophila orthologue EHMT was mutated (EHMTDD). Behavioral analyses identified 
17
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EHMT as a  regulator of peripheral dendrite development, larval locomotor behavior, non-
associative learning, and courtship memory. The requirement for EHMT in memory was mapped 
to predominantly mushroom body neurons, the learning and memory centre in Drososphila. 
Interestingly, memory was restored by EHMT re-expression during adulthood, indicating that 
cognitive defects are reversible in EHMT mutants (Kramer et al., 2011). 
From a  cellular perspective Ehmt1+/- mice and Drosophila  (EHMTDD) showed altered 
neuronal architecture (Balemans et al., 2013; Kramer et al., 2011). Morphological analysis by 
reconstructing hippocampal CA1 pyramidal neurons revealed a  reduction in complexity and 
in the  total length and branches of CA1 apical dendrites. A  similar dendritic phenotype was 
observed in Drosophila type 4 multiple dendrites neurons (Kramer et al., 2011). Ehmt1+/- mice 
also showed a  reduction in spine density in CA1 pyramidal neurons, in particular stubby and 
mushroom types were decreased in Ehmt1+/- mice compared to wildtype (Balemans et al., 2013). 
However, postnatal deletion of either Ehmt1 or Ehmt2 did not affect neuronal architecture of 
CA1 nor Drd1 neurons (Schaefer et al., 2009), indicating that the  repressive EHMT1/EHMT2 
complex might play a specific role during early development.
Long-term potentiation (LTP) is considered to be the  cellular mechanism for long-term 
memory formation (Kessels and Malinow, 2009; Makino and Malinow, 2009; Malenka  and 
Malinow, 2011; Malinow and Malenka, 2002). The requirement of EHMT1/EHMT2 for memory 
formation is also reflected at the synaptic level. Blockage of EHMT2 by bath application of BIX-
01294 impeded long lasting-LTP (L-LTP) induction at the Schaffer collateral SC-CA1 synapses, 
but not in the temporoammonic pathway (TA-CA1) (Gupta-Agarwal et al., 2012), nor was LTP 
altered at the  CA1-CA3 synapse in the  Ehmt1+/- mice. However, inhibition of EHMT2/EHMT1 
complex during protein synthesis-independent LTP (early LTP) reinforces both early-LTP and 
synaptic tagging and capture in the  hippocampal CA1, through increases in Brain Derived 
Neurotrophic Factor (BDNF) levels (Sharma  et al., 2016). At the  basal level however, paired-
pulse facilitation (PPF) was increased in Ehmt1+/- mice, indicative for a  pre-synaptic deficit 
associated with reduced release probability (Balemans et al., 2013). Furthermore, whole-cell 
patch clamping revealed that miniature excitatory postsynaptic currents frequencies, but not 
amplitudes, were significantly reduced in Ehmt1+/- CA1 pyramidal neurons, correlating with 
the reduction observed in PPF and decrease in mature spine density (Balemans et al., 2013).  
The  differences observed at the  level of structure, physiology and behavior between 
the  animal models - heterozygous versus conditional and pharmacological models - reveal 
a  complex scenario, but all point towards a  spatio-temporal specific requirement for 
the EHMT1/EHMT2 repressor complex in regulating neural connectivity and the formation or 
consolidation of long-term memories in the hippocampus (Table 1.1). Although perturbations 
of H3K9me2 clearly alter many aspects of neuronal function, given the  many homeostatic 
feedback pathways that influence neural circuit and brain development, it is unclear which 
perturbations are directly causal and which are induced secondarily as a  consequence of 
altered brain function. 
Although the  role of the  repressive complex EHMT2/EHMT1 in fear memory has been 
established, still very little is known regarding the downstream target genes being repressed 
18
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by this complex. Equally little is known regarding the upstream activation pathways. A possible 
mechanism that controls the  activity-dependent regulation of EHMT2, has recently been 
proposed (Gupta-Agarwal et al., 2014), in which the  NMDA  receptor subunit GluN2B via  ERK 
activation was shown to differentially recruit EHMT2 and LSD1 to the target gene promoters in 
the LA via ERK activation. Interestingly, fear memory deficits associated with NMDAR or ERK 
blockage could be rescued by the inhibition of LSD1, suggesting that H3K9me2 enhancement 
within the LA is downstream of NMDAR and ERK activation (Gupta-Agarwal et al., 2014). In this 
context it also of interest to note that the developmental NMDAR subunit switch from GluN2B 
to GluN2A, which is critical for learning and memory (Sheng et al., 1994; Williams et al., 1993; 
Yashiro and Philpot, 2008), at least in part involves the regulation of H3K9me2 levels (Rodenas-
Ruano et al., 2012). NMDA receptor mediated Ca2+ influx is known to result in signal transduction 
that induces de novo gene expression underlying LTP (Zhao et al., 2005). The  GluN2B-to-
GluN2A  switch is required for learning and memory, as GluN2B restricts AMPA  receptor 
incorporation into the synapse (Hall et al., 2007), lowers the LTP threshold, increases the LTP 
magnitude (Yashiro and Philpot, 2008), and promotes spine groWTh and dendrite patterning 
(Espinosa  et al., 2009; Lee et al., 2010; Ultanir et al., 2007). During the  developmental 
GluN2B-to-GluN2A switch, chromatin immunoprecitpitation (ChIP) experiments showed that 
REST/NRSF, EHMT2 and H3K9me3 were enriched at the  Grin2b promoter in postnatal day 15 
(P15) mice, time points which coincided with a  reduction in LTP induction (Gray et al., 2011; 
Rodenas-Ruano et al., 2012). Since the H3K9me3 mark is transient, the long-lasting repression 
of GluN2B is more likely mediated by additional mechanisms, such as the  persistent change 
in H3K27me3 at P15. Interestingly, a recent study linked EHMT1/EHMT2 to the PRC2 repressor 
complex indicative of a H3K9me2, H3K9me3 crosstalk with H3K27me3 in order to repress genes 
during neuronal development (Mozzetta et al., 2014). However, at P60 the levels of H3K9me3 at 
Table 1.1. Summary comparative table of the major behavioral and functional findings from three different 
studies using different means to manipulate EHMT2/EHMT1 function .
Ehtm1+/- mouse
(Balemans et al., 
2010, 2012)
ehmt1/2-/fl;camK2a-cre
(Schaeffer et al., 
2009)
ehmT1/2 inhibition
(Gupta et al., 2012)
ca1 infusion  ec infusion
Exploration decreased decreased non-tested non-tested
Social interaction decreased non-tested non-tested non-tested
Anxiety enhanced decreased non-tested non-tested
Fear memory (cued-CFC) enhanced decreased decreased enhanced
Fear extinction (cued-CFC) no extinction non-tested non-tested enhanced
Dendritic branching decreased no difference non-tested non-tested
Denditic spine density decreased no difference non-tested non-tested
Basal e-phys properties no difference no difference non-tested non-tested
LTP-induction no difference non-tested decreased no difference
Presynaptic plasticity enhanced non-tested enhanced non-tested
19
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the Grin2b promoter decreased, while the H3K27me3 stayed elevated. This could point towards 
a mechanism in which long-term gene repression is initiated by crosstalk between H3K9me2-3 
and H3K27me3 and is further maintained by different effectors. 
It is clear that chromatin remodeling mediated gene regulation is a  finely tuned and 
complex process, which requires the integration of different converging pathways onto histone 
modifying enzymes and DNA  methyltransferases. The  further understanding of the  “code” 
and crosstalk between the  histone PTMs and DNA-methylation will be extremely helpful to 
comprehend mechanisms of activity-driven gene expression.
inTerference of hisTone meThylaTion 
and addicTion 
Chronic consumption of “recreational” drugs, such as cocaine can lead to devastating 
psychiatric effects, which are caused by long-lasting changes in the  brain’s dopaminergic 
reward system. One well-characterized reward brain-system affected by cocaine intake is 
the  Ventral-Tegmental Area  (VTA) and nAc axis. The  VTA  projects dopaminergic afferents 
to the  nAc. Cocaine acts as a  dopamine reuptake inhibitor (Rothman, 1990) increasing 
neuronal activity in the nAc. In recent years, numerous studies have untangled how cocaine-
induced chromatin remodelling, at specific loci, affects gene expression, physiology and 
behavior. Repeated cocaine administration increased FosB/DFosB mRNA levels and H3K9/14-
acetylation at the FosB promoter in mice (Heller et al., 2014; Maze et al., 2010). In contrast, 
cocaine treatment decreased global H3K9me2 levels, and specifically reduced mRNA  levels 
of both, Ehmt1 and Ehmt2 compared to other histone lysine methyltransferases twenty-
four hours after the  last cocaine presentation in the  mouse nAc (Maze et al., 2010). At 
the  behavioral level, knockdown of EHMT2 by locally (Ac) injecting an AAV-Cre in Ehmt2fl/
fl mice significantly increased the  effects of cocaine in the  conditioning place preference 
(CPP) paradigm. In contrast, CPP memory for cocaine exposure was decreased when EHMT2 
was over-expressed in the nAc (Maze et al. 2010). These findings directly linked H3K9me2 to 
the expression of synaptic plasticity observed upon addictive behavior. Neuronal architecture 
was also affected by cocaine exposure. Local EHMT2 overexpression or EHMT2 knockdown 
in the  nAc respectively, blocked or enhanced the  increase in spine density on neurons 
from the nAc in mice that were chronically exposed to cocaine (Maze et al., 2010), whereas 
EHMT2 manipulation alone did not affect spine density, gene expression or behavior. In terms 
of gene regulation cocaine causes an increase in glutamatergic drive onto nAc (Ungless 
et al., 2001) and enhances the  expression of target genes implicated in cocaine-induced 
plasticity (Graham et al., 2007; Russo et al., 2009). Using microarrays the  authors found 
two interesting aspects; a) repeated cocaine exposure led to enhanced gene expression 
compared to animals that were acutely treated with cocaine and b) overexpression of EHMT2 
(HSV-EHMT2) in the  nAc was sufficient to block the  cocaine-dependent increase in gene 
expression (Maze et al., 2010). Amongst others, FosB and Bdnf expression were increased 
by chronic cocaine consumption (Nestler, 2014b; 2014a).  EHMT2 and H3K9me2 enrichment 
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in FosB/ΔFosB and Bdnf IV promoters was reduced when animals were chronically treated 
with cocaine (Maze et al., 2010). Interestingly, chronic HDAC1 inhibition by implanting mini-
osmotic pumps delivering HDAC inhibitor MS-275 (Kennedy et al., 2013) attenuated cocaine-
related increase in locomotor sensitivity. Simultaneously, it induced an increase in Ehmt2 
mRNA and global H3K9me2 expression in the nAc, thus counteracting the cocaine-induced 
decrease in H3K9me2. This indicated that EHMT2 serves as a  mediator for the  inhibition of 
addictive behavior observed after HDAC inhibition. At a  functional level, repeated cocaine 
consumption has been shown to cause an increase in frequency of GABA
A
 receptor-mediated 
miniature inhibitory postsynaptic currents (mIPSCs) in striatonigral medium spiny neurons 
in mice (Dixon et al., 2010). Reinstating EHMT2 expression through MS-275 HDAC1 inhibition 
suppressed the cocaine-dependent expression of GABA-receptor genes Gabra1, Gabra3 and 
Gabrb2, while it blocked the  cocaine-dependent increase in mIPSCs frequency (Kennedy 
et al., 2013). This study further highlighted the  possibility that EHMT2-mediated chromatin 
remodeling through H3K9me2 could serve as a  therapeutic target and venue to counteract 
drug-dependent psychiatric effects through gene repression. Indeed, site specific targeting 
of a specific locus within the FosB/ΔFosB promoter by using zinc finger-proteins (ZFPs) fused 
with EHMT2 C-terminal or using transcription activator like effectors (TALEs) have recently 
shown to be sufficient to counteract cocaine-induced plasticity (Heller et al., 2014).  
Interestingly, the dynamic response of H3K9me2 is not only restricted to cocaine addiction 
since similar epigenetic responses have been observed upon ethanol exposure. Qiang 
and colleagues (Qiang et al., 2011) showed that chronic intermittent ethanol withdrawal in 
primary cortical neurons lead to a global and local decrease in H3K9 di- and trimethylation at 
the Grin2b gene promotor. Ethanol exposure reduced the global expression levels of the HMTs 
Ehmt2, Suv39h1 and Setdb1, but not the  activity of HATs or HDACs. Moreover, EHMT2-
mediated H3K9me2 was shown to critically regulate ethanol-induced neurodegeneration 
and associated loss of cognition in rodents (Subbanna and Basavarajappa, 2014; Subbanna et 
al., 2013). Consequently, inhibiting EHMT2 before ethanol exposure at P7 prevented ethanol-
induced deficits in LTP, memory and social cognition (Subbanna et al., 2014). Similarly, nicotine 
exposure induced chromatin remodeling by decreasing H3K9me2 protein levels and Ehmt1/
Ehmt2 mRNA  levels in mouse cortical extracts both in vitro and in vivo (Chase and Sharma, 
2013). Chromatin immunoprecipitation (ChIP) analysis further showed that nicotine caused 
a  decrease in H3K9me2 enrichment at Bdnf I, IV and IXa  promoters thereby inducing an 
increase in Bdnf mRNA transcription. These results indicate that EHMT2-mediated chromatin 
remodeling is involved in different types of substance-dependence. Hence, the  underlying 
mechanisms might serve as a potential drug target and deserves further attention.
ehmT1/ehmT2 in cogniTive disorders
Defects in epigenetic mechanisms may contribute to the  development of several cognitive 
disorders. Many of these disorders involve, among others, memory impairment, learning 
deficits and neurodevelopmental delays (van Bokhoven, 2011; Barco, 2014; Kelly et al., 2010; 
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Kleefstra et al., 2014; Peña et al., 2014; Portela and Esteller, 2010). Intellectual disability (ID) is 
a common neurodevelopmental disorder arising before the age of 18 that affects approximately 
1–3% of the population. ID is defined by an intelligence quotient (IQ) lower than 70, associated 
with deficits in conceptual, social and adaptive skills. KS is an example of an emerging number 
of ID disorders caused by genes encoding epigenetic regulators of neuronal gene activity 
(Kleefstra et al., 2014). KS, previously known as the 9q subtelomeric deletion syndrome (9qSTDS) 
is caused by haploinsufficiency of the  EHMT1 gene. Heterozygous (or de novo) intragenic 
mutations and 9q34 microdeletions encompassing the  entire gene can both be responsible 
for this syndrome which is characterized by ID, hypotonia, and typical dysmorphisms, and 
may be associated with congenital heart and/or renal defects and epilepsy (Kleefstra  et al., 
2006; Willemsen et al., 2012). Behavioral phenotypes include sleep disturbances and apathy. 
The  effects of the  mutation in the  EHMT1 gene on a  molecular, cellular and behavioral level 
have been extensively investigated in Drosophila  and mouse models (Balemans et al., 2010; 
2013; 2014; Kramer et al., 2011; Parkel et al., 2013; Schaefer et al., 2009). Decreased levels of 
H3K9me2, the most studied marker for EHMT1 activity so far, have been found in particular in 
the  hippocampus and other brain regions of heterozygous Ehmt1 knockout mice (Ehmt1+/-), 
and were shown to lead to deviant neuronal morphology as well as aberrant dendritic spine 
formation, indicating alterations in plasticity in the  brain. Additionally, a  number of other 
epigenetic regulators have been found to play a  role in the  development of KS phenotypic 
spectrum (KSS). Kleefstra  and colleagues (Kleefstra  et al., 2012) described four genes which 
were found to be defective in KSS patients: MBD5, MLL3, SMARCB1 and NR1I3. Of these, MBD5, 
MLL3 and NR1I3 genetically interacted with EHMT1, and SMARCB1 influenced EHMT1 through 
its interaction with MLL3. EHMT1 is thus part of a larger epigenetic module underlying human 
cognitive disorders. 
ehmT1/ehmT2 in neurodegeneraTion
Disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease have been linked to 
age-related cognitive decline. This predominantly affects declarative, episodic and working 
memory, which is associated with decreased neuronal plasticity. The  epigenetic (dys)
regulation underlying aging is related to a  loss of open chromatin, mediated by reduced 
histone acetylation and by an increase in DNA  methylation (Akbarian et al., 2013) and 
repressive histone methylations (Fischer, 2014; Gräff et al., 2012a; Traynor and Renton, 2015; 
Wood et al., 2010). For example, histone methylation involves defects in axon myelination 
and white matter lesions which are found both in aging and in neurodegenerative diseases 
and, recently described, in KS patients (He et al., 2016: Yankner et al., 2008). Although, 
the involvement of histone methylation in aging has been proposed it remains unanswered 
to what extent histone methylation contributes to the progression of age related cognitive 
decline and associated changes in dendritic branching, spine density or LTP threshold, nor 
is it understood whether preventing the  activity of histone methyltransferases will restore 
the  loss of memory functions associated with aging. Specifically, in mouse models H3K9 
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methylation was found to increase with age, which was amplified further in an Alzheimer 
mouse model (3xTg-AD) (Walker et al., 2013). Recently a widespread loss of heterochromatin 
in tau-induced neurodegenerative Drosophila  and mouse models, and in human AD have 
also been observed (Frost et al., 2014). In particular, a reduction of H3K9me2 was observed 
in these neurodegenerative models, linking decreased H3K9me2 to neurodegeneration. As 
a  result, large-scale analyses from human AD brains revealed a  widespread transcriptional 
increase in genes that are silenced in controls. 
Further evidence for histone methylation in cognitive decline is found in Huntington’s 
disease, a  neurodegenerative disorder associated with gene expression changes early in 
the disease course (Borovecki et al., 2005; Sugars and Rubinsztein, 2003). It has been shown 
that H3K9me2 is increased in both patients and mouse models (Gardian et al., 2005; Ryu et 
al., 2006), and that acetylation is decreased. Interestingly, the application of HDAC inhibitors 
caused an arrest in neurodegeneration and lowered the  level of H3K9me2. The  resulting 
opening of chromatin leads to increased expression of glutathione S-transferase, striatin 
calmodulin-binding protein 3, ubiquitin-specific protease 29, proteosome subunit α type 3 and 
the proteosome 26 S subunit (ATPase 3), but it decreased expression of apoptotic genes, such 
as caspase 9, caspase 8/FADD-like apoptosis regulator, and proteasome 26 S subunit (non-
ATPase 10) (Gardian et al., 2005). This suggests that HDAC inhibitors work through histone 
acetylation and H3K9me2 to selectively modulate gene expression critical for neuronal survival 
and neuroprotection. 
Interestingly, there is some evidence that a  neurodegenerative process might also be 
involved in the  pathophysiology of KS.  A  ‘regressive’ phenotype has been observed in KS 
patients, which was associated with the GLP/EHMT1 gene. In particular, these patients showed 
signs of progressive apathy and showed multifocal subcortical signal abnormalities in MRI 
studies (Verhoeven et al., 2011). Thus, life-long decreased H3K9me2 levels, as in the  case in 
KS, could potentially lead to neurodegeneration at later stages in life. Longitudinal studies 
following KS patients will reveal whether this pathophysiology will be more widespread 
amongst KS patients. Studies using KS animal models have however, to date, not reported any 
neurodegenerative phenotype.
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The study of the contribution of epigenetic factors in controlling the expression of genetic 
programs related to cognition and development in response to environmental changes 
is a  novel and fascinating neurobiological frontier. The  aim of this thesis is to advance 
the  knowledge of the  epigenetic mechanisms that regulate dynamic changes of neuronal 
synaptic properties and in neurodevelopmental mechanisms related to cognition. The findings 
highlighted in this manuscript relate to the contribution of the epigenetic factor Euchromatic 
Histone Methyltransferase 1 (EHMT1) in regulating synaptic properties, cognition and 
neuronal development.
In chapter 2, I describe the  requirement of EHMT1 for a  specific form of non-hebbian 
synaptic plasticity, i.e. homeostatic plasticity. In this section, I describe how EHMT1 through 
histone methylation controls synaptic scaling in response to chronic changes in neuronal 
network activity. 
In chapter 3, I validate the results obtained in Chapter 2 in a human cellular model for KS. To 
this end I optimized a method to reliably produce excitatory neurons from hiPSCs derived from 
control volunteers and Kleefstra syndrome patients haploinsufficient for EHMT1.
In chapter 4, I highlight the  contribution of EHMT1 to cognition and adult hippocampal 
neurogenesis. In this chapter, I show that a mouse model for KS, haploinsufficient for Ehmt1 
displays an improved pattern separation and increased proliferation of neuronal stem cells in 
the adult dentate gyrus.
Finally, in chapter 5 I summarize and discuss the main findings of this thesis. 
24

two
1Department of Cognitive Neuroscience, Radboudumc, 6500 HB Nijmegen, the Netherlands; Donders Institute 
for Brain, Cognition, and Behaviour, Centre for Neuroscience, 6525 AJ Nijmegen, the Netherlands.
2Department of Molecular Biology, Faculty of Science, Radboud University, 6500 HB Nijmegen, the Netherlands.
3Department of Human Genetics, Radboudumc, 6500 HB Nijmegen, the Netherlands; Donders Institute for 
Brain, Cognition, and Behaviour, Centre for Neuroscience, 6525 AJ Nijmegen, the Netherlands.
4Department of Human Genetics, Radboudumc, 6500 HB Nijmegen, the Netherlands; Department of Molecular 
Developmental Biology, Faculty of Science, Radboud University, 6500 HB Nijmegen, the Netherlands.
5Department of Cognitive Neuroscience, Radboudumc, 6500 HB Nijmegen, the Netherlands; Department of 
Human Genetics, Radboudumc, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition, and 
Behaviour, Centre for Neuroscience, 6525 AJ Nijmegen, the Netherlands.
6Department of Cognitive Neuroscience, Radboudumc, 6500 HB Nijmegen, the Netherlands; Department of Human 
Genetics, Radboudumc, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition, and Behaviour, 
Centre for Neuroscience, 6525 AJ Nijmegen, the Netherlands. Electronic address: n.nadif@donders.ru.nl.
Neuron. 2016 Jul 20;91(2);341-55.
Doi: 10.1016/j.neuron.2016/06/003
two
hisTone meThylaTion By The KleefsTra 
syndrome proTein ehmT1 mediaTes homeosTaTic 
synapTic scaling
Marco Benevento1, Giovanni Iacono2, Martijn Selten1, Wei Ba1, Astrid Oudakker1, 
Monica Frega1, Jason Keller1, Roberta Mancini1, Elly Lewerissa1, Tjitske Kleefstra3, 
Hendirk G. Stunnenberg2, Huiqing Zhou4, Hans van Bokhoven5, Nael Nadif Kasri6
TWO 
aBsTracT
Homeostatic plasticity, a form of synaptic plasticity, maintains the fine balance between overall 
excitation and inhibition in developing and mature neuronal networks. Although the synaptic 
mechanisms of homeostatic plasticity are well characterized, the  associated transcriptional 
program remains poorly understood. We show that the  Kleefstra syndrome-associated 
protein EHMT1 plays a critical and cell-autonomous role in synaptic scaling by responding to 
attenuated neuronal firing or sensory drive. Chronic activity deprivation increased the amount 
of neuronal dimethylated H3 at lysine 9 (H3K9me2), the  catalytic product of EHMT1 and 
an  epigenetic marker for gene repression. Genetic knockdown and pharmacological 
blockade of EHMT1 or EHMT2 prevented the  increase of H3K9me2 and synaptic scaling up. 
Furthermore, BDNF repression was preceded by EHMT1/2-mediated H3K9me2 deposition at 
the Bdnf promoter during synaptic scaling up, both in vitro and in vivo. Our findings suggest 
that H3K9me2-mediated changes in chromatin structure govern a  repressive program that 
controls synaptic scaling.
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inTroducTion
Experience-dependent neuronal activity is crucial for promoting long-lasting modifications at 
functional synapses during development and in adulthood. To preserve neural network stability, 
a mechanism exists that maintains firing rates within a physiological range of activity. Neurons 
can continuously adapt their firing rates through synaptic and intrinsic cellular mechanisms, 
a  process generally referred to as homeostatic plasticity (Turrigiano and Nelson, 2004; 
Turrigiano, 2012). Disrupted homeostatic plasticity appears in several neurodevelopmental 
disorders, including Fragile X syndrome, Rett syndrome and Tuberous Sclerosis, suggesting 
that improper circuit refinement during development contributes to cognitive impairment 
(Cortés-Mendoza et al., 2013; Soden and Chen, 2010; Zhong et al., 2012).
Synaptic scaling, a  well-characterized form of homeostatic plasticity, stabilizes neuronal 
network activity by balancing excitation and inhibition. This occurs through bidirectional 
modulation of cell-wide synaptic strength, where prolonged unidirectional neuronal activity 
receives negative feedback (Turrigiano, 2012). An  important mechanism underlying synaptic 
scaling at glutamatergic synapses involves regulated trafficking of AMPA receptors into and 
out of the  post-synaptic membrane (Diering et al., 2014; Pozo and Goda, 2010; Turrigiano, 
2012). Chronic network activity elicits AMPA receptor removal, whereas chronic suppression 
increases synaptic AMPA receptor abundance (Goold and Nicoll, 2010). Mounting evidence 
indicates that the  intricate regulation of AMPA receptor trafficking during synaptic scaling 
requires de novo gene transcription and depends on intracellular Ca2+-signaling (Ibata et al., 
2008; Thiagarajan et al., 2005). Experiments have indeed shown that bidirectional scaling 
is prevented by the  transcription inhibitor actinomycin-D (Goold and Nicoll, 2010; Han and 
Stevens, 2009; Ibata et al., 2008). Also, chronic neuronal activity or suppression respectively 
activates or inactivates calcium/calmodulin-dependent protein kinase type IV (CaMKIV) (Goold 
and Nicoll, 2010; Ibata et al., 2008). This indicates that gene transcription through CaMKIV 
signaling plays a pivotal role in bidirectional scaling. Specifically, transcriptional repression of 
Arc and Bdnf is required for synaptic scaling up during chronic network suppression (Béïque et 
al., 2011; Gao et al., 2010; Rutherford et al., 1998; Shepherd et al., 2006).  
Since synaptic scaling requires gene transcription, a  picture is emerging that implicates 
epigenetic regulation in homeostatic plasticity.  Several studies have shown that DNA-
methylation at the  Bdnf promoter is dynamically regulated in an activity-dependent manner 
(Chang et al., 2010; Levenson et al., 2006; Lubin et al., 2008; Martinowich et al., 2003). Also 
methyl-CpG binding protein 2 (MeCP2) and Tet3 are required for synaptic scaling (Blackman et 
al., 2012; Qiu et al., 2012; Zhang et al., 2014; Zhong et al., 2012; Yu et al., 2015) and the REST/NRSF 
complex is required for intrinsic homeostatic plasticity induced by sustained electrical activity 
in hippocampal neurons (Pozzi et al., 2013). While evidence that epigenetic mechanisms are 
critical for synaptic scaling is mounting, it is currently unknown which chromatin modifications 
are involved and how they are regulated.
Disrupted epigenetic regulation is commonly found in neurological disorders such as 
intellectual disability (ID) (Kleefstra et al., 2014), autism spectrum disorder (ASD) (De Rubeis, 
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2014) and schizophrenia (McCarthy et al., 2014). Haploinsufficiency of the euchromatic histone-
lysine N-methyltransferase 1 (EHMT1) gene causes Kleefstra syndrome (Kleefstra et al., 2009; 
2006; 2012) and is associated with some cases of ASD (Talkowski et al., 2012) and schizophrenia 
(Kirov et al., 2012). EHMT1 (EHMT1) together with its paralog EHMT2 (EHMT2) form a chromatin 
remodeling complex that catalyzes the dimethylation of histone H3 at lysine 9 (H3K9me2), a PTM 
associated with transcriptional repression (Tachibana et al., 2005). Interestingly, H3K9me2 is 
an epigenetic mark that is dynamically regulated in the hippocampus and nucleus Accumbens 
during contextual fear memory formation, addiction and stress (Boulle et al., 2014; Chase and 
Sharma, 2013; Covington et al., 2011; Gupta et al., 2010; Gupta-Agarwal et al., 2012; 2014; Heller 
et al., 2014; Maze et al., 2010). Genetic and pharmacological manipulations of EHMT1/2 in vivo 
have also shown that EHMT signaling is important for long-term memory formation both in 
mouse and Drosophila (Balemans et al., 2013; Gupta-Agarwal et al., 2012; Kramer et al., 2011; 
Schaefer et al., 2009). 
Here, we report that H3K9me2 is bidirectionally regulated by chronic changes in neuronal 
activity. We show that EHMT1 and EHMT2 are part of a complex that regulates a transcriptional 
program essential for synaptic scaling. Specifically, EHMT1 and EHMT2 are required for 
the increase in H3K9me2 when network activity is chronically inhibited and for synaptic scaling 
up in vitro and in vivo. Moreover, we found that EHMT1 and EHMT2 repressed Bdnf expression 
during synaptic scaling up by increasing H3K9me2 at Bdnf promoter IV. We posit that EHMT1 
and EHMT2 act as cell-autonomous epigenetic regulators that govern a  repressive program 
required for synaptic scaling up. 
resulTs
neuronal activity elicits dynamic effects on synaptic scaling via h3K9me2
We first investigated whether chronic neuronal network manipulation alters the methylation 
levels of H3K4 (H3K4me1, H3K4me3), H3K9 (H3K9me2) or H3K27 (H3K27me3). We treated 
cultures of rat primary cortical neurons for 48 hours (h) beginning at 11 days in vitro (DIV) with 
either 1 µM tetrodotoxin (TTX) or 10 µM picrotoxin (PTX) to induce homeostatic scaling up or 
scaling down, respectively (Turrigiano et al., 1998). The fluorescence intensity of immunolabeled 
H3K9me2 (Vedadi et al., 2011) revealed that nuclear H3K9me2 increased significantly in 
TTX-treated compared to untreated neurons, whereas H3K9me2 decreased significantly in 
neurons treated with PTX (Figure 2.1A and 2.1B). In a  mixed primary culture, H3K9me2 was 
most prominently detected in MAP2-positive neurons (Figure 2.1A). Accordingly, we did not 
observe any network activity-dependent changes in H3K9me2 within MAP2-negative glial cells 
(Figure 2.1B), suggesting that changes in H3K9me2 were restricted to neurons.
Although we did observe less pronounced changes in H3K4me3 and H3K27me3, they were 
not bidirectionally correlated with synaptic scaling up or down (Figure 2.2).
Synaptic scaling is a  progressive process that develops gradually over a  time period 
of 48h (Ibata et al., 2008; Sutton et al., 2006). To evaluate the  temporal dynamics of H3K9 
dimethylation induced by TTX, we measured H3K9me2 fluorescence at sequential time points 
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after adding TTX. H3K9me2 fluorescence was significantly elevated by 12h, further enhanced 
at 24h, and plateaued from 36-48h after TTX treatment (Figure 2.3A). Synaptic scaling is also 
a reversible process (Goel and Lee, 2007; Goel et al., 2011); therefore, we investigated the effect 
of removing TTX on H3K9me2 in our neuronal cultures. Cultures were first treated with TTX 
for 48h, the  medium was then refreshed with pre-conditioned untreated culture medium, 
figure 2.1. EHMT1 is required for network activity dependent H3K9me2 dynamics. a) Representative 
confocal images of H3K9me2 immunoreactivity in untreated (NT) and neurons treated with PTX or TTX for 
48h. Scale bar 5µm. (continues next page). B) Quantitative analysis of H3K9me2 levels in neurons (MAP2 
positive) and glial (MAP2 negative cells) treated with PTX or TTX for 48h and untreated (NT). Data are 
represented as mean±SEM. ***, p<0.001; n=34-41; n.s., non significant; glia p>0.05; one-way ANOVA.
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figure 2.2. Changes in histone methylation marks during synaptic scaling. Representative images 
of H3K4me1, H3K4me3 and H3K27me3 immunoreactivity and relative intensity levels quantifications 
expressed as mean±SEM fold change from NT cultures. Scale bars, 20µm. **, p<0.01; ***; p<0.001. H3K4me1: 
NT, TTX, PTX, n=31-48. one-way ANOVA. H3K4me3: NT, TTX, PTX, n=24-30. one-way ANOVA. H3K27me3: 
NT, TTX, PTX, n=31-39. one-way ANOVA.
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and H3K9me2 fluorescence intensity was measured 48h later. Interestingly, after TTX was 
withdrawn, we found that H3K9me2 fluorescence in treated neurons returned to an intensity 
equal with untreated neurons (Figure 2.3B). 
Various protocols that reduce Ca2+
 
influx are used to induce synaptic scaling in cultured 
neurons. These include blocking L-type calcium channels or AMPA receptor function respectively 
with nimodipine or CNQX for 48h (Lee et al., 2013; Wierenga et al., 2005; Thiagarajan et al., 2005, 
Ibata et al., 2008). Either nimodipine or CNQX alone increased H3K9me2 fluorescence but they 
occluded the TTX-induced increase in H3K9me2 (Figure 2.4A and 2.4B). In contrast, blocking 
NMDA-dependent calcium influx with APV for 48h did not increase H3K9me2 nor was there 
a  cumulative effect when combined with TTX (Figure 2.4A and 2.4B) (Turrigiano et al., 1998). 
Furthermore, the TTX-induced increase in H3K9me2 was prevented (Figure 2.4A and 2.4B) when 
endoplasmic reticulum calcium reuptake was blocked by thapsigargin (Lee et al., 2013).
To identify Ca2+-dependent signaling pathways upstream of H3K9me2, we pharmacologically 
blocked CaMK signaling. Previous studies showed that chronic network suppression reduced 
CaMKIV- and CaMKK-mediated phosphorylation due to decreased intracellular calcium 
(Thiagarajan et al., 2005; Ibata et al., 2008). We used STO-609 to block CaMKK, which in turn 
inhibits CaMKIV (Ibata et al., 2008). STO-609 treatment increased H3K9me2 comparable to 
TTX treatment (Figure 2.4A and 2.4B), suggesting that TTX reduces CaMKK/CaMKIV signaling, 
and this pathway directly contributes to increased H3K9me2 during synaptic scaling up. 
Collectively, these experiments indicate that chronically increased or decreased neuronal 
activity bidirectionally alters H3K9me2 levels in cortical neurons. 
ehmT1 is required for the TTx-dependent increase in neuronal h3K9me2
Since EHMT1 catalyzes H3K9 dimethylation, we focused on the  role of EHMT1 in synaptic 
scaling up. We first evaluated whether EHMT1 is required for the TTX-dependent increase in 
figure 2.3. H3K9me2 increases after TTX treatment are gradual and reversible. a) Quantitative analysis 
of time course of H3K9me2 levels in TTX-treated neurons. Data are represented as mean±SEM. *, p<0.05; 
***, p<0.001; n.s., non significant; n=20-25; one-way ANOVA. B) Analysis of reversibility of TTX-induced 
H3K9me2 changes. H3K9me2 intensity expressed as mean±SEM fold change from NT cultures. ***, p<0.001; 
n=23-27; one-way ANOVA.
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H3K9me2 by designing GFP-expressing constructs to encode shRNA sequences (Ehmt1#1-4) 
that specifically knockdown EHMT1 in neurons (Figure 2.5A, 2.5B and 2.5C).
We sparsely transfected cortical cultures with either control vector or shRNA-expressing 
vectors (Ehmt1#1 or Ehmt1#2) at DIV 0. Cultures were then treated at DIV 11 with TTX for 48h. 
H3K9me2 fluorescence was measured in transfected (GFP+) and untransfected (GFP-) neurons 
figure 2.4. H3K9me2 respond dynamically to chronic variations in intracellular Ca2+ concentration. 
a) Representative images of H3K9me2 immunoreactivity levels in neurons treated with: TTX, nimodipine, 
STO-609, thapsigargin, APV and CNQX. Scale bars, 20µm. B) Quantitative analysis of H3K9me2 levels in 
conditions as indicated. Data are represented as mean±SEM, fold change from NT cultures. ***, p<0.001; 
n=28-50; n.s., non significant; two-way ANOVA. 
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and compared to untreated neurons. As expected, we found that TTX increased H3K9me2 
in GFP- and GFP+ neurons treated with the  control vector. Conversely, TTX did not increase 
H3K9me2 in neurons transfected with either of the  Ehmt1 hairpins (Figure 2.6A and 2.6C). 
Moreover, we observed that basal H3K9me2 fluorescence, before adding TTX, was significantly 
lower in neurons transfected with the Ehmt1 hairpins (Figure 2.6A and 2.6C). Importantly, co-
transfection of Ehmt1#1, which targets the 3’ UTR of the endogenous Ehmt1 mRNA, together 
with a  construct that over-expresses mouse Ehmt1 cDNA (Ehmt1-OE) restored both basal 
H3K9me2 levels and the TTX-induced increase (Figure 2.6A and 2.6C). 
Next, we pharmacologically blocked the methyltransferase activity of EHMT1 and EHMT2 
with UNC0638 (Vedadi et al., 2011). We treated neurons with UNC0638 in the  presence or 
absence of TTX and measured the  immunofluorescence intensity of H3K9me2. UNC0638 
blocked the increase in H3K9me2 by TTX (Figure 2.6B and 2.6C). We also found that UNC0638 
alone reduced the basal H3K9me2 levels, similar to Ehmt1#1 and Ehmt1#2 (Figure 2.6A, 2.6B and 
2.6C). These results suggest that EHMT1, through activity-dependent dimethylation of H3K9, 
functions as an epigenetic regulator of homeostatic synaptic scaling up.
ehmT1 is required for the TTx-dependent increase in mepsc amplitude
To determine if EHMT1 is required for homeostatic synaptic scaling up, we recorded miniature 
excitatory postsynaptic currents (mEPSCs) from untreated and TTX-treated neurons that were 
transfected with Ehmt1#1, Ehmt1#2 or control vector. Consistent with previous observations, 
TTX significantly increased mEPSC amplitudes recorded from untransfected and control 
neurons (Figure 2.7A and 2.7B)but not mEPSC frequency (Figure 2.8) (Hou et al., 2008; Kim and 
Ziff, 2014; Wierenga et al., 2006).
figure 2.5. Production and validation of shRNA against Ehmt1.  a) B50 
rat neuroblastoma cells were transfected with control, Ehmt1#1, 
Ehmt1#2, Ehmt1#3, Ehmt1#4 expressing vectors. Protein extracts 
were probed by immunoblotting with antibodies against EHMT1 
and g-tubulin. B) Primary cortical neurons were transduced with 
control, Ehmt1#1 and Ehmt1#2 expressing lentivirus at DIV1. Protein 
extracts were prepared at DIV 14 and were probed by immunoblotting 
with antibodies against EHMT1 and g-tubulin. c)  Quantification of 
the immunoblot signals. Data are represented as mean±SEM, n=3; ***, 
p<0.001; t-test.
a B
c
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figure 2.6. Neuronal H3K9me2 levels increase after TTX treatment depend on EHMT1 function. 
a)  Representative images of H3K9me2 immunofluorescence levels in neurons transfected with control 
vector; Ehmt1#1, Ehmt1#2, Ehmt1#1+ Ehmt1-OE, in untreated (NT) and neurons treated with TTX for 48h. 
Scale bars 5 µm. B) Representative images of H3K9me2 immunofluorescence levels of untreated or TTX-
treated neurons (48h) with UNC0638 (48h). Scale bars 5µm. c) Quantitative analysis of H3K9me2 levels in 
neurons transfected with control vector; Ehmt1#1, Ehmt1#2, Ehmt1#1+Ehmt1-OE, UNC0638, in untreated 
(NT) and neurons treated with TTX for 48h. Data are represented as mean±SEM, fold change from NT. *, 
p<0.05; ***, p<0.001; n=21-41; n.s., non significant; two-way ANOVA. 
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figure 2.7. TTX treatment induce an increase in mEPSC amplitudes in WT neuronal cultures. Representative 
mEPSC traces, cumulative plots and mean ± SEM amplitude bar graphs of cortical neurons, untreated 
(NT) or TTX-treated (TTX) (48h). a) Untransfected neurons NT, TTX, n=9-11, B) neurons transfected with 
a Control vector, NT, TTX, n=10-11. Vertical scale 25pA and horizontal scale 50ms.
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However, when EHMT1 was knocked down, mEPSC amplitudes did not increase in response 
to chronic TTX treatment (Figure 2.9A and 2.9B). We also found that neurons co-transfected 
with Ehmt1#1 and Ehmt1-OE had increased mEPSC amplitudes after TTX treatment, similar to 
control neurons (Figure 2.9C). Therefore, specific knock down of EHMT1 appears to prevent 
synaptic scaling up. We then recorded mEPSCs from neurons treated with either UNC0638 
alone or in combination with TTX. Inhibiting EHMT1/2 with UNC0638 alone for 48h had no 
effect on either mEPSC amplitude or frequency compared to untreated neurons, whereas 
synaptic scaling up was impeded in neurons co-treated with UNC0638 and TTX (Figure 2.9D, 
2.9E and 2.9F).  Collectively, these findings provide further evidence that EHMT1 is required for 
homeostatic scaling up of synapses.
Interestingly, we found that pharmacological inhibition or genetic knock down of Ehmt1, 
despite reducing basal H3K9me2 fluorescence (Figure 2.6A and 2.6C), did not affect basal mEPSC 
amplitude or frequency (Figure 2.9A, 2.9B, 2.9D, 2.9E and 2.9F). To investigate whether increasing 
H3K9me2 levels was sufficient to scale up synapses, we used the class-1 HDAC inhibitor MS-275. 
When used in combination with cocaine, MS-275 was shown to enhance Ehmt1/2 expression and 
subsequently raise H3K9me2 levels in the nucleus Accumbens (Kennedy et al., 2013). Treating 
neurons with MS-275 alone for 48h significantly increased H3K9me2 fluorescence (Figure 2.10A); 
however, it did not increase mEPSC amplitude (Figure 2.10B). We therefore propose that EHMT1 
acts as an epigenetic regulator which represses a genetic program required but not sufficient 
for homeostatic synaptic scaling up.
ehmT1 is required for surface ampa receptor expression upon  
TTx-induction
Previous studies have shown that neurons increase their mEPSC amplitudes by increasing 
the surface expression of AMPA receptors GluA1 and GluA2 (Diering et al., 2014; Gainey et al., 
2009). We performed live-cell fluorescent labeling of surface GluA1 and GluA2 and compared 
the  signal between control and TTX-treated neurons (Wierenga et al., 2005). TTX caused 
a significant increase in fluorescent puncta in control neurons but not in Ehmt1#2 transfected 
neurons (Figure 2.11). We conclude that Ehmt1 knock down prevents increased surface 
expression of AMPA receptors during synaptic scaling up, which supports our notion that 
EHMT1 protein is required for this process.  
figure 2.8. mEPSC frequencies in untransfected and control 
transfected neurons. Quantification of mEPSC frequency in 
indicated conditions. Data are represented as mean±SEM, 
untransfected NT, TTX, n=9-11; control vector NT, TTX, n=10-10. 
Data are represented as mean±SEM; n.s., non significant; two-way 
ANOVA. 
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figure 2.9. EHMT1 is required to increase the  mEPSC amplitude without altering mEPSC frequency in 
response to chronic network deprivation. Representative traces and quantification of mEPSC amplitudes 
from neurons transfected with a) shRNA Ehmt1#1, NT, TTX, n=10-11, B) shRNA Ehmt1#2, NT, TTX, n=8-8, c) 
co-transfected with shRNA Ehmt1#1+Ehmt1-OE neurons, NT, TTX, n=11-14, d) UNC0638 treated neurons 
NT, TTX, n=10-10. ***, p<0.001; n.s., non significant; two-way ANOVA. Vertical scale 25pA and horizontal 
scale 50ms. Quantification of mEPSC frequency in e) Ehmt1#1 NT, n=10-11 and Ehmt1#2 NT, TTX n=8-8 and 
f) Ehmt1#1+Ehmt1-OE NT, TTX, n=11-14 and UNC0638 NT, TTX n=10-10. Data are represented as mean±SEM; 
n.s., non significant; two-way ANOVA. 
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figure 2.10. Effect of HDAC class-1 inhibitor, MS-275, on H3K9me2 levels and synaptic transmission. 
a)  Representative images of H3K9me2 immunoreactivity (red) levels in neurons (MAP2 positive cells, 
gray) untreated or treated with TTX or MS-275. Scale bars 20µm. Quantitative analysis of H3K9me2 levels 
in untreated or TTX and MS-275 treated neurons. Data are represented mean±SEM fold change from NT 
cultures; n=34-55, ***, p<0.001; n.s., non significant; one-way ANOVA. B) mEPSC amplitude bar graphs from 
untreated neurons, TTX and MS-275 treated neurons. Data are represented mean±SEM; n=8; **, p<0.01; 
n.s., non significant; one-way ANOVA.
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figure 2.11. EHMT1 is required to increase surface AMPA receptor expression in response to TTX. 
Representative images of GluA1 and GluA2 surface immunoreactivity in control vector and Ehmt1#2 
transfected neurons, untreated (NT) or TTX-treated (TTX) (48h). Scale bar 5µm. Immunoreactivity intensity 
quantification analysis expressed as fold change from NT. *, p<0.05; ***, p<0.001; n.s., non significant. GluA1: 
Control vector NT, TTX n=8-10; Ehmt1#2 NT, TTX, n=8-8. GluA2: Control vector NT, TTX n=8-8; Ehmt1#2 
NT, TTX, n=8-8; two-way ANOVA.
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ehmT1/ehmT2 complex is required for synaptic scaling up
EHMT1 interacts with EHMT2 to form a functional complex that catalyzes H3K9 dimethylation 
(Tachibana et al., 2008; 2005).  Thus, the TTX-mediated increase in H3K9me2 may be caused by 
the modulation of gene or protein expression levels of EHMT1, EHMT2 or both. Alternatively, 
neuronal activity could change the  subcellular distribution of EHMT1/2, similar to histone 
deacetylases such as HDAC4 (Sando et al., 2012). To assess these possibilities, we analyzed 
the distribution of EHMT1 and EHMT2 after TTX treatment. EHMT1 and EHMT2 were primarily 
expressed in the  nucleus under normal conditions, and TTX treatment did not change their 
subcellular localization (Figure 2.12A and 2.12B). 
Next, we examined EHMT1 and EHMT2 protein and mRNA levels before and after TTX 
treatment. TTX caused a  significant increase in both the  short and long isoforms and total 
EHMT2 protein levels, but EHMT1 protein levels were unaffected (Figure 2.13A and 2.13B). 
Consistent with previous studies (Bateup et al., 2013a; Shepherd et al., 2006), we found that 
ARC protein levels were significantly reduced after TTX treatment (Figure 2.13A and 2.13B). 
figure 2.12. Subcellular expression of EHMT1 and EHMT2. a, B) Representative images of EHMT1 and 
EHMT2 immunostainings in primary cortical neurons and quantification of relative EHMT1 and EHMT2 
levels in the  cytoplasm versus nucleus in untreated and TTX-treated neurons. Data are represented as 
mean±SEM; n=22-23; n.s., non significant; t-test. Scale bars 20µm.
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figure 2.13. EHMT1 and EHMT2 protein levels dynamics after synaptic scaling up induction. a) Representative 
immunoblot images of EHMT1, EHMT2 short and long isoform (s and l) and ARC in untreated and TTX-
treated neurons (48h). B) Quantification of protein levels of EHMT1, EHMT2 (s, l and total bands) and ARC 
in untreated and TTX-treated neurons expressed as mean±SEM fold change from NT cultures. **, p<0.01; 
***, p<0.001; n.s., non significant; n=3-5; t-test. 
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Transcriptional regulation has been shown to occur as early as 4h after TTX treatment (Ibata 
et al., 2008). To determine when changes in EHMT1/2 occur, we profiled Ehmt1 and Ehmt2 
mRNA expression at two time points after TTX treatment (4h and 48h). Ehmt2 mRNA levels 
were significantly increased after 48h but not after 4h. Ehmt1 expression, however, did not 
change and was comparable to untreated neurons at both time points (Figure 2.14).
figure 2.14. EHMT1 and EHMT2 transcript levels 
dynamics after synaptic scaling up induction. 
Analysis of time course expression of Ehmt1 
and Ehmt2 mRNA in neurons after 0h, 4h and 
48h after treating neurons with TTX.  Changes 
in mRNA levels are expressed as mean±SEM fold 
change from untreated neurons. n=3; **, p<0.01; 
n.s., non significant; one-way ANOVA.
figure 2.15. EHMT1 interacts with EHMT2 during synaptic scaling up. a) H3K9 dimethyltransferase 
enzymatic assay expressed as mean±SEM fold change from NT cultures. **, p<0.01; n=3, t-test. B) Western 
blot of EHMT1 and EHMT2 input (1%) and after co-immunoprecipitation of nuclear cell lysates with 
antibody against EHMT1 and a mouse IgG, from NT or TTX-treated (48h) cortical cultures. Quantification 
of EHMT2/EHMT1 ratio expressed as mean±SEM. ***, p<0.001; n=7; t-test. 
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Since EHMT1 dimerizes with EHMT2 to form a functional complex (Tachibana et al., 2005; 
2008), we hypothesized that the TTX-dependent increase in H3K9me2 levels may result from 
an  enhanced interaction leading to higher enzymatic activity. First, we measured enzymatic 
activity using an ELISA-based assay for histone methyltransferase (HMT) and found increased 
HMT activity in nuclear extracts from TTX-treated neurons (Figure 2.15A). Next, using nuclear 
protein lysates, we co-immunoprecipitated EHMT2 with an  EHMT1 antibody. Similar to 
previous findings (Tachibana et al., 2005), EHMT2 co-immunoprecipitated with EHMT1 (Figure 
2.15B). Interestingly, Western blot analysis showed that TTX treatment significantly increased 
the interaction between EHMT1 and EHMT2 (Figure 2.15B).
Based on these results, we hypothesized that EHMT2 is also required for the  functional 
expression of homeostatic scaling up. We designed and validated two independent shRNAs 
(Ehmt2#1 and Ehmt2#3) to downregulate endogenous EHMT2 (Figure 2.16).
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Chronic TTX treatment failed to increase H3K9me2 levels and scale up in neurons transfected 
with either Ehmt2#1 or Ehmt2#3 (Figure 2.17A, 2.17B, 2.17C and 2.17D). 
Interestingly, we found that knocking down Ehmt2 specifically reduced mEPSC frequency 
but did not affect amplitude in basal conditions (Figure 2.17E), suggesting a specific function for 
EHMT2 in early synapse formation. Indeed, EHMT2- but not EHMT1-deficient cortical neurons 
showed fewer juxtaposing PSD-95/VGLUT puncta and hence fewer synapses (Figure 2.18A). 
However, neither Ehmt1 nor Ehmt2 knock down affected neurite outgroWTh (Figure 2.18B). 
Collectively, our data suggest that chronic network deprivation activates a repressive program 
whereby upregulated EHMT1-EHMT2 complex increases H3K9me2 and scales up synapses. 
ehmT1 is required for TTx-induced gene repression
Next, we sought to decipher the  genetic program that is associated with synaptic scaling 
up. We generated strand-specific RNA-Seq libraries from WT and Ehmt1#2-transduced 
neuronal cultures, with and without TTX-treatment. In Ehmt1#2 neurons, Ehmt1 transcript 
was significantly down-regulated (DEseq2, p<0.026, log
2
(fc)=-0.61), whereas Ehmt2 transcript 
remained unaffected (DEseq2, p<0.43, log
2
(fc)=-0.21). In the absence of TTX treatment, Ehmt1#2 
exhibited differential expression of a relative small number of genes, with an equal amount of 
down and upregulated genes (89 upregulated genes, and 88 down-regulated genes, DEseq2 
p<0.01, Figure 2.19A). TTX-treatment of WT neurons induced a larger change in the number of 
genes and Spearman correlations sharply segregated the untreated and TTX-treated conditions 
(301 genes, Figure 2.19B). 
TTX-treatment of WT neurons mostly triggered gene repression, since the  number of 
DOWN-regulated genes was approximately 7-fold higher than UP-regulated ones (263 against 
38, Figure 2.20A). Also, TTX treatment of Ehmt1#2 neurons led to a significant down-regulation, 
but only a  partial overlap was found with the  genes down-regulated in WT neurons (Figure 
2.20A left, 2.20B and 2.20C). UP-regulated genes were few in both conditions and the overlap 
was low (Figure 2.21A right).
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figure 2.16. Validation of Ehmt2 knockdown. Cortical neurons were transduced with Ehmt2#1, Ehmt2#3 
and control neurons. Western blot showing EHMT1, EHMT2 and γ-tubulin expression. Data are represented 
as mean±SEM, n=3; *, p<0.05; t-test.
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figure 2.17. EHMT2 is required for synaptic scaling up. a) Representative images of H3K9me2 
immunofluorescence levels in transfected neurons with hairpins Ehmt2#1 and Ehmt2#3. Scale bars 
5µm. B)  Quantitative analysis of H3K9me2 levels in indicated conditions, expressed as mean±SEM fold 
change from NT cultures. ***, p<0.001; n.s., non significant; control vector NT, TTX, n=41-41; Ehmt2#1 
NT, TTX, n=30-34; Ehmt2#3 NT, TTX, n=49-50; two-way ANOVA. c, d) Representative mEPSC traces (1s), 
cumulative plots and mEPSC amplitude bar graphs expressed as mean±SEM from Ehmt2#1 and Ehmt2#3 
transfected neurons, untreated (NT) or TTX-treated (TTX) (48h). Vertical scale, 25pA, and horizontal scale, 
50ms. Control vector NT, TTX, n=10-10 (Figure 2B); Ehmt2#1 NT, TTX, n=10-10; Ehmt2#3 NT, TTX. n.s., 
non significant; n=9-8; two-way ANOVA. e) mEPSC frequency bar graphs from transfected with shRNA 
Ehmt2#1 and Ehmt2#3. Data are represented as mean±SEM; n=9-10; *** p<0.001; n.s., non significant; 
two-way ANOVA. 
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figure 2.18. EHMT2 is required for synaptogenesis but does not affect neurite outgrowth. a) Representative 
images of VGLUT and PSD-95 colocalizing punctae immunolabeling in control and Ehmt1#2 and Ehmt2#1 
transduced neuronal. Data are represented as mean± SEM colocalized PSD-95/VGLUT punctae on a stretch 
of 10µm of dendritic length. n=20-23 neurons; **, p<0.01; one-way ANOVA. B) Mean neurite length was 
determined from data obtained by live cell imaging (IncuCyte) and plotted as a  function of time. Left, 
representative images at DIV 4 of cortical neurons transfected with control, Ehmt1#2 or Ehmt2#1 shRNA. 
Right, quantification of mean neurite length per neuron. Mean neurite length is not significantly different 
between conditions. n= 42-53 neurons, 3 independent experiments, multiple t-test. Scale bar represent 10µm.
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Interestingly, we found a  significant reduction in the  global TTX-induced repression 
of Ehmt1#2 neurons as compared to control neurons (p<5.8e-13, Figure 2.21A). Moreover, in 
Ehmt1#2 neurons, the TTX responsive genes showed significantly higher basal expression level 
(Figure 2.21B), suggesting that these genes are directly or indirectly controlled by EHMT1. 
Overall, these data indicate that in Ehmt1#2 neurons the TTX-induced repression is impaired, 
and suggests that a subset of TTX-responsive genes is EHMT1-dependent.
When looking in greater detail at individual genes, we found that ~30 % of the genes normally 
repressed in WT neurons by TTX were not repressed in EHMT1-deficient neurons (Figure 2.22A 
and 2.22C). This subset of genes can therefore be categorized as EHMT1-dependent. We 
performed GO enrichment analysis to gain insights into the  functional properties of TTX 
responsive genes (Figure 2.22B). Genes down-regulated by TTX treatment are implicated in 
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figure 2.20. EHMT1 knock down gene repression profile respond differently to network activity deprivation. 
a) Venn diagrams of differentially expressed genes at 48h following TTX treatment in WT and Ehmt1#2 
transduced neurons, as determined by RNA-seq, n=3 replicates, p<0.01. Left, amount of downregulated 
genes: in gray WT, 263 genes (184+79), and in blue Ehmt1#2, 156 genes (77+79). The intersection consists 
of 79 common genes. Right, number of upregulated genes: in gray WT, 38 genes (34+4), and in blue 
Ehmt1#2, 33 genes (29+4). B) The  intersection consists of 4 common genes.  Clustering of Spearman 
correlations (Complete linkage) segregates untreated Ehmt1#2 neurons from TTX–treated Ehmt1#2 
neurons (n= 3 samples per condition, p<0.01). c) Clustering of Spearman correlations (Complete linkage) 
for the  complete RNA-seq dataset and the  complete set of responsive genes (576 genes associated 
with either of the treatments/conditions). he main division splits TTX treated from untreated neurons. 
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figure 2.19. EHMT1-dependent gene repression program associated with synaptic scaling up. a) Clustering 
of Spearman correlations (complete linkage) partially segregates Ehmt1#2 samples from WT samples. 
A total of 177 dysregulated genes (89 UP-regulated and 88 DOWN-regulated) are determined by use of 
the  DEseq2 algorithm, which models the  sequencing noise with a  negative binomial distribution (n=3 
biological replicates, p<0.01). Color code represents Spearman correlation. B) Clustering of Spearman 
correlations (complete linkage) segregates for the TTX samples (48h) from NT samples in WT neurons. 
A total of 301 differentially regulated genes (38 UP-regulated and 263 DOWN-regulated) are determined by 
use of the DEseq2 algorithm (n=3 replicates, p<0.01). Color code represents Spearman correlation.
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figure 2.21. EHMT1 is required for the  repression of a  subset of genes after chronic TTX treatment. 
a) Boxplot representing the distribution of the log
2
(fc) for TTX DOWN- and UP-regulated genes in WT and 
Ehmt1#2 neurons. Wilcoxon signed-rank test, n=3, downregulation p<5.8e-13 and upregulation p<0.002. 
The upregulation p-value is lower because of the much smaller size of the gene set (38 vs. 263). Center line: 
median value; box limits: 25th and 75th percentile values; whiskers: maximum and minimum data points 
excluding the outliers; outliers: data points that are higher or lower than the 1.5 times the quartile (25th 
and 75th) values. B) Boxplot comparing the distribution of the log
2
(fc) caused by Ehmt1#2 transduction. 
The distributions show the genome-wide (all genes) and the subset of TTX-responsive genes (301 genes) 
effect in Ehmt1#2 transduced neurons. One-way ANOVA, n=3, p<7.0e-10. 
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Exception is the TTX treated Ehmt1#2-rep1 sample, which is clustered together with the untreated ones 
because of a stronger impairment of the TTX effect. Beyond the division in treated and untreated samples 
segregations are less clear mainly because the impact of Ehmt1#2 over the basal transcriptome is mild. 
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a  number of processes including: cholesterol biosynthesis (p<2e-6), potassium ion channels 
(p<6e-7), calcium signaling (p<4e-6), and synaptic transmission (p<4e-7). Interestingly, EHMT1-
dependent and EHMT1-independent genes segregated in different functional groups. More 
precisely, Ehmt1#2 neurons were unable to properly repress genes linked to ion channels 
(p<1.5e-5), synaptic-vesicle (p<1.4e-4) and calcium signaling (p<1.4e-5). On the  other end, 
c
a
45
TWO 
figure 2.22. Behavior of EHMT1-dependent and independent repressed genes. a) Behavior of TTX-
repressed genes (WT neurons) in Ehmt1#2 neurons. The pie chart represents all the genes (263, p<0.01) that 
are DOWN-regulated by TTX in WT neurons and divided in groups according to their DOWN-regulation 
in Ehmt1#2 neurons (based on their p-value). Dark gray group encompasses those genes that in Ehmt1#2 
neurons are downregulated by TTX with the  same strength as in WT neurons (p<0.01). Bright gray area 
features genes that are downregulated in Ehmt1#2, but with milder strength (p<0.05). Light blue delimits 
an intermediate area with uncertain behavior. Dark blue area isolates those genes that in Ehmt1#2 neurons 
are not downregulated after TTX treatment. B) Scatter plots comparing the  strength of transcriptional 
repression induced by TTX in WT and Ehmt1#2 neurons. Each dot represents a gene. P-values (n= 3 samples 
per condition) on the  axes are represented in Z score scale and decreasing numbers indicate stronger 
repression. Genes have been divided in four groups, associated with progressively impaired repression in 
Ehmt1#2 conditions as compared to WT conditions. Essentially, 50% of the genes (pie chart, dark gray and 
light gray) seem significantly repressed also in Ehmt1#2 conditions whereas 31% show (dark blue) a lack of 
repression. c) EHMT1-dependent and independent functional pathways related to homeostatic plasticity. 
The radar plot shows GO enrichment main terms and scores (Benjamini-adjusted p-values, represented in 
Z-score scale) for the 263 genes DOWN-regulated by TTX. Outer rings correspond to higher enrichment. 
Threshold for p<0.01 is indicated by the red circle.
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the  modulation of the  cholesterol biosynthesis was normal in Ehmt1#2 neurons (p<5.7e-11), 
suggesting that this specific pathway does not seem to be dependent on EHMT1.
chronic neuronal deprivation induces ehmT1/2-mediated repression of 
Bdnf 
Our RNA-Seq analysis revealed that Bdnf is misregulated in Ehmt1#2-transduced neurons. BDNF 
is a groWTh factor secreted from excitatory neurons that bidirectionally modulates homeostatic 
synaptic scaling and Bdnf (exon IX) repression is known to be required for synaptic scaling 
up (Rutherford et al., 1998; Desai et al., 1999; Lindskog et al., 2010). We therefore validated 
Bdnf IX mRNA expression, which is the most common Bdnf splicing variant (Aid et al., 2007) 
(Figure 2.23A). Together with Bdnf IX, we analyzed a set of EHMT1-dependent and -independent 
TTX-responsive genes, by performing real-time quantitative PCR (qPCR), including Arc, Rab3b 
and Prnp (Figure 2.23B). We were intrigued to find that in Ehmt1#2 transduced neurons, basal 
Bdnf IX mRNA was high and it was not repressed by TTX (Figure 2.23A), indicating that EHMT1 
is required for TTX-mediated repression of BDNF. Furthermore, UNC0638 also prevented Bdnf 
mRNA repression in neurons that were co-treated with TTX (Figure 2.23C).
Previous studies have shown that BDNF decreases in response to chronic network 
deprivation (Castrén et al., 1992; Karpova et al., 2010) and exogenous BDNF can block synaptic 
scaling up in pyramidal neurons (Desai et al., 1999; Rutherford et al., 1998). In addition, 
scavenging BDNF with TrkB-Ig was sufficient to induce synaptic scaling up in neuronal cultures. 
We therefore hypothesized that scavenging excess BDNF from Ehmt1#2 transduced neurons 
with a soluble form of TrKB receptor (TrkB-FC) could restore plasticity. First, we confirmed that 
BDNF blocked synaptic scaling up when neurons were co-treated with TTX, whereas BDNF 
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figure 2.23. EHMT1-dependent BDNF mRNA repression in response to chronic TTX treatment. a) qPCR 
analysis of Bdnf exon IX mRNA levels in control vectors and Ehmt1#2 transduced neurons treated with 
TTX (48h) and untreated. Data are represented as mean±SEM. ***, p<0.001; n.s., non significant; n=6; 
two-way ANOVA. B) Transcript levels analysis with quantitative PCR of Arc, Rab3b and Prnp genes from 
primary neuronal cultures transduced with control and Ehmt1#2 vectors and treated or untreated with 
TTX. Data are reprensented as mean±SEM fold change from control NT; n=6; *, p<0.05; **, p<0.01; ***, 
p<0.001; p<0.01; n.s., non significant; two-way ANOVA. c) Bdnf transcription levels in primary neurons 
treated with UNC0638 and/or TTX. Data are represented as mean±SEM; n=3; **, p<0.01; ***, p<0.001; n.s., 
non significant; two-way ANOVA. 
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alone did not have any effect on mEPSC amplitudes (Rutherford et al., 1998) (Figure 2.24A). 
Applying TrkB-FC alone to the neuronal cultures was sufficient to augment mEPSC amplitudes 
(Figure 2.24A). Synaptic scaling up was restored in Ehmt1 shRNA#2 transduced neurons when 
co-treated with TTX and TrkB-FC (Figure 2.24B). These results strongly suggested that synaptic 
scaling up is achieved at least in part through H3K9me2-mediated repression of BDNF. 
Previous studies have shown that BDNF expression is regulated by H3K9me2 occupancy at 
Bdnf promoter IV in the nucleus Accumbens when stimulated by cocaine (Maze et al., 2010) and 
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figure 2.25. EHMT1 and EHMT2 are specifically enriched at Bdnf promoter IV in response to chronic 
network deprivation. Chromatin immunoprecipitation with EHMT1 and EHMT2 antibody and qPCR analysis 
of the specified Bdnf promoter I, IV, VI, exon IX and Actin promoter from WT neurons treated with TTX 
(48h) and not, expressed as EHMT1 or EHMT2 % input recovery. Data are represented mean as mean±SEM, 
n=4-4; *, p<0.05; ***, p<0.001; n.s., non significant; t-test. Above the  bar graphs, Bdnf gene structure is 
depicted. Each blue box represents an  exon, while the  red boxes indicate the  promoter sequences 
analyzed and their position within the rat Bdnf gene.
figure 2.24. EHMT1 and EHMT2 repress BDNF expression to scale up synapses. a) Cumulative plots and mEPSC 
amplitude bar graphs of control neurons in conditions as indicated: untreated (NT), TTX, BDNF (25 ng/ml), 
BDNF+TTX or TrkB-FC (500 ng/ml). All drugs were added for 48h. Data are represented as mean±SEM. ***, 
p<0.001; n.s., non significant; n=10; one-way ANOVA. B) Cumulative plots and mEPSC amplitude bar graphs 
of Ehmt1#2 transduced neurons, in conditions as indicated: untreated (NT), TTX or TrkB-FC (500ng/ml) 
(48h). Data are represented as mean±SEM. ***, p<0.001; n.s., non significant; n=10; two-way ANOVA. 
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figure 2.26. EHMT1 and EHMT2 are required to specifically catalyze H3K9me2 enrichment at Bdnf promoter 
IV after chronic TTX treatment. a) Chromatin immunoprecipitation with H3K9me2 and qPCR analysis of 
the specified Bdnf promoter I, IV, VI, exon IX and Actin promoter from WT and transduced with Ehmt1#2 
neuronal cultures, untreated (NT) or TTX-treated (48h), expressed as H3K9me2 % input recovery. n=8-8 
B) Chromatin immunoprecipitation with H3K9me2 and qPCR analysis of the specified Bdnf promoter I, IV, VI, 
exon IX promoter from primary neuronal cultures transduced with control vector, Ehmt2#3 or treated with 
UNC0638 in untreated (NT) or TTX-treated condition, expressed as H3K9me2 % input recovery. n=8-4-4  
Data are represented as mean±SEM; *, p<0.05; ***, p<0.001; n.s., non significant; two-way ANOVA. Above 
the bar graphs, Bdnf gene structure is depicted. Each blue box represents an exon, while the red boxes 
indicate the promoter sequences analyzed and their position within the rat Bdnf gene.
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at Bdnf promoters I, IV and IXa in primary rat cortical neurons when stimulated by nicotine (Chase 
and Sharma, 2013). We immunoprecipitated chromatin (ChIP) with EHMT1 and EHMT2 antibodies, 
separately, and analyzed their enrichment at four Bdnf promoter regions. EHMT1 and EHMT2 
occupancy was specifically enriched at Bdnf promoter IV after TTX treatment (Figure 2.25). 
Next, we performed H3K9me2 ChIP-qPCR and confirmed that in TTX-treated WT neurons 
H3K9me2 occupancy was also increased at BDNF promoter IV, with no significant changes in 
other Bdnf promoter regions (Figure 2.26A). In contrast, H3K9me2 enrichment at the  Bdnf 
promoter regions in Ehmt1#2 transduced neurons was significantly lower compared to untreated 
WT neurons and lacked any kind of regulation after TTX treatment (Figure 2.26A). Accordingly, 
TTX did not alter H3K9me2 enrichment in either EHMT2-deficient or UNC0638-treated neurons 
(Figure 2.26B). Together, these results suggest that the EHMT1/2 complex modifies chromatin 
specifically at Bdnf promoter IV by increasing H3K9me2 during synaptic scaling up.
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ehmT1 is required for homeostatic synaptic scaling in vivo
Synaptic scaling can be induced in mice by ≥2 days of light deprivation (Desai et al., 2002; 
Goel et al., 2011; Maffei and Turrigiano, 2008). Light deprivation paradigms cause scaling up 
at glutamatergic synapses of layer II/III pyramidal neurons in the primary visual cortex (V1) 
of p21 and adult mice (Goel and Lee, 2007). This suggests that synaptic scaling plays a critical 
role in experience-dependent development. We evaluated H3K9me2 fluorescence and 
mEPSCs in V1 after 3 days of light deprivation (dark-reared (DR)), comparing wild type (WT) 
to Ehmt1+/- mice, since the Ehmt1+/- mouse recapitulates core features of Kleefstra syndrome 
(Balemans et al., 2013; 2014; 2010). H3K9me2 fluorescence was significantly higher in NeuN-
positive V1 layer II/III cells of WT DR mice (Figure 2.27A and 2.27B). In contrast, H3K9me2 was 
not significantly different between normal reared (NR) and DR Ehmt1+/- mice (Figure 2.27A 
and 2.27B).
In addition, basal H3K9me2 levels were significantly lower in Ehmt1+/- mice, compared to 
WT. These data support our observations in primary cortical neurons, where chronic activity 
deprivation induces an EHMT1-dependent increase in neuronal H3K9me2. 
To evaluate the effect of light deprivation on synaptic strength, we recorded mEPSCs in 
layer II/III pyramidal neurons from acute slices of V1. As previously shown (Desai et al., 2002; 
Goel et al., 2011; Maffei and Turrigiano, 2008), mEPSC amplitudes increased significantly in 
WT DR mice (Figure 2.28A and 2.28B). However, DR Ehmt1+/- mice did not show an increase 
in mEPSC amplitudes compared to NR Ehmt1+/- mice (Figure 2.28A and 2.28B). The  basal 
amplitude of the  mEPSCs was not different between the  genotypes nor did we find any 
differences in the frequency of mEPSCs between the genotypes or between the treatments 
(Figure 2.28C).
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figure 2.27. H3K9me2 levels increase in the primary visual cortex of light deprived mice. a) Representative 
confocal images of primary visual cortex showing H3K9me2 immunostaining and NeuN immunoreactive 
neurons from WT and Ehmt1+/- dark-reared (DR) and normal-reared (NR) WT and Ehmt1+/- mice. Scale bar, 
200µm, lower panel. B) Quantification of H3K9me2 immunofluorescence in the primary visual cortex layer 
II/III expressed as mean±SEM fold change. WT and Ehmt1+/- normal-reared (NR) and dark-reared (DR), 
4 animals each, n=16 frames each. Data are represented as mean±SEM; lower and top-most ***, p<0.001; 
n.s., non significant; two-way ANOVA. 
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figure 2.28. ehmT1 is required for synaptic scaling up in vivo in response to light deprivation in 
the mouse primary visual cortex. a, B) Mean mEPSC amplitude bar graph from whole-cell patch clamp 
recordings in the  layer II/III in the primary visual cortex and representative traces (1s) from dark-reared 
(DR) and normal-reared (NR) WT and Ehmt1+/- mice, n=11-16. Vertical scale 20pA, horizontal scale 20ms; 
Data are represented as mean±SEM; lower and top-most   ***, p<0.001; n.s., non significant; two-way 
ANOVA. c) Mean mEPSC frequency bar graph from whole-cell patch clamp recordings in the layer II/III 
in the primary visual cortex from dark-reared and normal-reared WT and Ehmt1+/- mice, n=11-16; Data are 
represented as mean±SEM; *, p<0.05; n.s., non significant; two-way ANOVA.
We showed in vitro that EHMT1 is required for synaptic scaling up and increases H3K9me2 
at Bdnf promoter IV (Figure 2.25 and 2.26). We next tested whether this was also the case in 
vivo. To this end, we measured mRNA expression (qPCR) and H3K9me2 enrichment (ChIP-
qPCR) in V1 from NR or DR WT and Ehmt1+/- mice (Figure 2.29A and 2.29B). Dark rearing did 
not affect Ehmt1 mRNA expression in WT mice, which was significantly lower in the Ehmt1+/- 
mice (Figure 2.29A). Instead, Ehmt2 mRNA expression increased significantly in DR WT 
mice (Figure 2.29A). Importantly, we found that dark rearing downregulated Bdnf  mRNA 
expression in WT mice, confirming previous observations (Karpova et al., 2010). Bdnf mRNA 
downregulation was also associated with an increase in H3K9me2 at Bdnf promoter IV (Figure 
2.29B). In contrast, DR Ehmt1+/- mice were unable to repress Bdnf expression (Figure 2.29B) 
and did not show an  increase in H3K9me2 at Bdnf promoters I, IV and VI (Figure 2.29D). 
In accordance with our in vitro data (Figure 2.23), Rab3b and Arc mRNA were significantly 
downregulated in DR WT mice but not in DR Ehmt1+/- mice (Figure 2.29C). In contrast, Prnp 
expression was significantly downregulated irrespective of the  genotype, indicating that 
Prnp regulation is independent of EHMT1 activity (Figure 2.29C). Similar to Bdnf, we found 
that Rab3b mis-repression in Ehmt1+/- mice correlated with insufficient H3K9me2 enrichment 
at the  Rab3b promoter (Figure 2.29D), suggesting that Rab3b expression depends on 
H3K9me2. This was not the case for Arc (Figure 2.29D). Finally, we did not find any significant 
changes in H3K9me2 levels at the Actin promoter, confirming the specificity of our results 
(Figure 2.29D). 
These results provide evidence that EHMT1 is required for homeostatic scaling up after 
sensory deprivation in vivo and suggest that the increase in mEPSC amplitudes parallels the rise 
in H3K9me2 levels, which represses Bdnf expression. 
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discussion
role of ehmT1 and ehmT2 in homeostatic plasticity
In this study, we provide several lines of evidence for the requirement of EHMT1 and EHMT2 for 
synaptic scaling up. First, sustained chronic deprivation or activation in primary cortical neurons 
increased or decreased H3K9me2 levels, respectively. Similarly, chronic visual deprivation 
resulted in increased H3K9me2 levels in layer II/III of the  mouse visual cortex. Second, 
the changes in H3K9me2 were pivotal for the  functional expression of synaptic scaling since 
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figure 2.29. EHMT1-mediated gene expression and H3K9me2 levels regulation after light deprivation 
in the mouse primary visual cortex. a) mRNA expression analysis in the primary visual cortex from dark-
reared (DR) and normal-reared (NR) WT and Ehmt1+/- mice (n=6-6) of Ehmt1, Ehmt2, and Bdnf IX. Data are 
represented as mean±SEM; lower and top-most *, p<0.05, **, p<0.01, ***, p<0.001; n.s., non significant; n=6-6; 
two-way ANOVA. B) Chromatin immunoprecipitation with H3K9me2 and qPCR analysis of the specified Bdnf 
promoter IV from WT and Ehmt1+/- mice, dark-reared (DR) and normal-reared (NR), expressed as H3K9me2 
% input recovery.  Data are represented as mean±SEM, n=6-6; lower and top-most   *, p<0.05; ***, p<0.001; 
n.s., non significant; two-way ANOVA. c) mRNA expression analysis in the primary visual cortex from dark 
reared and non WT and Ehmt1+/- mice of Rab3b, Prnp, and Arc. Data are represented as mean±SEM, n=6-6; 
*, p<0.05, **, p<0.01, ***, p<0.001; n.s., non significant; two-way ANOVA. d) Chromatin immunoprecipitation 
with H3K9me2 and qPCR analysis of the specified Bdnf promoter I, VI, Rab3b, Prnp, Arc and Actin promoters 
from WT and Ehmt1+/- mice, dark reared (DR) and non reared (NR), expressed as H3K9me2 % input recovery. 
Data are represented as mean±SEM, n=6-6; *, p<0.05; ***, p<0.001; two-way ANOVA. 
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genetic or pharmacological blockade of EHMT1/2 in vitro prevented the increases in H3K9me2, 
mEPSC amplitudes and synaptic expression of AMPA receptors. Furthermore, visual deprivation 
did not cause synaptic scaling up in Ehmt1+/- mice. Third, EHMT1 and EHMT2 occupancy as well 
as H3K9me2 deposition were increased at Bdnf promoter IV after chronic activity suppression. 
Consequently, loss of EHMT1 or EHMT2 prevented Bdnf repression during synaptic scaling up. 
Together our data indicate that EHMT1 and EHMT2 comprise a repressive epigenetic complex 
that is engaged during synaptic scaling up. 
Specifically, we found that chronic activity suppression upregulated EHMT2 protein levels, 
leading to more EHMT1/2 complex. Previous studies showed that H3K9me2 is catalyzed by 
the EHMT1-EHMT2 heteromer and is enriched at the promoters of silenced genes (Tachibana 
et al., 2002). A direct correlation between EHMT1/2 expression, H3K9me2 and gene repression 
was shown in studies where chronic cocaine abuse decreased EHMT1 and EHMT2 levels in 
the  nucleus Accumbens and this correlated with reduced H3K9me2 (Maze et al., 2010; Feng 
et al., 2014). Conversely, they also showed that increasing EHMT1 and EHMT2 expression by 
pharmacologically inhibiting HDAC1/2 with MS-275 in combination with cocaine treatment 
or by site-directed targeting zinc finger proteins fused with EHMT2 at the  ΔfosB promoter, 
caused an  increase in global and site specific H3K9me2 levels, respectively (Kennedy et al 
2013; Heller et al., 2014). Unlike other repressive marks, H3K9me2 does not correlate with 
a  terminally repressed state. Rather it functions as a  permissive tag to recruit a  machinery 
that adds more stable repressive markers such as H3K9me3, H3K27me3 and DNA methylation 
through HP1 recruitment (Mozzetta et al., 2014; Rothbart and Strahl, 2014; Yearim et al., 2015). 
Taken together a picture is emerging in which H3K9me2 could act as an epigenetic mark that 
represents the activity state of a neuronal network and could serve as a general mechanism for 
poising a state in the genome in a “ready to repress” mode. The H3K9me2 can thus be viewed as 
a dynamic regulatory histone mark as opposed to only a mark for heterochromatin. 
ehmT1 contributes to a genomic repressive program required for 
scaling up synapses
Consistent with previous studies, we found that 48h of activity suppression mainly resulted in 
gene repression (Bateup et al., 2013b). Interestingly, in EHMT1-deficient neurons, the  set of 
genes implicated in synaptic scaling showed aberrantly high basal expression and misregulated 
expression after TTX treatment. Essentially, there were fewer repressed genes compared to 
control neurons. GO analysis showed that the  misregulated genes clustered in functional 
groups related to ion channel activity, potassium channel activity, synaptic vesicles and calcium 
ion binding, suggesting that EHMT1 regulates these synaptic-scaling related pathways. BDNF is 
a central mediator of homeostatic excitatory synaptic plasticity in vitro and in vivo (Rutherford 
et al., 1998: Desai et al., 1999). Although Bdnf repression has been linked to synaptic scaling 
up, its transcriptional and epigenetic regulation has not been resolved (Rutherford et al., 1998; 
Yu et al., 2015). We show that EHMT1 and EHMT2 are both required to repress Bdnf expression 
during synaptic scaling up. Furthermore, we show that both are recruited specifically to Bdnf 
promoter IV after TTX treatment, leading to increased H3K9me2 at this promoter region, 
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in vitro and in vivo. EHMT1 and EHMT2 are recruited to chromatin via their ankyrin repeats and 
anchor to histone H3 N-terminals containing H3K9me1-2 (Collins et al., 2008). Interestingly, 
EHMT1 has a higher affinity for H3K9me1 compared to EHMT2. Since we found that only EHMT2 
but not EHMT1 protein levels increased after TTX, we propose a model in which EHMT1 serves 
as a scaffold, and during chronic network inactivity, EHMT1 may increase its association with 
EHMT2. Using co-IP experiments, we found that EHMT1 interacts significantly more with EHMT2 
after TTX, supporting the above scenario. However, we cannot exclude that other mechanisms, 
including PTMs, contribute to enhanced EHMT1/2 activity. 
An interesting finding from our studies is that scavenging BDNF excess in conditions 
of network deprivation restored the  ability to scale up synapses in EHMT1-lacking cortical 
neurons. However, in contrast to controls, we could not increase mEPSC amplitudes by 
scavenging BDNF from untreated Ehmt1 knockdown neurons. This may be caused by 
disengagement of parallel signaling pathways normally recruited in conditions of lowered 
intracellular calcium concentration, therefore leading to a  failure in synaptic scaling up in 
the Ehmt1 knockdown neurons. In addition, Bdnf levels are likely affected by other epigenetic 
mechanisms, such as DNA methylation and the activity of DNA methylation binding proteins, 
both of which rely on histone modifications (Yu et al., 2015).  This might explain why Bdnf 
upregulation was less pronounced in normally reared Ehmt1+/- mice compared to neurons 
in vitro, and might function as a  compensatory mechanism to keep Bdnf expression within 
a normal range during development.
Another intriguing possibility is that EHMT1/2 cooperates with the  Rett syndrome related 
protein MECP2 to repress gene transcription (Noh et al., 2012; Subbanna et al., 2014). MECP2 is also 
required for synaptic scaling (Blackman et al., 2012; Chao et al., 2007 and Qiu et al., 2012). A recent 
study suggests that MeCP2 is involved in the  repression of long genes, >100 Kb. Interestingly, 
the same authors showed an overlap in the long genes that were misregulated in DNMT3A and 
MeCP2 knock-down mice (Gabel et al., 2015; Guo et al., 2014). Elucidation of a parallel action would 
be interesting to trace a potential cooperation between EHMT1/2 and MeCP2 in the repression of 
genes required for synaptic scaling up based on their gene body length. 
Other genes that deserve attention are Arc and Rab3b. Both genes were repressed during 
synaptic scaling up, but not in EHMT1 lacking conditions. Although Arc mRNA levels failed 
to be repressed in EHMT1-deficient neurons, our experiments did not show any regulation 
of H3K9me2 levels at the  promoter region of Arc. This suggests that Arc is only indirectly 
regulated by EHMT1, potentially via BDNF (Bateup et al., 2013b; Ji et al., 2010; Shepherd 
et al., 2006). On the  contrary and similar to Bdnf, the  changes in H3K9me2 at the  Rab3b 
promoter were in line with a  direct regulation of Rab3b by EHMT1, during synaptic scaling. 
Interestingly, at the Drosophila neuro muscular junction (NMJ), Rab3b has been suggested to 
facilitate homeostatic up-regulation of presynaptic strength at a late stage of synaptic vesicle 
exocytosis by relieving an inhibitory control over homeostatic changes (Müller et al., 2011). In 
mammals Rab3b is enriched presynatically at inhibitory synapses where it is required for LTD of 
hippocampal inhibitory synapses (Tsetsenis et al., 2011) and thus could potentially be involved 
in scaling of gabaergic synapses during homeostatic plasticity. 
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Further studies should be addressed to characterize the full complement of epigenetic events 
that characterize synaptic scaling. In this regard sequencing for multiple histone modifications 
by analyzing in parallel different histone markers at different gene regulatory elements could 
provide further information of how the genome rearranges gene transcription in conditions of 
chronic deprivation in order to scale up synapses (Sun et al. 2012; Feng et al., 2014).
role of ehmT1 in Kleeftsra syndrome
Although loss of function of EHMT1 has directly been associated to Kleefstra syndrome, 
the nature of the synaptic deficits underlying the neurological symptoms has remained unclear. 
Previously we found that LTP was unaffected in Ehmt1+/- mice. We showed that pyramidal CA1 
hippocampal neurons of Ehmt1+/- mice had significant reductions in spine density, number 
of mature spines and dendritic arborization, indicating a  post-synaptic deficit (Balemans 
et al., 2013). Decreased mEPSC frequency and increased paired-pulse facilitation indicated 
a presynaptic locus of action for EHMT1. In our current study, we found normal basal synaptic 
transmission in primary cortical neurons after EHMT1 knockdown and in layer II/III neurons 
from acute slices of Ehmt1+/- mouse primary visual cortex. The discrepancies may derive from 
altered homeostatic regulation during development and/or could be attributable to brain 
region differences (Gupta-Agarwal et al., 2012; 2014). 
Unlike Hebbian plasticity, homeostatic plasticity has not been shown to directly influence 
learning and memory. However, the  inability of a neuronal network to adapt to long-lasting 
changes in activity might lead to imbalances during development. In this way, loss of EHMT1/2 
function could dynamically alter the responsiveness of a neuronal network to certain stimuli 
(Kennedy et al., 2013; Maze et al., 2010) and affect a wide range of cognitive functions. 
maTerial and meThods
electrophysiology
Whole-cell voltage clamp recordings were performed as previously described (Nadif Kasri et al., 
2011). In brief, for acute slices, mice (p23, Ehmt1+/+ and Ehmt1+/-) of both genotypes were anesthetized 
with isoflurane prior decapitation. 350 µm thick coronal slices were cut using a  microtome 
(HM650V, Thermo Scientific) in ice cold artificial cerebrospinal fluid (ACSF) containing: NaCl 87 
mM; Glucose 11 mM; Sucrose 75 mM; KCl 2.5 mM; NaH
2
PO
4
 1.25 mM; CaCl
2
 0.5 mM; MgCl
2
 7 mM; 
NaHCO
3
 26 mM continuously oxygenated with O
2 
95%/CO
2
 5% and incubated for 1h at 32°C after 
which they were allowed to cool down to room temperature (RT). For recordings, acute slices or 
primary cortical neurons attached to glass coverslips were transferred to the recording setup and 
incubated in recording (ACSF) containing: NaCl 124 mM, NaH
2
PO
4 
1.25 mM, KCl 3 mM, NaHCO
3
 
26 mM, Glucose 10 mM, CaCl
2 
2 mM, MgCl
2
 1 mM at continuously oxygenated with O
2 
95%/CO
2
 
5% at 30°C. Cells were visualized with an upright microscope (Olympus). Patch pipettes (5-7 MΩ) 
were made from borosilicate glass capillaries and filled with intracellular solution containing: 
CsMeSO
3 
115 mM; CsCl 20 mM; HEPES 10 mM; MgCl
2 
2.5 mM; Na
2
ATP 4 mM; NaGTP 0.4 mM; Na-
Phosphocreatine 10 mM; EGTA 0.6 mM (pH 7.2-7.3, 285-295 mOsm). 
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neuronal cultures and treatments
Low-density primary cortical neuronal cultures were prepared from embryonic day 18 (E18) 
rat pups as previously described (Nadif Kasri et al., 2011). Cell cultures were incubated in 
Neurobasal media (GIBCO-Invitrogen) supplemented with B27, penicillin, streptomycin, and 
L-glutamine at 37˚C in CO
2 
5%. Medium was half refreshed with unconditioned culturing 
medium every third day until treatment, which coincided with last medium renewal. At days 
in vitro 11 (DIV 11) low-density primary cortical neuronal cultures were treated for 48h (unless 
specified differently), with TTX (1 µM, Tocris 1069), PTX (10 µM, Tocris 1128), nimodipine (5 
µM, Tocris 0600), STO-609 (2 µM, Tocris, 1551), thapsigargin (1 µM, Tocris 1138), CNQX (40 
µM, Tocris 0190), APV (100 µM, Tocris 0106), UNC0638 (85 nM, Sigma-Aldrich U4885), 
MS-275 (5 µM, Sigma-Aldrich EP-S002) TrkB-FC (500 ng/ml, R&D systems 688-TK) and 
BDNF (25 ng/ml, PeproTech 450-02). Amaxa Rat Nucleofector kit (Lonza, VSPI-1003) was 
used to transfect primary neurons with shRNAs prior plating (DIV 0) as described by 
manufacturer. In different set of experiments neurons were transduced with lentiviruses 
co-expressing GFP and shRNAs.
immunocytochemistry
Primary neurons were fixed with paraformaldehyde 4%/ sucrose 4% in phosphate buffered 
saline (PBS 1X, Sigma Aldrich, P5493-1L) at 37˚C for 15min. After fixation cells were washed 
and permeabilized with PBS 1X and Triton 0.1%. Cells were blocked in normal goat serum 
(NGS) 10% and triton 0.05%. Primary antibodies were incubated in PBS 1X with NGS 5% and 
Triton 0.01% overnight at 4˚C. Secondary antibody incubation was done the  next day with 
Alexa-488 and Alexa-568 (Molecular Probes) for 1h at room temperature. Cells were washed 
in PBS 1X to remove secondary antibody excess and finally mounted using DAKO (DAKO, 
S3023) fluorescent mounting medium and stored at 4˚C. Signal intensity was measured with 
ImageJ and data was normalized to untreated condition (NT). Primary antibodies: H3K9me2 
(1:500, Millipore 07-441); H3K4me3 (1:500, Abcam ab8580); H3K4me1 (1:500, Diogenode CS-
037-100); H3K27me3 (1:500, Millipore 07-449); MAP2 (1:2000, Sigma-Aldrich M4403); EHMT1 
(1:100, Abcam ab41969); EHMT2/EHMT2 (1:100, Cell Signaling Technology 3306); PSD-95 (1:50, 
Thermo Scientific MA1-045); VGLUT (1:2000, Synaptic Systems 135302). Secondary antibodies: 
Goat anti-Mouse Alexa Fluor® 488 (1:2000, Invitrogen A11029), Goat anti-Mouse Alexa Fluor® 
568 (1:2000, Invitrogen A11031), Goat anti-Mouse Alexa Fluor® 647 (1:2000, Invitrogen A21236), 
Goat anti-Rabbit alexa fluor 488 (1:2000, Invitrogen A11034), Goat anti-Rabbit Alexa Fluor® 568 
(1:2000, Invitrogen A11031).
surface ampa receptor labeling and quantification
GluA1 (1:50, Millipore MAB2263) and GluA2 (1:50, Millipore MAB397) antibodies were diluted in 
culturing medium and incubated to primary neurons for 10 min in the incubator at 37˚C and 
CO
2 
5% (Zhou et al., 2008)
.
 Cells were fixed and stained as described above. Data was acquired 
from confocal images, analyzed by using ImageJ plug-in Foci picker 3D and 2D (Du et al., 2011), 
and normalized to untreated control vector. Two-way ANOVA with Bonferroni comparison 
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was used to compare between genotypes (control and EHMT1 knockdown) and the treatment 
(NT vs. TTX).
neurite outgrowth assay
Neurons were prepared and electroporated at DIV 0 with constructs expressing shRNA against 
Ehmt1 or Ehmt2. Neurons were imaged every 4h for 5 days using the Incucyte live cell imaging 
system (Essen Bioscience). Phase contrast images of the GFP positive neurons were analyzed 
online using a custom neurite outgrowth detection program, Neurotrack (Essen Bioscience).
immunohistochemistry 
Dark-reared and normal-reared mice were anaesthetized with Isofluran and transcardially 
perfused with PFA 4%/sucrose 4% in PBS 1X. Brains were removed and kept overnight in PFA 
4%/sucrose 4% in PBS 1X at 4˚C. 60 µm thick coronal slices in correspondence of primary visual 
cortex were derived using a vibratome V1000S (Leica) in ice-cold PBS. Free-floating slices were 
stored in PBS with 0.01% sodium-azide 0.01% at 4˚C prior IHC procedure. Slices were washed 
and permeabilized in TBS 1X with Triton 0.1% and blocked with 10% NGS 10%, NDS 10% for 2h at 
RT. Primary antibodies H3K9me2 (1:200, Millipore 07-441) and NeuN (1:300, Millipore ABN91) in 
TBS 1X-Triton 0.1% with NGS 5% and NDS 5% were incubated for 3 days at 4˚C on a horizontal 
shaker. Tissue was washed and incubated with secondary antibodies (Goat anti-Rabbit Alexa 
fluor 568; 1:1000, Invitrogen A11031 and Donkey anti-Chicken; 1:300, Jackson Immuno Research 
Laboratories 703-545-155) in NGS 5%, NDS 5% in TBS 1X-Triton 0.1% for 2h on a  horizontal 
shaking plate at RT in darkness. Free-floating slices were then washed with TBS 1X and mounted 
on a glass slide for imaging. Intensity signals were measured from confocal images. Two-way 
ANOVA with Bonferroni comparison was used to compare between genotypes (Ehmt1+/+ and 
Ehmt1+/-) and visual manipulation.
dna constructs and virus production 
For RNAi knockdown experiments, DNA fragments encoding short hairpin RNAs (shRNAs) 
directed against mouse/rat Ehmt1 mRNA (Ehmt1#1: 5’-GGTGATTGAGATGTTTAA-3’; Ehmt11#2: 
5’-GCCTCTTACTGGTGTTTCT-3’; Ehmt2#1: 5’-GGGTGGACTCTGACAGCAA-3’, Ehmt2#2: 
5’-CCCAGAGGACTATAAGTA-3’; Ehmt2#3: 5’-CGAAGCTCTAGCTGAACAG-3’ and control shRNA 
(src#1: 5’-GCTCACCCTTCCTACTCTC-3’) were cloned into the  pSuper vector (Oligoengine) and 
pTRIPΔU3-EF1α-EGFP lentiviral vector (Janas et al., 2006; Kasri et al., 2008). Empty vector was 
used as control vector. Mouse Ehmt1 cDNA over-expression was produced by combining two 
overlapping mRNA clones: D430022D24 containing mRNA AK084994 and IRAKp961B18195Q 
containing mRNA BC089302 under the control of a CMV promoter. Lentiviral supernatants were 
prepared, concentrated, and tittered as described (Janas et al. 2006; Kasri et al. 2008). Briefly, 
lentiviruses were generated by co-transfecting the transfer vector, the HIV-1 packaging vector 
Δ8.9, and the VSVG envelope glycoprotein vector into HEK293T cells, using calcium phosphate 
precipitation. Supernatants of culture media were collected 48h after transfection and centrifuged 
at 100,000x g to concentrate the viral vector. Viral particles were then stored at -80˚C until use.
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Western blot and co-immunoprecipitation
Proteins extracts were separated by SDS-PAGE, transferred on nitrocellulose membranes 
(BioRad, 170-4158) and probed with antibodies against EHMT1 (1:7000, Abcam AB41969), 
EHMT2 (1:500, Cell Signaling C6H3), Arc (1:500, Synaptic systems 156003), H3K9me2 (1:1500, 
Millipore 07-441), Histone 3 (D1H2) (1:4000, Cell signaling 4499) and g-Tubulin (1:10000, 
Sigma-Aldrich T-5326). Proteins were then detected with horseradish peroxidase-conjugated 
goat anti-Mouse (1:8000, Jackson ImmunoResearch Laboratories 115-035-062) and goat anti-
Rabbit (1:8000, Invitrogen G21234). Proteins were revealed with Super Signal West Femto 
and Pico ECL (Thermo Scientific, 34095 and 34080) and visualized with ChemiDoc Touch 
Imaging system (BioRad). Histone protein extraction was performed by using EpiQuickTM 
Total Extraction Kit (Epigentek, OP-0006-100). Nuclear and Cytoplasmic protein fractions 
were extracted EpiQuickTM Nuclear Extraction Kit I (Epigentek, OP-0002). Densitometric 
measures were acquired with Image lab 2.0 (Bio-Rad) and intensity signals were normalized 
to untreated condition. Unpaired student t-test was used to compare the  two treatments 
(NT vs. TTX).
For co-immunoprecipitation experiments EHMT1 (5 µg, Abcam AB41969) or mIgG1k (5 
µg, BD Pharmigen, 557273) antibodies were coupled to Protein A/G Plus-Agarose (12.5 µl 
beads, Santa Cruz Biotechnologies sc-2003) for 2h rotating at 4˚C. Whole protein extract 
from primary neurons were first obtained by cell lysis with lysis buffer (NaCl 300 nM; HEPES 
50 mM pH=8; IGEPAL CA-630 1%; Sodium-Deoxycholate 0.1%; DTT 1 mM; protease inhibitors 
EDTA-free 1 mM, Roche) while coupling beads and antibodies. Coupled Ab-beads were 
extensively washed with Protein binding buffer (PBB) (NaCl 150 mM; HEPES 50 mM pH=8.0; 
IGEPAL CA-630 0.25%; DTT 1 mM) to remove unbound antibody in excess. Salt and IGEPAL 
concentration was reduced from protein extract with Low salt buffer (NaCl 150 mM, HEPES 
50 mM pH=8.0, IGEPAL CA-630 0.25%; DTT 1 mM; protease inhibitors EDTA-free 1 mM). 
Subsequently, whole protein extract and Ab-beads complex were coupled and incubated 
overnight at 4˚C on a rotating wheel. After the beads-Ab-protein complex was extensively 
washed with PBB and washing buffer (NaCl 150 mM, HEPES 50 mM pH=8.0; DTT 1 mM), 
resuspended in Laemni buffer. Half of the sample was used for Western blot against EHMT1, 
the other half for Western blot against EHMT2. 
Densitometric measures were acquired with Image lab 2.0 (Bio-Rad) and intensity signals 
were normalized to untreated condition. Unpaired student T-test was used to compare the two 
treatments (NT vs. TTX).
rna-isolation primary cortical cultures
Total RNA was isolated from cultured neurons with NucleoSpin RNA (Macherey-Nagel 
740955.50) according to the supplied protocol. Concentration and purity of the RNA samples 
was determined using Nano drop ND1000. Total RNA (500 ng) was reverse transcribed (RT) 
with iScriptTM Reverse Transcription Supermix for RT-qPCR (Bio-Rad 170-8840) according to 
manufacturer instructions.
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rna-isolation from primary visual cortices
For qPCR in vitro and in vivo total RNA was obtained from either primary neuronal cultures or 
from biopsies of primary visual cortices by using QiAzol (Qiagen, 79306), followed by Phenol/
Chloroform RNA extraction. Subsequently RNA was purified with RNeasy Lipid Tissue Mini 
Kit (Qiagen, 74804) and DNA digested with DNase (Qiagen, 79254). Retrotranscription was 
performed to obtain cDNA with iScriptTM Reverse Transcription Supermix for RT-qPCR (Bio-Rad 
170-8840) according to manufacturer instructions.
Whole genome rna sequencing and analysis
2000 ng of Total RNA were treated with the Ribo-Zero rRNA Removal Kit (Human/Mouse/Rat; 
Illumina MRZH11124). Depleted RNA was precipitated 1h at -80˚C in three volumes of ethanol 
plus 1 µg of glycogen. RNA was then washed and resuspended in 36 µl of RNase free water. 
RNA fragmentation buffer (NEBNext® Magnesium RNA Fragmentation Module, E6150S) was 
added to the solution and the RNA was fragmented by incubation at 95˚C for 3min. Reverse 
transcription: cDNA first strand synthesis was performed with random examer primers. cDNA 
second strand synthesis was performed with dNTPs, to ensure strand specificity. 
The RNA-seq library was synthetized with KAPA Hyper prep kit (KK8504): a treatment with 
USER enzyme (NEB, M5505L) was added to digest the unspecific strand. The libraries were pooled 
(4/lane) and sequenced on the illumina HiSeq, which yielded approximately 40 million single-
end reads per sample. The RNA-seq libraries were mapped with GSNAP, gene expression counts 
were calculated with a custom C++ script and DEseq2 was used to call the dysregulated genes. 
The GO enrichments were calculated in the gene David website (http://david.abcc.ncifcrf.gov/) 
The  Z-scores of Figure 2.22C were calculated by fitting the  local distribution of the  variable 
log2(TTX
i
/untreated
i
) against the  variable log2(TTX
i
+untreated
i
), where TTX
i 
and untreated
i 
represent the number of tag counts for the i-th transcript. RNA-Seq data are deposited in GEO 
ID: GSE68960. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68960.
GEO data: Excel tables including the  normalized read counts for all the  samples, as well 
as the  DEseq2 p-values for each of the  comparisons. The  normalized counts are found in 
the columns. The values in these columns represent the DEseq-normalized counts multiplied 
by 42 (bp coverage of one tag). Therefore, they represent the normalized total numer of bp 
sequenced for each transcript. There are 5 pair-wise comparisons of expression and each has 
its table. WT_ttx and shrna_ttx for the study of ttx effect in WT samples or transduced sampes. 
Startpoint_WT_shrna_VS_WT for the effect of shrna alone on WT neurons. Endpoint_ttx_shrna_
VS_ttx for the effect of shrna on the TTX treated samples. Rattus_shrna_total_6vs_6_effect for 
the effect of shrna regardless to the TTX treatment. Gene David GO enrichments for the TT 
down-regulated genes (Down-reg), their shrna blocked subset (Blocked_shrna) and shrna 
independent subset (Common).
chromatin immunoprecipitation (chip)
Cell cultures and primary visual cortices were cross-linked with formaldehyde to 
immunoprecipitate H3K9me2 at a final concentration of 1% for 9min at room temperature. For 
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EHMT1 and EHMT2 chromatin immunoprecipitation primary neuronal cultures were cross-linked 
priory with disuccinimidyl glutarate (DSG) 2 mM for 45min room temperature and followed by 
formaldehyde 1% for 9min at RT. Glycine 125 mM, was added to stop crosslink reaction. Cells 
were washed and harvested in PBS 1X with 1 mM protease inhibitors EDTA-free. Cells were then 
lysed in lysis buffer (Tris HCl 10 mM, pH=7.5; NaCl 10 mM; IGEPAL-CA630 0.2%; Triton 0.2%; EDTA 
1 mM, pH=8.0; EGTA 0.5 mM, pH=8.0; protease inhibitors EDTA-free 1 mM) for 10min rotating 
at 4˚C. Pelleted nuclei were washed in buffer C (NaCl 150 mM; EDTA 1mM, pH=8.0; HEPES 50 
mM, pH=7.6; protease inhibitors EDTA-free 1 mM) for 10min rotating at 4˚C and resuspended 
in sonication buffer (HEPES 20 mM, pH=7.6; SDS 1%; protease inhibitors EDTA-free 1 mM) and 
sonicated with Bioruptor Power-up (Diagenode) to shear DNA into 150-300bp fragments. 
Chromatin was precleared with Dynabeads Protein A  and G (Life Technologies, 10003D and 
10001D) for 2h rotating at 4˚C. Immunoprecipitated with H3K9me2 (2 µg/reaction, Abcam 
ab1220), EHMT1 (5µg/reaction, Abcam Ab41969) and EHMT2 (5 µg, Cell Signaling Technology 
3306) overnight rotating at 4˚C. Beads were washed twice in buffer 1 (SDS 0.1%, sodium-
Deoxycholate 0.1%; Triton 1.0%; NaCl 150 mM; EDTA 1 mM; EGTA 0.5 mM, pH=8.0;  HEPES 20 
mM), once in buffer 2 (SDS 0.1%; Sodium-Deoxycholate 0.1%; Triton 1.0%; NaCl 500 mM; EDTA 
1 mM, pH=8.0; EGTA 0.5 mM, pH=8.0; HEPES 20 mM), once in buffer 3 (LiCl 250 mM; Sodium-
Deoxycholate 0.5%; IGEPAL-CA630 0.5%; EDTA 1 mM, pH=8.0; EGTA 0.5 mM, pH=8.0; HEPES 20 
mM), twice in buffer 4 (EDTA 1 mM, pH=8.0; EGTA 0.5 mM, pH=8.0; HEPES 20 mM) and eluted 
in elution buffer (SDS 1%;  NaHCO
3 
0.1M) rotating at RT for 20min. Eluate was de-crosslinked in 
elution buffer with 24 µg proteinase-K and NaCl 200 mM for 4h at 65˚C and DNA material was 
cleaned with NucleoSpinâ Gel and PCR Clean-up (Macherey-Nagel) according to manufacturer 
instructions. DNA was resuspended in water and qPCR was performed. ChIP-qPCR results are 
expressed as percentage of IP/input signal (% input). Unpaired student T-test was performed to 
compare the NT and TTX % EHMT1 and EHMT2 recovery from input for each of the promoters 
separately. Whereas two-way ANOVA was used to compare % H3K9me2 recovery from input to 
compare between WT and Ehmt1#2 transduced neurons untreated and TTX-treated. 
list of primers designed to amplify raT promoter regions (chip)
name sequence
Bdnf p i fw GTGCCTCTCGCCTAGTCATC
Bdnf p i rev CTGAGCCAGTTACGTGACCA
Bdnf p iv fw AGGGATTGGGGATAAACTAGACTC
Bdnf p iv rev CACGCAAGTCCCTGAACTC
Bdnf p vi fw GGAATTAGGGATACCCCAAGG 
Bdnf p vi rev TTATTTAGCTCTTCGGTTGAGCTTC 
Bdnf exon ixa fw TGGGTCACAGCGGCAGATAAAAAG 
Bdnf exon ixa rev TAAGGGCCCGAACATACGATTGG
Actin Fw CTCGAGCCATAAAAGGCAACT
Actin Rev AAAATGCTGCACTGTGCGG
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Quantitative chip-qpcr (qpcr) analysis 
Each decrosslinked gDNA immunoprecipitated sample was amplified using SYBR Green 
(Promega) on the 7500 fast Real-time PCR system (Applied Bio-systems Life Technologies). Every 
reaction carried 3 µl gDNA, 0.8 µM primers in a final volume of PCR mix. Each cycle consisted of 
denaturation at 95˚C for 15s, annealing and extension at 60˚C for 60s. The primers used for this 
study are listed in table. For data analysis, the ratio between the dilutions of ChIP-ed material 
over the input times the amount in µl loaded of input over ChIP-ed times 100 was used. As control 
Actin was used as a constitutively expressed gene to compare to a gene not regulated by either 
EHMT1, EHMT2 and H3K9me2. All data are expressed as mean ± SEM, statistical comparisons 
were performed by t-test for EHMT1 and EHMT2 separately, and H3K9me2 two-way ANOVA was 
used to compare the treatments and the genetic manipulations used for this study. Below list of 
primers used for ChIP-qPCR to amplify rat and mouse promoter regions.
Quantitative pcr (qpcr) analysis 
Each cDNA sample was amplified using SYBR Green (Promega) on the  7500 fast Real-time 
PCR system (Applied Bio-systems Life Technologies). Every reaction carried 5 µl cDNA, 0.8 
µM primers in a final volume of PCR mix. Each cycle consisted of denaturation at 95˚C for 15s, 
annealing and extension at 60˚C for 60s. The  primers used for this study are listed in table. 
For data analysis Livak Method was used (Livak and Schmittgen, 2001), PPIA was used as 
an endogenous control (housekeeping gene) to normalize each sample. All data are expressed 
as mean±SEM, statistical comparisons were performed by two-way ANOVA. Below list of 
primers used for qPCR to amplify rat and mouse gene regions.
list of primers designed to amplify mouse promoter regions (chip)
name sequence
Bdnf p i fw CAAAATAGGGCAGCGACTCT
Bdnf p i rev CTGAGCGAAAAGGTGTAGGC
Bdnf p iv fw TGTGGAGGTGGAGAAGAACA
Bdnf p iv rev CTCCAATCCCTCCATCTTCA
Bdnf p vi fw CTTTGTGTGGACCCTGAGGT
Bdnf p vi rev TGCAGTCCCACAACTTCTCA
Rab3b fw CAACCCATCTTCAGCCAGAG
Rab 3b rev TCGGATAAGAGCTGGCTCAC
Actin Fw CTCGAGCCATAAAAGGCAACT
Actin Rev AAAATGCTGCACTGTGCGG
Prnp Fw GATCAGCAGACCGATTCTGG
Prnp Rev ACGACGGAAGGCTGAGTG
Arc Fw GGAGGAGCTTAGCGAGTGTG
Arc Rev AGCATAAATAGCCGCTGGTG
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histone methyltransferase enzymatic assay
Histone H3 lysine 9 methyltransferase activity of EHMT1/2 on H3K9me2 was measured using 
EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit (H3K9) (EpiGentek P-3003-1) 
following manufacturer instructions. An ELISA plate reader at 450 nm (Perkin Elmer VictorTM 
list of primers designed for qpcr experiments targeting mouse gene regions
gene name sequence
Ehmt1 fw AAGAGACCAAGCAGGATTGC
Ehmt1 rev TGTGGAACCTTCATCAGCAG
Ehmt2 fw CATGTCCAAACCTAGCAACG
Ehmt2 rev GAAGTCACCTTCCCCAGATG
Bdnf exon ixa fw GCGCCCATGAAAGAAGTAAA
Bdnf exon ixa rev TTCGATGACGTGCTCAAAAG
Arc fw ACCAGTGAAGAAGAGCAGAGC
Arc rev CCTTGAGACCTGGTGTCATTC
Rab3b Fw TGGCCCCAGCTACAGATACT
Rab3b Rev GTAGGAGGAGGGGCTTGGTA
Prnp Fw CCAAGGAGGGGGTACCCATA
Prnp Rev CCCAGTCGTTGCCAAAATGG
Ppia Fw AAGGGTTCCTCCTTTCACAG
Ppia Rev CCATTATGGCGTGTGAAGTC
list of primers designed for qpcr experiments targeting raT gene regions
gene name sequence
Ehmt1 fw CTTGGACGCAGTGAAGTACC
Ehmt1 rev CGTCATAGTGGCCTTTCTTG
Ehmt2 fw ACGCGTACTCTGTGGATGAG
Ehmt2 rev TCAGCTAGAGCTTCGACTTCAG
Bdnf exon ixa fw GAGAAGAGTGATGACCATCCT
Bdnf exon ixa rev TCACGTGCTCAAAAGTGTCAG 
Arc fw ACGACACCAGGTCTCAAGC
Arc rev AGGCAGCTTCAAGAGAGGAG
Rab3b Fw GCAGAGCAACTTGGGTTTGA
Rab3b Rev TCTTATCGCAGATGGCGTCC
Prnp Fw CCAAGCCGACTATCAGCCAT
Prnp Rev GCTTTTTGCAGAGGCCAACA
Ppia Fw AAGGGTTCCTCCTTTCACAG
Ppia Rev CCATTATGGCGTGTGAAGTC
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X3) was used to read the methyltransferase activity.  The results were normalized against NT 
neurons and analyzed by unpaired student t-test. 
animals, genotyping and dark rearing.
For cell cultures, female Wistar Rat were used as described (Watabe-Uchida et al., 2006). For 
visual experience deprivation experiments we used Ehmt1+/- heterozygous and Ehmt+/+ wild 
type mice backcrossed in C57Bl6/J background (Balemans et al., 2010). P21 heterozygous and 
WT littermate mice were dark-reared in complete darkness for 3 days and compared to both 
genotypes normal-reared animals. All procedures involving animal experimentation were 
approved by the Animal Care Committee of the Radboudumc, The Netherlands, conforming 
to the guidelines of the Dutch Council for Animal Care and the European Communities Council 
Directive of 24 November 1986 (86/609/EEC). 
imaging
Confocal images were acquired using a  Fluoview FV1000 confocal microscope (Olympus). 
Epifluorescent images were taken with Zeiss Imager 2.1. All histone methylation intensity 
data and Western Blot intensity signal measures were generated by using ImageJ and Image 
Lab 2.0 (Bio-Rad), respectively. All conditions were acquired with the  same settings (laser 
power % and/or exposure time) in order to compare signal intensities between the different 
experimental conditions.
electrophysiology acquisition and analysis
mEPSC races were recorded using a Multiclamp 700B amplifier (molecular devices), sampled 
at 10 kHz and filtered at 2 kHz. Cells were excluded from analysis if the  access resistance 
exceeded 20 MΩ. mEPSCs were recorded in the  presence of TTX (1 µM) and PTX (100 µM). 
Miniature recordings were analyzed using Mini Analysis Program (Synaptosoft, http://www.
synaptosoft.com/MiniAnalysis/). mEPSC amplitudes and frequencies were statistically tested 
against untreated control vector or normal-reared Ehmt1+/+ by using two-way ANOVA with 
Bonferroni comparison. 
data acquisition and statistical analysis 
Comparisons between immunohistochemical, immunocytochemical, western blotting, qPCR, 
mEPSC amplitudes and frequencies, were performed based on the  number of means to 
compare. The H3K9me2 immunohistochemical intensity signal in WT and Ehmt1+/- mice dark 
and normal-reared were acquired by dividing the layer II/III primary visual cortical column in 16 
frames. The intensity signals were measured from every frame and averaged across n=3 animals 
within the  same genotype and treatment. A  Two-way ANOVA was used to test differences 
between the  genotypes and the  treatment in H3K9me2 immunostaining intensity, therefore 
yielding to n=64 in the F-value. Analysis of two sets of measurements were performed by using 
unpaired Student t-Test. Multiple sets of measurements were analyzed by one-way ANOVA 
and further analyzed with Bonferroni post-hoc comparisons. Unpaired two-way ANOVA 
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comparison was used when two independent variables (e.g. genotype and treatment) were 
considered in the analysis of only one dependent variable, with Bonferroni post-hoc test. All 
data is expressed as mean±SEM. Statistical significance: (*, p<0.05; **, p<0.01, ***, p<0.001). For 
RNA-sequencing t-test and negative binomial (DEseq2) were used.
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aBsTracT
We recently showed in rodent models that the KS-associated protein EHMT1 plays a critical and 
cell-autonomous role in synaptic scaling by responding to attenuated neuronal firing or sensory 
drive. To functionally determine whether EHMT1 is required for homeostatic synaptic scaling 
in human we investigated cortical neurons from a healthy individual and an individual with KS. 
For this, we adapted a protocol to rapidly and reliably produce a homogeneous population of 
upper layer cortical neurons from human induced pluripotent stem cells. We show that also in 
humans EHMT1 is required for synaptic scaling, indicating that the epigenetic and homeostatic 
role of EHMT1 is evolutionarily conserved and may contribute to KS. 
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Functional assays in neurons-derived From iPscs From Ks Patients
inTroducTion
Haploinsufficiency of the  Euchromatic Histone Methyl-Transferase 1 (EHMT1) gene is one of 
the major causes of Kleefstra syndrome (KS) (Kleefstra et al., 2006, 2012), a rare disorder disease 
associated with intellectural disability (ID) and Autism spectrum disorders (ASD). Recently, 
genetic interference with EHMT1 function was shown to give rise to improper neuronal circuitry 
refinement during cortical neuronal network development (Martens et al., 2016). Circuit 
refinements depends on synaptic scaling, a  homeostatic plasticity mechanism that plays an 
important role in shaping neuronal connectivity during embryonal and early post-natal periods 
(Turrigiano et al., 2008). Homeostatic synaptic scaling is a  global compensatory mechanism 
that maintains neuronal excitability within a physiological range of activity, relative to network 
activity. This is achieved by altering the  synaptic strength via regulation of the  a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor abundance at the post-synaptic 
terminal (Turrigiano et al., 1998). Several reports describe that synaptic scaling is disrupted 
in neurodevelopmental disorders like Rett-syndrome, Fragile X and Tuberous sclerosis (Qiu 
et al., 2012; Soden et al., 2010; Bateup et al., 2013 a; b). In Chapter 2, we showed that EHMT1 
plays an important role in regulating synaptic scaling up in response to neuronal network 
activity deprivation, in rodent models in vitro and in vivo (Benevento et al., 2016). In particular, 
we showed that EHMT1 reacts to chronic neuronal inactivity by increasing di-methylation 
of the  Lysine 9 of histone H3 (H3K9me2) levels specifically at gene promoter IV of Bdnf, 
subsequently leading to repression of Bdnf. the repression of BDNF was previously shown to 
be necessary to increase miniature excitatory post-synaptic currents (mEPSCs) amplitudes in 
response to neuronal network deprivation (Rutherford et al., 1998). 
To identify whether this mechanism can also be observed in a human neurons, we generated 
excitatory cortical neurons from human induced pluripotent stem cells (hiPSCs) of KS patients 
and healthy individuals. hiPSCs allow to model neurological and neurodevelopmental disorders 
associated with genetic mutations directly in a  human genetic background (Takahashi 
and Yamanaka, 2006; Yu et al., 2007). Since the  advent of neuronal induction from hiPSCs, 
several research groups have developed protocols to convert hiPSCs into neurons (LaVaute 
et al., 2009; Chamber et al., 2009). Differentiation into neurons has somewhat lagged 
behind research of other organs, given the  large variability and low efficiency of producing 
functionally mature neurons, using the  initial developed differentiation protocols (Johnson 
et al., 2007; Hu et al., 2010; Kim et al., 2011; Shi et al., 2012). Recently, two studies from 
independent research groups showed that overexpressing Neurogenin-2 (Ngn2) is sufficient 
to induce a  rapid and reproducible conversion of human upper-layer cortical neurons from 
hiPSCs (iN-hiPSCs) with nearly 100% efficiency (Zhang et al., 2013; Busskamp et al., 2014). In 
addition, the authors showed that the neuronal population was homogeneous, and exhibited 
mature synapses and robust synaptic activity already after 20 days post-neuronal-induction. 
Here, we refined the  fast converting neuron strategy of Zhang and colleagues (Zhang et al., 
2013). We transduced hiPSC lines with a lentivirus expressing a tri-cistronic vector encoding for 
reversed tetracycline-controlled induced activator (rtTA), Neurogenin 2 (Ngn2) and puromycin 
(puro) (rtTA/Ngn2-puro). the transduced hiPSC lines were selected for puromycin and Ngn2 
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expression was induced by doxycycline. This allowed us to increase reproducibility and to 
have control over the neuronal cell density, which is critical for neuronal network formation 
(Frega et al. 2016). We tested whether the neurons derived directly from hiPSCs of KS patients, 
bearing a mutation in the EHMT1 gene, displayed deficits in homeostatic synaptic scaling as we 
previously reported in the rodent models. 
In this chapter, we describe for the first time that iN-hiPSCs exhibit homeostatic plasticity 
in response to chronic neuronal network activity deprivation. Moreover, we found that this 
synaptic scaling response was impeded in iN-hiPSCs from KS-patients, corroborating our 
previous results obtained in rodent models for KS (Benevento et al., 2016)
resulTs
generation of mature and functionally active neurons induced from hipscs
To establish a reliable and robust neuronal differentiation protocol we first generated a stable 
hiPSCs cell line, expressing Ngn2 under a doxycycline-dependent promotor (Frega et al., 2016). 
To this end, hiPSCs from a  healthy volunteer were transduced with a  tri-cistronic lentivirus 
expressing rtTA/Ngn2-puro. the transduced cells were subsequently treated with pumomycin 
to select hiPSC clones in which the  rtTA/Ngn2-puro was stably integrated into the  genome. 
Next, to derive a homogenous and mature neuronal population, we induced Ngn2 expression 
in the hiPSCs with doxycycline through activation of tetracyclin-activated receptor (rtTA), as 
previously described (Zhang et al., 2013; Busskamp et al., 2014). We found that the expression 
of the  neuronal marker MAP2 was already visible 7 days in vitro (DIV) after doxycycline 
induction (Figure 3.1). At DIV 13, we observed the expression of the presynaptic vesicle marker, 
Synapsin (Südhof et al., 1989). During the  following days, the  intensity and the  amount of 
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figure 3.1. hiPSC derived neurons time course characterization after induction. Representative 
epifluorescent images from induced neurons at different maturative stages. Induced hiPSCs neurons were 
immunolabeled for: MAP2, green; Synapsin, red; Hoechst, blue. Scale bars: 15µm.  
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Synapsin punctae on MAP2 positive cells increased abundantly. This observation suggests that 
the induced neurons form critical presynaptic components already at DIV 20 (Figure 3.1). 
To investigate, whether iN-hiPSCs make contact to post-syaptic sites, we analysed synapsin 
puncate juxtaposed to the post-synaptic marker PSD-95. We found that the synapsin punctae 
were juxtaposed to PSD-95 punctae at DIV 23, indicating the presence of pre- and post-synaptic 
components (Figure 3.2).
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To confirm whether the anatomical observed pre-and post-synapse are forming functional 
synapses, we next performed whole-cell current and voltage patch-clamp recordings on 
the  hiPSCs-induced neurons. At DIV 7, iN-hiPSCs were able to fire action potentials when 
depolarized. From DIV 7 to DIV 20, the  amount of evoked action potentials increased over 
the time, showing that the iN-hiPSCs acquired mature firing properties (Figure 3.3A). Indeed, 
at DIV 16, the percentage of neurons showing action potentials reached nearly 100%, and was 
maintained until DIV 23 (Figure 3.3B).
To investigate the network activity, we recorded spontaneous excitatory post-synaptic currents 
(sEPSC). We found that the  iN-hiPSCs received excitatory synaptic input already at DIV 7, which 
further increased in both frequency and amplitude of the sEPSC during development (Figure 3.4). 
figure 3.2. hiPSCs induced neurons synapse formation at DIV 23. hiPSC-derived neurons were stained for 
PSD-95 (green) and Synapsin-1/2 (red) DIV 23 after neuronal induction. Synapsin punctae are juxtaposed 
to PSD-95 punctae. Right insert shows a magnification of a 10 µm dendritic stretch depicting juxtaposed 
PSD-95/Synapsin punctae.
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figure 3.3. Induced hiPSCs neurons show active properties. a) Representative current patch-clamp 
recordings depicting action potential generation induced at three different maturative stages at DIV 7, 
10 and 20. B) Time course depicting the percentage of spiking neurons at different days after rtTA/Ngn2 
hiPSCs induction.
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These data indicate that we were able to generate iN-hiPSCs, which show mature neuronal intrinsic 
properties and show high network activity. Importantly, the addition of glial cells as structural and 
functional support was essential for the proper maturation of the iN-hiPSCs (data not shown).
synaptic scaling induction in induced neurons from hipscs
In the  next step, we investigated the  impact of synaptic scaling in iN-hiPSCs from KS patients. 
We generated neurons from a control and a patient affected by KS hiPSCs. the KS iN-hiPSCs were 
generated from a  patient with a  heterozygous 132-bp deletion in the  EHMT1 gene, leading to 
a premature stop codon (c.3181-80_3233del pTyr1061fs, patient 25 in Willemsen et al, 2012) using 
lentiviral transduction of the Yamanaka factors (Takahashi and Yamanaka, 2006; Warlich et al., 2011). 
Three different clones resulting from the reprogramming were expanded, stored and validated 
through a  battery of quality control tests including morphological assessment, expression of 
pluripotent markers measured by RT-qPCR and immunocytochemistry, ability to generate cells 
from the 3 germ layers when spontaneously differentiated. Karyotype and genomic integrity was 
assessed by high-density SNP arrays, all to ensure they are suitable for our investigations (data not 
shown). One validated clone was selected to make a stable cell line, expressing the doxycycline 
inducible Ngn2 cassette. No differences were observed between iN-hiPSCs from control and KS 
patient during the differentiation process. Both lines showed neuronal morphology as assessed 
with MAP2 staining starting at DIV 7. After DIV 20, we could reliably record sEPSCs from the Kleefstra 
line and morphological detect synaptic punctae (data not shown). 
figure 3.4. Induced hiPSCs neurons display spontaneous excitatory network activity. a) Representative 
traces of excitatory postsynaptic currents (EPSCs) received by hiPSC-derived neurons at different days 
after differentiation. B) and c) Frequency and amplitude of spontaneous excitatory postsynaptic currents 
during development. 
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Homeostatic synaptic scaling induction in neurons is dependent on Bdnf expression. 
Previous studies have shown that exogenous application of BDNF to neuronal cultures prevents 
synaptic scaling up after chronic neuronal network activity deprivation induced by tetrodotoxin 
(TTX) for 48h (Rutherford et al., 1998). Given that BDNF is one of the  supplemented factors 
used in the medium to maintain iN-hiPSCs, we removed BDNF completely from the culturing 
medium at DIV 17 after iN-hiPSCs induction. Next, we induced synaptic scaling up by treating 
DIV 21 iN-hiPSCs for 48h with TTX 1 µM. After 48h TTX-induction (DIV 23), we found a significant 
increase in the miniature EPSC (mEPSC) amplitude in the control iN-hiPSCs (Figure 3.5A), but 
no changes in frequency (Figure 3.5B). These data are similar to what was previously extensively 
shown by us and others in rodent neuronal preparations (Turrigiano et al., 1998; Benevento et 
al., 2016) and show that homeostatic synaptic scaling up can reliably be induced in iN-hiPSCs. 
Next, we performed the  same experiment in iN-hiPSCs from the  KS patient. Interestingly, 
the  TTX-dependent increase in mEPSC amplitude was absent in these neurons (Figure 3.5A), 
Also no changes in mEPSC frequency was observed (Figure 3.5B). This is consistent with our 
previous observations in rodent models for EHMT1 deficiency (Figures 2.7, 2.9, 2.24, and 2.28). 
Similar to our previous observations (Benevento et al., 2016), we did not observe any 
baseline differences between genotypes (non-treated) in the  mEPSC amplitudes and 
frequencies, suggesting that there are no basal differences between control and KS neurons 
(Figure 3.5A and 3.5B).  
discussion
In this chapter, we have successfully generated active neurons from hiPSCs. By modifying 
previously established protocols, we converted with nearly 100% efficiency hiPSCs into 
functionally connected neurons (Zhang et al., 2013; Busskamp et al., 2014). We temporally profiled 
the development of the neuronal network after doxycycline induction of rtTA/Ngn2 of hiPSCs 
at different time points. We found that iN-hiPSCs were expressing synaptic markers (Synapsin 
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and PSD-95) as early as DIV 7 after doxycycline induction. the  expression of these markers 
increased over the time course of maturation. Importantly, this was paralleled by an increment in 
the number of action potentials evoked by depolarization, and in the frequency and amplitude 
of the spontaneous events (sEPSCs). Together these findings confirmed that the generated iN-
hiPSCs showed active membrane properties and formed organized neuronal networks.
The optimized production and synchronization of human neuronal population from control 
and KS-patients iN-hiPSCs allowed us to functionally use human neurons to validate our previous 
findings in rodent models for KS (Benevento et al., 2016). We validated the functional requirement 
of EHMT1 in regulating synaptic scaling directly in iN-hiPSCs. In line with our previous studies, 
our preliminary experiments indicate that the TTX-dependent rise in the mEPSCs amplitude is 
blocked in KS iN-hiPSCs. Synaptic scaling defects have been found in rodent models for various 
neurodevelopmental disorders such as Tuberous-sclerosis, Fragile X and Rett syndrome (Qiu et 
al., 2012; Soden et al., 2010; Bateup et al., 2013 a; b). However, this is the first demonstration of 
deficits in synaptic scaling using iN-hiPSCs derived neurons from patient lines.
Importantly, we are the first research group showing that iN-hiPSCs respond homeostatically 
to chronic neuronal network activity suppression by scaling up glutamatergic synapses. This 
result suggests that both homeostatic synaptic scaling and EHMT1 function have an important 
evolutionarily conserved function in regulating the  epigenetic mechanisms associated with 
synaptic plasticity, neuronal circuitry refinement and brain development in humans. 
The successful validation of our previous results using rodent models directly in iN-hiPSCs 
from controls and KS-patients provides us with an in vitro human model that can be used 
to biochemically and genetically study how EHMT1 regulates aspects of neuronal circuitry 
development in humans. For example, determining whether also in BDNF expression is also 
misregulated in iN-hiPSCs from KS patients could provide a powerful indication to strategize 
therapies for phenotype reversion. Moreover, by using genomic editing techniques like 
CRISPR-Cas9 technology, we could determine during development the  temporal window of 
EHMT1 requirement during neuronal network formation or brain development, and possibly 
use this information to rescue the phenotype.   
However, to finally cross-validate our findings in a  human genetic background, more 
experiments should be conducted by using various isogenic iN-hiPSCs from different healthy 
individuals and KS patients.
maTerials and meThods
All experiments on animals were carried out in accordance with the  approved animal care 
and use guidelines of the  Animal Care Committee, Radboud University Medical Centre, 
the Netherlands, (RU-DEC-2011-021, protocol number: 77073).
glia cell isolation and culture
The protocol is based on the  work of McCarthy and de Vellis published in 1980, and a  very 
similar detailed protocol for mouse astrocytes is available (Schlidge et al., 2013).  To generate 
78
THREE 
Functional assays in neurons-derived From iPscs From Ks Patients
primary cultures of cortical astrocytes from embryonic (E18) rat brains, a  pregnant rat was 
sacrificed and embryos were collected from the uterus, and the brains need to be isolated from 
the  embryos as recently described (Frega et al., 2016). To fill a T75 flask, the cortices from 2 
embryonic brains need to be combined. 
generation of puromycin-rtTa/ngn2-positive hipscs
hiPSCs were generated as previously described in (Frega et al., 2016). hiPSCs were plated in 12 
well plate and cutured in DMEM/F12 (Gibco; 11320-074) in a humidified incubator at 37˚C with an 
atmosphere of CO
2 
5%. For hiPSCs transduction the DMEM/F12 was substituted with pre-warmed 
E8 medium (Gibco; A1517001) supplemented with Penicillin/Streptomycin (Sigma-Aldrich; P4333), 
ROCK-inhibitor (RevitaCell™, Gibco; A2644501) and polybrene (Sigma-Aldrich; AL-118). hiPSCs 
were transduced with lentiviruses expressing puromycin-rtTA/Ngn2, produced as previously 
described (Ba et al., 2016; Frega et al. 2016). After transduction, hiPSCs were washed in DPBS 
(Sigma-Aldrich; D8662) and kept in E8 medium at 37˚C in a humidified incubator with a CO
2 
5% 
atmosphere. For selecting cells stably integrating the  puromycin-rtTA/Ngn2 lentivirus, hiPSCs 
were selected with Puromycin 0.5µg/ml (Sigma-Aldrich; P9620-10ML) and G418 50µg/ml (Sigma-
Aldrich; G8168-10ML) for 5 days in a humidified 37 °C incubator with an atmosphere of CO
2
 5%.
neuronal induction of rtTa/ngn2-positive hipscs
For neuronal induction, we used DMEM/F12 medium and E8 supplemented with Pennicilin/
Streptomycin 1% (v/v), Doxycycline 4 µg/ml (Sigma-Aldrich; D9891-5G) and ROCK inhibitor. Cells 
after treatment were kept in 24 wells plate in a humidified 37 °C incubator with an atmosphere 
of CO
2 
5% overnight. the following day, E8 supplemented medium was replaced with DMEM/
F12 supplemented with N-2 supplement 1% (v/v) (Gibco; 17502-048), non-essential amino acids 
1% (v/v) (Sigma-Aldrich; M7145), Penicillin/Streptomycin 1% (v/v), Neurotrophin-3 (NT-3) 10 
ng/ml (Promokine; C66425), human recombinant brain-derived neurotrophic factor (BDNF) 10 
ng/ml (Promokine; C66212) and Doxycycline 4 µg/ml. After one day rat astrocytes were added 
as previously described (Frega et al., 2016). After 4 days of rtTA/Ngn2 induction medium was 
replaced with Neurobasal supplemented with B-27 supplement 2% (v/v) (Gibco; 0080085SA), 
L-alanyl-L-glutamine 1% (v/v) (GLUTAMAX) (Gibco; 35050-038), Penicillin/Streptomycin 
1% (v/v), NT-3 10 ng/ml, Doxycycline 4 µg/ml and cytosine β-D-arabinofuranoside (ARA-C) 
(Sigma-Aldrich; C1768-100MG). iN-hiPSCs were maintained in a humidified 37°C incubator with 
an atmosphere of CO
2 
5%. At DIV 10 after rtTA/Ngn2 induction, FBS 2% (v/v) (Sigma-Aldrich; 
F2442-500ML) was added to Neurobasal supplemented medium. For homeostatic plasticity 
induction, starting from DIV 17, BDNF was completely removed from Neurobasal supplemented 
medium. Neurobasal supplemented medium was refreshed every third day from the iN-hiPSCs 
and maintained in a humidified 37 °C incubator with an atmosphere of CO
2
 5%. 
immunocytochemistry
iN-hiPSCs were fixed with paraformaldehyde 4% / sucrose 4% in phosphate buffered saline (PBS 
1X) (Sigma-Aldrich, P5493-1L) at 37˚C for 15min. After fixation cells were washed with PBS 1X. 
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Cells were blocked in normal goat serum (NGS) 10%. Primary antibodies were incubated in PBS 
1X with NGS 5% overnight at 4˚C. Secondary antibody incubation was done the next day with 
Alexa-488 and Alexa-568 (Molecular Probes) for 1h at room temperature. Cells were washed 
in PBS 1X to remove secondary antibody excess and nuclei were labeled. Finally, cells were 
mounted using DAKO (DAKO, S3023) fluorescent mounting medium and stored at 4˚C. Primary 
antibodies: Synapsin (1:500, Synaptic systems, 106 001); MAP2 (1:2000, Sigma-Aldrich M4403); 
PSD-95 (1:50, Thermo Scientific MA1-045). Secondary antibodies: Goat anti-Mouse Alexa Fluor® 
488 (1:2000, Invitrogen A11029), Goat anti-Mouse Alexa Fluor® 568 (1:2000, Invitrogen A11031), 
Goat anti-Mouse Alexa Fluor® 647 (1:2000, Invitrogen A21236), Goat anti-Rabbit alexa fluor 488 
(1:2000, Invitrogen A11034), Goat anti-Rabbit Alexa Fluor® 568 (1:2000, Invitrogen A11031).
electrophysiology
Whole-cell voltage- and current-clamp recordings were performed as previously described 
(Nadif Kasri et al., 2011). In brief, iN-hiPSCs attached to glass coverslips were transferred to 
the  recording setup and incubated in recording (ACSF) containing: NaCl 124 mM, NaH
2
PO
4 
1.25 mM, KCl 3 mM, NaHCO
3 
26 mM, Glucose 10 mM, CaCl
2 
2 mM, MgCl
2 
1 mM at continuously 
oxygenated with O
2 
95% / CO
2 
5% at 30°C. iN-hiPSCs were visualized with an upright microscope 
(Olympus). Patch pipettes (5-7 MΩ) were made from borosilicate glass capillaries and filled 
with intracellular solution containing: CsMeSO
3 
115 mM; CsCl 20 mM; HEPES 10 mM; MgCl
2 
2.5 mM; Na
2
ATP 4 mM; NaGTP 0.4 mM; Na-Phosphocreatine 10 mM; EGTA 0.6 mM (pH 7.2-7.3, 
285-295 mOsm). 
hipscs-induced neuronal cultures treatments
Low-density 20000 cell/well iN-hiPSCs were used. iN-hiPSCs cultures at DIV 21 were treated 
for 48h with TTX (1 µM, Tocris 1069). In order to study synaptic scaling BDNF was completely 
removed from the  medium at DIV 17 and hiPSCs-induce neurons were kept in a  BDNF-free 
culturing medium for the reason that BDNF was reported to block synaptic scaling up induction 
(Rutherford et al., 1998).
imaging
Images were acquired with an epifluorescent upright Zeiss Axio Imager 2.1 microscope, using 
a 40X objective, equipped with a camera (AxioCam MRm, Zeiss). Images were processed using 
Axiovision Rel (V4.6) and analysed using ImageJ (NIH, Bethesda, Maryland, USA).  Synapsin and 
PSD-95 punctae were quantified by using ImageJ plug-in Foci picker 3D and 2D (Du et al., 2011).
electrophysiology acquisition and analysis
Intrinsic electrophysiological properties were recorded in current clamp mode. Only cells 
showing a  resting membrane potential < -50mV and stable passive and active properties 
during recording were taken into consideration. Passive intrinsic membrane properties were 
determined via injection of a  0.5s hyperpolarizing current of -25pA at a  holding potential of 
-60mV. At the same holding potential action potential (AP) characteristics were determined 
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from the first AP elicited by a 0.5s depolarizing current just sufficient to bring the membrane 
potential of the  cell to threshold. the  rheobase was determined by the  amount of current 
required to generate this first AP. AP threshold was defined as the voltage at which the slope of 
the membrane potential strongly increases and exceeds 10mV/ms.
sEPSC and mEPSCs were recorded using a  Multiclamp 700B amplifier (molecular devices), 
sampled at 10kHz and filtered at 2kHz. Cells were excluded from analysis if the access resistance 
exceeded 20 MΩ. mEPSCs were recorded in the presence of TTX (1 µM). sEPSCs and mEPSCs 
recordings were analyzed using Mini Analysis Program (Synaptosoft, http://www.synaptosoft.
com/MiniAnalysis/). mEPSC amplitudes and frequencies were statistically tested against 
untreated control or KS iN-hiPSCs by using two-way ANOVA with Bonferroni comparison. 
statistics
Student-T-test was used for pair-wise comparisons. Unpaired two-way ANOVA comparison 
was used when two independent variables (e.g. genotype and treatment) were considered in 
the analysis of only one dependent variable, with Bonferroni post-hoc test. All data is expressed 
as mean±SEM. Statistical significance: (**, p<0.01).
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haploinsufficiency of ehmT1 improves 
paTTern separaTion and increases 
hippocampal cell proliferaTion
Marco Benevento1, Charlotte A. Oomen1, Alexa E. Horner2,3,4, 
Houshang Amiri1,5, Tessa Jacobs1, Charlotte Pauwels1, Monica Frega1, 
Tjitske Kleefstra6, Maksym V. Kopanitsa2, Seth G. N. Grant7, Timothy J. Bussey3,4, 
Lisa M. Saksida3,4, Catharina E.E.M. Van der Zee8, Hans van Bokhoven1,6, 
Jeffrey C. Glennon1, Nael Nadif Kasri1,6
FOUR 
aBsTracT
Heterozygous mutations or deletions of the human Euchromatin Histone Methyltransferase 1 
(EHMT1) gene are the main causes of Kleefstra syndrome, a neurodevelopmental disorder that 
is characterized by impaired memory, autistic features and mostly severe intellectual disability. 
Previously, Ehmt1+/- heterozygous knockout mice were found to exhibit cranial abnormalities 
and decreased sociability, phenotypes similar to those observed in Kleefstra syndrome patients. 
In addition, Ehmt1+/- knockout mice were impaired at fear extinction and novel- and spatial 
object recognition. In this study, Ehmt1+/- and wild-type mice were tested on several cognitive 
tests in a touchscreen-equipped operant chamber to further investigate the nature of learning 
and memory changes. Performance of mutant mice in the Visual discrimination and reversal 
learning, object-location paired-associates learning- and extinction learning tasks was found 
to be unimpaired. Remarkably, Ehmt1+/- mice showed enhanced performance on the location 
discrimination test of pattern separation. In line with improved location discrimination ability, 
an increase in BrdU-labelled cells in the subgranular zone of the dentate gyrus was observed. 
In conclusion, reduced levels of EHMT1 protein in Ehmt1+/- mice do not result in general 
learning deficits in a touchscreen-based battery, but lead to increased adult cell proliferation in 
the hippocampus and enhanced pattern separation ability. 
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inTroducTion
Haploinsufficiency of the  Euchromatic histone methyltransferase 1 (GLP/EHMT1) gene is 
the cause of Kleefstra syndrome (KS; #OMIM 610253) (Kleefstra et al., 2006). the core features 
of KS are intellectual disability (ID), hypotonia and cranio-facial abnormalities, frequently 
associated by various other conditions as congenital (heart) defects, epilepsy and Autism 
Spectrum Disorder (ASD) (Kleefstra et al., 2006; Willemsen et al., 2012). the effects of mutations 
in the  Ehmt gene studied in Drosophila (EHMT) and in mouse models (Ehmt1) at molecular, 
cellular and behavioral levels recapitulated some core features of the KS (Balemans et al., 2010, 
2013, 2014; Benevento et al., 2015; Parkel et al., 2009; Schaefer et al., 2009). 
We previously reported that haploinsufficiency of the  Ehmt1 gene can result in altered 
performance on several classical tests of learning and memory (Balemans et al., 2013). Ehmt1+/- 
mice show reduced novelty preference in both novel object and spatial recognition tests, 
indicating putative perirhinal cortex- and hippocampus-dependent memory impairments. 
However, Ehmt1+/- mice showed normal performance on a spatial navigation task (Barnes maze) 
and exhibited increased freezing during acquisition of a cued fear-conditioning paradigm and 
during the  test phase of contextual fear conditioning. Finally, Ehmt1+/- mice were impaired 
at cued fear extinction. These findings may be, in part, explained by putative differences in 
anxiety- and exploration-related behavior (Balemans et al., 2013; Schaefer et al., 2009). 
Therefore, a thorough characterization of the learning and memory ability of Ehmt1+/- mice in 
low-aversive and low-stress tests, using positive reinforcers, would improve our insight into 
the cognitive phenotype of this mouse model of intellectual disability. 
Here we tested Ehmt1+/- and litter-matched wild-type (WT) mice on several learning and 
memory tests in a touchscreen-equipped operant chamber (Bussey et al., 2008). This cognitive 
testing method requires animals to respond to visual stimuli by touching a  touch-sensitive 
screen in order to receive an appetitive reward. It imposes a low demand on the motor ability 
or innate novelty driven exploration of animals and is relatively non-aversive. Due to the flexible 
nature of this method, animals can be tested on several cognitive domains within the  same 
setup, allowing for between-task comparison. In this study, six different tests of learning and 
memory were implemented (Figure 4.1), some of which also assessed executive functions such 
as response inhibition and behavioral flexibility (Oomen et al., 2013; Horner et al., 2013; Mar 
et al., 2013). In addition, animals were tested on the Location Discrimination task (Oomen et 
al., 2013; McTighe et al., 2009) in order to assess spatial learning and, in particular, pattern 
separation (Gilbert et al., 2001). 
Although we could confirm lower levels of spontaneous activity in the Ehmt1+/- mice compared 
to WT mice, learning and memory performance of Ehmt1+/- mice was mostly unimpaired. 
Interestingly however, Ehmt1+/- mice performed better on the location discrimination task, in 
particular when similarity of locations was high. Using the location discrimination task, it has 
been shown that adult born neurons in the  hippocampal dentate gyrus (DG) are involved in 
pattern separation (Clelland et al., 2009). Furthermore, this touchscreen task was found to be 
sensitive to changes in adult hippocampal neurogenesis in different animal models, both in 
the case of increased adult neurogenesis (Creer et al., 2010) and decreased adult neurogenesis 
87
FOUR 
(Coba et al., 2012). Accordingly, in Ehmt1+/- mice, we found that increased location discrimination 
ability was paralleled by increased neuronal stem cell proliferation in the subgranular zone of 
the DG as assessed by BrdU incorporation.
resulTs
Ehmt1+/- mice show reduced activity but normal learning and memory in 
the touchscreen operant chamber
To test cognitive function of Ehmt1+/- mice in low-aversive and low-stress conditions with 
the use of positive reinforcers, we tested Ehmt1+/- and WT mice on several learning and memory 
tests in touchscreen-equipped operant chambers (for an overview, see Figure 4.1). Cognitive 
testing was preceded by habituation to the testing chambers, during which activity registration 
was performed. In accordance with earlier findings (Balemans et al., 2010; Schaefer et al., 2009), 
Ehmt1+/- mice exhibited hypoactivity in the  novel environment reflected, in this instance, by 
a significantly lower number of beam breaks (U
Mann-Whitney test
=149.5, p=0.007), chamber traversals 
(t
46
=4.383, p<0.001) and screen touches (t
46
=2.635, p=0.011) compared to their WT counterparts 
on the first day of habituation (Figure 4.2A, 4.2B and 4.2C). This was replicated in the second 
cohort of animals tested for behavior in which Ehmt1+/- mice made significantly fewer chamber 
traversals compared to WT mice (WT 36.79±2.17; Ehmt1+/- 29.39±1.10; p=0.034).
figure 4.1. Cognitive testing in the touchscreen operant chamber. a) Example of a Campden touchscreen 
operant chamber for mice. B) Overview of the cognitive tasks: Ehmt1+/- and WT mice were tested on operant 
conditioning (Pretraining); Visual Discrimination; object-location Paired-Associates Learning; Reversal 
Learning; Extinction Learning and Location Discrimination for pattern separation. (Panel B; Adapted by 
permission from Macmillan Publishers Ltd: Nature Neuroscience, copyright (2013) (Nithianantharajah et al., 
2013) and Cold Spring Harbor Laboratory Press, copyright (2013) (Oomen et al., 2013)
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Next, we tested learning and memory abilities of Ehmt1+/- mice. Touchscreen testing 
commenced with instrumental acquisition (pretraining). This was followed by the  visual 
discrimination and reversal-learning task, which was implemented to assess more complex 
learning and cognitive flexibility. Subsequently, mice were subjected to object-location paired-
associates learning task to study their visuospatial learning ability and after this, animals were 
trained on a  simple instrumental response followed by the  extinction learning task to study 
response inhibition. Firstly, Ehmt1+/- mice did not differ from WT animals with respect to 
the average reward collection latency (p>0.1) and response latencies (p>0.1). As for cognitive 
performance, Ehmt1+/- mice required a similar amount of trials to reach criterion on pretraining, 
visual discrimination & reversal learning, object-location paired-associates learning and 
extinction learning tasks (see Table 4.1). During the early phase of reversal learning, Ehmt1+/- 
mice were found to have a  higher perseverative index, which may be indicative of reduced 
cognitive flexibility, however this did not affect the  rate of reversal acquisition. Overall, we 
confirmed that Ehmt1+/- mice showed reduced spontaneous activity in a  novel environment. 
Furthermore, Ehmt1+/- mice did not exhibit gross impairments in their general learning and 
memory abilities compared to their WT control counterparts.
enhanced location discrimination ability in Ehmt1+/- mice
In addition to the learning and memory tests described above, a separate cohort of Ehmt1+/- mice 
and WT animals was subjected to the location discrimination task of pattern separation. In this 
task, animals were required to discriminate and choose between two square response windows. 
Distance between the  locations was varied (i.e. small, intermediate, large), which resulted in 
increased or decreased similarity of these locations. the rationale behind this is that increased 
similarity of the to-be-remembered stimuli places a higher demand on resolving confusability 
between input representations and thus requires, at the  network level, increased pattern 
separation of such inputs (Oomen et al., 2013). Putative impairments of location discrimination 
at a  small distance (but not at a  large distance) would be interpreted as a  pattern separation 
Benevento, Oomen et al., 2015-Figure 2
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figure 4.2. Measures of activity during the first exposure of animals to the touchscreen chamber. Ehmt1+/- 
mice (n=23) are hypoactive as they make less. a) Beam breaks (p=0.007) B) Chamber traversals (p<0.001) 
and c) Screen touches (p=0.011) when compared to WT mice (n=25).
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impairment. Surprisingly, Ehmt1+/- mice outperformed their WT counterparts during location 
discrimination acquisition at intermediate distance. the  Ehmt1+/- group required significantly 
fewer trials and made fewer errors to reach the overall acquisition criterion (Figure 4.3A). Pattern 
separation probe sessions (using small or large distance between locations) revealed that Ehmt1+/- 
mice required fewer trials to reach the within-session acquisition criterion on such sessions. This 
seemed to be particularly pronounced on sessions in which animals were required to choose 
between stimuli at a small separation distance (Figure 4.3B). a main effect of genotype on probe 
session performance was found (F
(1,25)
=6.36; p=0.019), but no genotype × separation interaction 
F
(1,25)
=1.19; p=0.286). No differences were found in the average reward collection latency (Ehmt1+/- 
mice 1.7±0.2s; WT mice 1.7±0.1s) or response latencies (correct response latencies: Ehmt1+/- 
mice 7.4±1.3s; WT mice 7.6±0.7s; incorrect response latencies: Ehmt1+/- mice 6.7 ± 0.9s; WT mice 
6.9±0.6s, all p>0.1). To summarize, Ehmt1+/- mice showed enhanced acquisition of the  location 
discrimination task and enhanced performance on post-acquisition pattern separation probe 
sessions. the improvement was most pronounced on sessions in which stimuli were presented at 
a small or intermediate distance, indicating enhanced pattern separation ability.
increased neural stem cell proliferation in the subgranular zone of 
the dg of Ehmt1+/- mice
Performance in the  location discrimination task, particularly on trials which pose a  high 
demand on pattern separation ability, was previously found to depend on adult neurogenesis 
Table 4.1. Outcome-parameters of cognitive testing of Ehmt1+/- mice in learning and memory tasks in 
the touchscreen operant chamber.
Task
outcome behavioral
phenotype performance (*) significance
Pretraining Visual 
Discrimination
Normal 
WT          8.8±0.5
Ehmt1+/- 10.7±0.8
p>0.1
Pretraining Location 
Discrimination
Normal
WT          25.0±1.0
Ehmt1+/- 23.0±1.1
p>0.1
Visual Discrimination Normal
WT          249.2±37.2
Ehmt1+/- 234.0±29.6
p>0.1
Reversal Learning Normal
WT          549.2±55.6
Ehmt1+/- 492.0±63.0
p>0.1
Reversal Learning
early phase
Higher perseverative index  
(PI) in Ehmt1+/- mice
WT          3.5±0.2 (PI)
Ehmt1+/- 4.9±0.5 (PI)
p=0.009
Object-location Paired-
Associates Learning
Normal
WT          1182±127
Ehmt1+/- 1422±128
p>0.1
Acquisition
Instrumental Response
Normal
WT          163.8±7.3
Ehmt1+/- 177.0±9.4
p>0.1
Extinction
Instrumental Response
Normal
WT          200.8±18.4
Ehmt1+/- 206.7±31.4
p>0.1
(*) Performance is reported as the  average number of trials required to reach the  task-criterion for all tests, 
with the exception of Reversal learning - early phase, in which the perseverative index is reported (PI). PI = total 
number of errors made/ number of first presentation errors.
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in the DG (Clelland et al., 2009). Additionally, increased location discrimination performance 
has been correlated with enhanced adult neurogenesis (Creer et al., 2010). Given the better 
performance of Ehmt1+/- mice in this task compared to WT controls, we assessed whether 
Ehmt1 haploinsufficiency led to an alteration in the number of proliferating neural stem cells 
in the  DG subgranular zone (SGZ). To do this, we first analyzed the  expression pattern of 
EHMT1 in the DG SGZ (Figure 4.4A). We observed that EHMT1 intensity levels were significantly 
higher in the  subgranular layer compared to the  granular cell layer of  the DG (Figure 4.4B) 
(SGZ=68.55±3.20 a.u.; DG=53.85±4.83 a.u.; n=5-5; t=2.53, p=0.035, t-test). Interestingly, 
H3K9me2 immunolabeling pattern paralleled the  EHMT1 expression pattern (Figure 4.4C), 
which together with G9a/EHMT2 are responsible for the catalysis of H3K9me2 (Kubicek et al., 
2007; Vedadi et al., 2011). 
The increase in EHMT1 levels in the SGZ prompted us to test whether EHMT1 is involved in 
the regulation of cell proliferation in the DG. To this end, we quantified the number of cells in 
the SGZ that were positive for Ki-67 (Ki-67+), a marker of proliferating cells. Although we observed 
a nominal increase in the amount of Ki67+ cells in Ehmt1+/- mice, this was not significant (Figure 
4.5A), (WT mice 4796±721 cells; Ehmt1+/- mice 6296±803 cells; n=8 and 7 animals respectively; 
t=1.392, p=0.187, t-test). Ki-67 is a proliferative marker expressed during G1, S and G2 phase of 
the cell cycle. Although Ki-67 expression is informative, its temporal resolution is not precise 
enough to give information about the actual pool of cells with replicating DNA. To gain more 
insight we used BrdU labeling, since this marker only labels the cells that are actively replicating 
DNA (Kee et al., 2002). WT and Ehmt1+/- P70 mice were injected with BrdU (50µg/g) four times 
every 4h during a 12h period and animals were sacrificed 24h later. BrdU+ cells were quantified 
using serial sections as described previously Hayes and Nowakowski (2002). Ehmt1+/- mice 
had a higher number of BrdU+ cells compared to WT animals (Figure 4.5B) (WT 3216±415 cells; 
Ehmt1+/- 4826±361 cells; n=8 and 7 animals respectively; t=2.882, p=0.012, t-test). Collectively, 
these experiments suggest that EHMT1 is involved in regulating proliferation of neural stem 
cells in the DG SGZ.
figure 4.3. Location Discrimination performance. a) the  number of trials and errors animals required 
to reach the  performance criterion during the  initial acquisition phase at an intermediate distance. 
B) Performance on Location Discrimination large separation and small separation probe sessions. Ehmt1+/- 
(n=8) mice outperform WT mice (n=17), as they needed on average fewer trials to reach the within-session 
criterion of 7 correct out of 8 consecutive responses (main effect F
(1,25)
=6.36; p=0.019). 
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discussion
We show here that Ehmt1 haploinsufficient mice perform normally on several tests of 
learning and memory in a  touchscreen-equipped operant chamber. Ehmt1+/- mice acquired 
visual discrimination and reversal learning, object-location paired-associates learning  and 
extinction learning to the same level and at the same rate as did WT controls. Ehmt1+/- mice 
did show signs of reduced flexibility, as reflected in an increased perseveration index during 
the early phase of reversal learning. However, this did not impact overall acquisition speed 
of the  reversed contingencies and perseverative behavior did not differ during location 
discrimination training, which also contains a  reversal component. It can therefore be 
concluded that Ehmt1+/- mice are generally unimpaired at learning and memory tasks when 
tested in a low-stress and unaversive environment, using highly translatable cognitive tests. 
This is quite remarkable, as patients with KS have in most cases severe intellectual disability 
(Pagon et al., 1993) and exhibit significant behavioral and psychiatric problems including 
anxiety (personal communication). It is possible that impairments found earlier in classical 
learning and memory tests (Balemans et al., 2013) such as novel object (and object in place) 
figure 4.4. EHMT1 expression pattern in the DG. a) EHMT1 staining intensity in the DG at different levels of 
magnification B) Quantification of EHMT1 staining intensity in the subgranular zone (SGZ) (n=30 cells) and 
DG (n=30 cells). c) Representative H3K9me2 immunolabeling in a hippocampal section (Scale bar: 100µm). 
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recognition memory and fear conditioning, could be partially driven by enhanced anxiety 
in Ehmt1+/- mice (Balemans et al., 2013) and to a  lesser extent by impaired cognitive ability. 
Extended training time during operant conditioning may therefore be beneficial for cognitive 
performance of Ehmt1+/- mice as it ensures thorough habituation to the  testing setup. 
Comparing cognition in mice and humans has traditionally been difficult. the development 
of touchscreen test for rodents now makes it possible to perform the  same test in both 
species. In a  recent study, mice lacking the  Dlg2 gene (Dlg2-/-) and individuals with DLG2 
CNV deletions were tested in a  touchscreen test for object-location paired-associates task 
(Nithianantharajah et al., 2015). Interestingly, both mice and humans lacking the  DLG2 gene 
showed impaired performances. It will therefore be interesting to compare the observations 
in this study with the  results from Cambridge Neuropsychological Test Automated Battery, 
(CANTAB) performed on KS patients.
figure 4.5. Increased cell proliferation in the  DG of Ehmt1+/- mice. a) Ki67 immunoreactivity (red) in 
the DG SGZ. White arrows indicate the Ki67+ cells. Below total quantification of Ki67+ cells (WT=8; Ehmt1+/-
=7; p=0.187) B) BrdU immunolabeling (green) in the DG SGZ. White arrows indicate the BrdU+ cells. Total 
amount of BrdU+ cells (WT n=8 animals; Ehmt1+/- n=7 animals; p=0.012). For all images scale bar: 20µm.
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As for the enhanced performance of Ehmt1+/- mice compared to WT controls on the location 
discrimination task, this may indicate an improved DG-dependent pattern separation function 
(McTighe et al., 2009; Oomen et al., 2013). Previously, pattern separation ability (as assessed 
by location discrimination performance), was shown to be sensitive to disruptions in adult 
hippocampal neurogenesis (Clelland et al., 2009; Coba et al., 2007), whereas enhanced 
performance was found to correlate with increased neural stem cell (nsc) proliferation in 
mice housed with a  running wheel (Creer et al., 2010). In line with this, we found that adult 
Ehmt1+/- mice have higher levels of cell proliferation in the DG, as measured by the number of 
BrdU+ cells in the SGZ. Although this was not paralleled by a significant increase in the number 
of Ki67+ cells, there was a  nominal trend for a  higher number of cells in Ehmt1+/- mice. While 
both Ki67 and BrdU are considered bona fide markers of cell proliferation (Kee et al., 2002), 
Ki67 is expressed during most cell cycle phases, potentially giving a less precise estimation of 
the actual pool of cells that are replicating the DNA. This is in contrast with BrdU, which is only 
incorporated into DNA during the S-phase (Gitlin et al., 2014). Enhanced proliferation levels in 
the Ehmt1+/- mice are in line with the fact that EHMT1 likely restricts proliferation of neural stem 
cells in the SGZ and with its higher expression in the SGZ demonstrated in this study. Several 
lines of evidences suggest that EHMT1, together with its partner EHMT2, is required to restrict 
developmental genetic programs for correct cell proliferation and cell differentiation (Ogawa 
et al., 2002; Chen et al., 2014; Zylicz et al., 2015). Interestingly, the lack of EHMT1/EHMT2 was 
shown to result in a failure of cells to undergo cell commitment and increased proliferation of 
human hematopoietic stem cells, brown adipose cells and retinal layering (Chen et al., 2012; 
Katoh et al., 2012; Schones et al., 2014; Ohno et al., 2013).  Moreover, EHMT1/2 interacts with 
PRC2 (Polycomb complex) to repress and prevent re-expression of time developmental genes 
(Mozzetta et al., 2015). In this regard, it is interesting to note that Ezh2-/- homozygous mice, 
a known component of PRC2 complex, showed a higher number of BrdU+ cells in the developing 
cerebral cortex (Pereira et al., 2010). Further studies are needed to clarify the role of EHMT1 
in the  generation of new neurons in the  DG, and whether this histone methyltransferase is 
involved in regulating the balance between self-renewal and differentiation of neurons or glial 
cells. Furthermore, this would provide valuable information about the cellular mechanisms that 
underlie KS.
maTerials & meThods
animals
For the experiments presented in this study, mice heterozygous for a targeted loss-of-function 
mutation in the  Ehmt1 gene (Ehmt1+/- mice) and their WT littermates on C57BL/6 background 
were used, as previously described (Balemans et al., 2010). Animal experiments were performed 
at two sites, the  Radboudumc (Nijmegen, the  Netherlands) and the  University of Cambridge 
(Cambridge, UK). Each test was done entirely at one site or completely at both sites, when done in 
duplicate. Mice used in experiments executed at the Radboudumc (Nijmegen, the Netherlands) 
were bred in-house. For behavioral experiments performed at the  University of Cambridge, 
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male mice from Radboudumc (Nijmegen, the Netherlands) were re-derived into the Biological 
Services Unit of the Babraham Research Campus (Cambridge, UK) on a C57BL/6Babr background. 
Males bearing the mutation were then crossed with C57BL/6Babr WT females to generate the mice 
used in the present study. These mice were transferred to the animal facility of the University 
of Cambridge (Cambridge, UK) for behavioral testing around 8 weeks of age. Only males were 
used for all the experimental procedures here described. Male mice were housed in standard 
size cages (396mm w × 215mm d × 172mm h) containing a plastic shelter and enrichment material 
in a temperature and humidity-controlled room under a 12h light/dark cycle (lights off at 7:00 
am). All procedures involving animal experimentation and experimental protocols were carried 
out in accordance and were approved by the  Animal Care Committee of the  Radboudumc, 
the  Netherlands, conforming to the  guidelines of the  Dutch Council for Animal Care and 
the  European Communities Council Directive of 24 November 1986 (86/609/EEC) or were 
executed in accordance with the United Kingdom Animals (Scientific Procedures) Act (1986). 
cognitive testing in the touchscreen operant chamber
Experimental design: Ehmt1+/- mice and their WT littermates were tested using touchscreen-
equipped operant chambers, which make use of positive reinforcement (liquid or food reward). 
Two cohorts of mice were used, which were tested during daily, 1h sessions (4-7 times per 
week) for several months. the first cohort was tested at the University of Cambridge and was 
composed of WT n=25 and Ehmt1+/- n=23 mice that were 12 weeks of age when testing began. 
Mice were first subjected to a simple measure of activity registration, which occurred during 
the  first habituation session. Following this, 13 WT and 10 Ehmt1+/- mice were given further 
testing. After pretraining, these mice were subjected to the  following learning and memory 
tasks: Visual Discrimination and Reversal learning, object-location paired-associates learning 
and extinction learning, consecutively. a second cohort of mice was tested at the Radboudumc 
(Nijmegen, Netherlands). This cohort was composed of 19 WT and 10 Ehmt1+/- mice that 
were 11 weeks old at the start of testing. Similar to the first cohort, mice were first tested on 
a  simple measure of activity and subjected to pretraining. This was followed by the  location 
discrimination task for spatial pattern separation, which consisted of an initial acquisition phase 
followed by pattern separation probe-sessions. In order to ensure that animals were motivated 
to perform the  task for a  food reward, all mice were subjected to mild food restriction to 
85-90% of their free feeding body weight.
Apparatus:  automated touchscreen operant chambers were used of two similar types; 
Bussey-Saksida touchscreen chambers (Campden Instruments, Loughborough, UK) and testing 
chambers assembled from separate parts (Med Associates, Inc., St. Albans, VT, USA) in-house. 
For a detailed description of both types of boxes, see Horner et al., 2013. In short, both types 
of chambers consisted of a modular chamber made out of black Perspex walls and a metal grid 
floor within a  sound-attenuating box, a  reward tray, equipped with a  tray-light, was situated 
opposite to the screen in which either strawberry milkshake (Campden) or sugar pellets (Med-
Associates) was delivered. Chambers were equipped with a light on the ceiling (house-light, 3W), 
a tone generator and a touch-sensitive screen using infrared photocells. Campden chambers 
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were additionally equipped with infrared beams at the front and back of the chamber for activity 
registration. a  black plastic mask with response windows was used to cover the  touchscreen 
during testing, dimensions of which were dependent on the specific task.
Learning and memory tests:   for an overview of the  tests see Figure 4.1 and a  short 
description below. Detailed protocols used in this study are available elsewhere (Oomen et 
al., 2013; Horner et al., 2013; Mar et al., 2013). Pretraining was utilized to train mice to touch 
the  screen for a  reward and familiarize animals to common trial elements: a  training session 
(maximum 1h) consisted of 30 trials and to start each trial, mice were required to nose-poke 
in the  reward tray to “initiate” stimulus presentation on the  screen. Upon making a  correct 
response, touching the screen resulted in the delivery of a food reward and the sound of a tone 
(secondary reinforcer). An incorrect response resulted in a time-out (5s) and the presentation 
of a correction trial (i.e. the same stimulus and stimulus location) until a correct response was 
made. Correction trials were used to prevent the formation of a stimulus- or side-bias and were 
also utilized in the  visual discrimination and reversal learning task and the  paired-associates 
learning task. Trials were separated by an inter-trial interval lasting 20s. the first two pretraining 
sessions consisted of habituation to the  testing chamber, during which activity registration 
was performed by recording the  number of infrared beam breaks at the  front and back of 
the chamber. Pretraining preceding the visual discrimination task was performed using a 2-hole 
mask and a  range of 40 visual stimuli (randomly presented one at a  time, in one of the  two 
locations), whereas pretraining for the  location discrimination task was performed without 
a mask and using a white square presented in 1 of 6 locations. 
For visual discrimination and reversal learning (Horner et al., 2013; Mar et al., 2013), mice 
had to discriminate between two stimuli: “fan” (correct, S+) and “marbles” (incorrect, S-), (see 
Figure 3b) (Horner et al., 2013), presented in a pseudorandom location. Mice were considered 
to have acquired visual discrimination when they reached a performance criterion of at least 
80% of trials correct (not including correction trials) on two consecutive 30-trial sessions. 
Mice were moved on to reversal learning individually, after they attained visual discrimination 
criterion. Reversal was identical to visual discrimination, except that S+ and S- were reversed. 
Criterion for completion of reversal learning was considered to be at least 80% correct on 2 
consecutive sessions, but all mice received a minimum of 20 sessions regardless. Mice that did 
not attain criterion were tested for 25 sessions. the first two sessions of visual discrimination 
and reversal learning were each run over two days, in four sessions of 15 trials. These sessions 
were not counted towards the acquisition or reversal criteria.
Mice trained on visual discrimination and reversal learning were transferred to object-
location paired-associates learning but were first subjected to the  final phase of pretraining 
using a  3-hole mask. For paired-associates learning, three stimuli were used; flower, plane 
and spider. Whether a  stimulus was correct was determined by the  location in which it was 
presented (flower/left; plane/middle; spider/right). On each trial, one stimulus was presented 
in its correct location and one in its incorrect location resulting in 6 trial types (Figure 4.3) 
(Horner et al., 2013). Criterion for paired-associates learning acquisition was 70% correct on 2 
consecutive sessions, but all mice received 50 sessions regardless.  
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Acquisition and extinction of a  simple instrumental response (Mar et al., 2013) was done 
after paired-associates learning, using the same 3-hole mask. Animals were required to touch 
a  single white square in the  central window and criterion was attained when 30 trials were 
finished in < 14.5min for 5 consecutive days. During the  subsequent extinction phase, there 
was no requirement to initiate, but an initiation delay was implemented (5s). the stimulus was 
presented in the central touchscreen window for 10s. If the stimulus was not touched during 
this time (“omission”), it disappeared at the end of the 10s, followed by a 5s inter-trial interval. 
If the stimulus was touched, it disappeared immediately and the 5s inter trial interval began. 
Criterion for this phase of the task was ≥ 77% (23/30) omissions on 2 consecutive days, but mice 
were tested for a minimum of 10 sessions. 
Finally, location discrimination was used to assess memory for screen locations and spatial 
pattern separation ability (Oomen et al., 2013; McTighe et al., 2009) in a  separate cohort of 
mice. Animals had to discriminate and choose between two illuminated (100% white) squares 
that were presented at small, intermediate or large distance (separation), within a  row of 6 
potential locations. Inactive locations were identifiable from the  background of the  screen 
through low illumination (10% white) and no mask was used. Mice were required to respond 
correctly in 7 out of 8 consecutive trials (acquisition) after which reward contingencies were 
reversed (reversal). Mice were first trained on intermediate separation (locations 2 and 5) until 
they could attain the  overall acquisition criterion (perform one acquisition and one reversal 
within a session of maximum 60 trials, for 3 out of 4 consecutive days). Subsequently, pattern 
separation ability was assessed during probe sessions of unlimited trials, using only small 
separation (locations 3 and 4) or large separation (locations 1 and 6). In total, 12 probe sessions 
were applied, 6 of each separation in blocks of 2 sessions. 
adult neurogenesis and Brdu injections 
In order to investigate differences in adult neurogenesis in the  SGZ of the  DG, proliferation 
rate of neural stem cells in Ehmt1+/- mice (n=7) was compared to that of WT animals (n=8) was 
assessed using BrdU and Ki-67 immunohistochemistry. For this, mice were intraperitoneally 
injected with BrdU 50 µg/g (Sigma, B9285) at postnatal day 70±10 days for four times every 4h 
during 12h period, as previously described (Hayes and Nowakowski, 2002). Mice were perfused 
transcardially, 24h after the first BrdU injection with PFA 4% and sucrose 4% in PBS 1X. Brains 
were removed and kept in the same perfusion solution o/n at 4˚C and then replaced with PBS 
1X with NaN
3 
0.025%. Coronal 30µm thick sections throughout the  hippocampus were cut 
with a Leica VT 1000S vibratome. One in ten brain sections were collected for BrdU and Ki-67 
immunohistochemistry and kept at 4˚C in PBS 1X with NaN
3
 0.025%.
Brdu and Ki-67 immunohistochemistry and stereological counting
For BrdU immunolabeling sections were first post fixed for 2h in PFA 4%/ sucrose 4% and washed 
in PBS 0.1 M/ 0.1% triton. Subsequently, the sections were immersed in pre-cooled HCl 1 M for 
10min at 4˚C, after 10min in HCl 2 M at room temperature, and transferred for additional 10min 
at 37˚C in the same solution. After this, sections were rinsed in boric acid 0.1 M (pH 8.5) for 
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12min at room temperature. Subsequently, sections were washed and permeabilized in PBS 1X 
with Triton 0.1% and then blocked with Normal Goat Serum (NGS) 10%, Normal Donkey Serum 
(NDS) 10% in PBS 1X/ 0.1% triton pH: 7.6 for 1h at room temperature. Primary antibodies against 
BrdU (1:200, Abcam ab1893), Ki67 (1:50, BD Pharmigen 550609) and H3K9me2 (1:100, Millipore 
07-449) in PBS 1X/ 0.1% triton with NGS 5% and NDS 5% were incubated overnight at 4˚C. Brain 
sections were washed and incubated in Donkey anti-sheep Alexa Fluor 488 (1:1000, Invitrogen 
A11015) and Goat anti-Mouse 568 (1:1000, Invitrogen A11031) secondary antibodies in NGS 5%, 
NDS 5% in PBS 1X/ 0.1% triton for 1h at room temperature in darkness. Nuclear staining with 
Hoechst 33342 (1:5000, Invitrogen H3570) was performed after additional washing of secondary 
antibody excess in PBS 1X/ 0.1% triton. Free-floating sections were then washed with PBS 1X 
and mounted on a glass slide. Imaging was performed either with a Fluoview FV1000 confocal 
microscope (Olympus) for representative pictures or with a  ZEISS IMAGER 2.1 epifluorescent 
microscope that was used for counting BrdU+ and Ki67+ cells. the  total number of cells was 
calculated by counting the amount of either of BrdU+ or Ki67+ cells in the SGL on 8 coronal 30µm 
brain sections. Every section was a cranio-caudal transition of 300 µm encompassing the entire 
length of the  hippocampus, thus the  total number of cells was calculated by the  summing 
the number of cells per section times 10 (Quadrato et al., 2012).
ehmT1 immunostaining and brain preparation
A separate group of WT, n=5 mice at postnatal 70±10 days, were sacrificed by cervical dislocation 
and brains were snap frozen in liquid nitrogen and stored at -80°C. Brains were embedded in 
the Shandon M-1 embedding matrix (Thermo Scientific). the brains were sectioned on a cryostat 
at -20°C in the sagittal plane from medial to lateral and mounted on Superfrost Plus glass slides 
(Thermo Scientific). Brain sections were first fixated onto glass slides with ice-cold methanol 
for 10min at -20°C. After washing with Tris buffered saline (TBS) 1X, pH: 7.6 with Tween 0.05% 
(TBS-T), slides were treated with  hydrogen peroxide 0.3% for 10min RT and washed in TBS-T. 
Ultra-Tek Superblock for 5min was used to block nonspecific immunolabeling. Incubation with 
an EHMT1 primary antibody (1:100 Abcam, ab 41969) was conducted, initially for 30min at room 
temperature and then continued overnight at 4°C. the next day, the incubation box was left at 
room temperature for 30min before washing with TBS-T. Thereafter, the slides were incubated 
with the Ultra-Tek anti-polyvalent staining system. After another 5 times 10min washing steps with 
TBS-T, slides were incubated with Ultra/Tek HRP for 10min. After washing with Tris buffer (TB) 
pH: 7.6, 3,3’ diaminobenzidine tetrahydrochloride 0.05% (DAB, Sigma) was added. After 10min 
the DAB reaction was stopped by washing in TB, followed by washing in TBS. Dehydration was 
done in a series of ethanol dilutions (50%, 70%, 96%, 96%, 100%, 100%; each for 1min). Then slides 
were treated with xylene and coverslipped with Pertex (Histolab Products AB, Göteborg, Sweden). 
Analysis of EHMT1 immunostaining was performed using a bright light microscope (Leitz 
Dialux 22, Leitz Microscopes) and pictures were taken with a  microscope camera (Nikon 
Coolpix 990, Nikon Corporation, Tokyo, Japan). EHMT1 intensity levels were compared 
between the SGZ and the granular cell layer in the DG in WT animals only (n=5). We selected 
the SGZ by delineating a distance of one cell layer at the border of the hilus and granular cell 
98
FOUR 
Pattern seParation and adult hiPPocamPal Proliferation in ehmt1 mice
layer. Mean density was measured by analyzing the  intensity levels of EHMT1 staining in cell 
nuclei. Measurements were performed in 30 cells within the  DG, 30 cells in the  SGZ, and in 
the outer area for background density values. the values measured ranged between 0 (dark) 
and 256 (light), here reported as arbitrary units (a.u.). All the values were then transposed (i.e. 
subtracted from 256), in order to have a higher value corresponding to higher density. In this 
way, a dark stained cell was represented by a high-density value. These density values were then 
used to calculate the mean and standard error mean (SEM), and shown in tables and bar-graphs. 
analysis & statistics 
Touchscreen operant training. For activity assessment during habituation, total beam breaks, 
chamber traversals and screen touches in 30min were compared between genotypes. For 
pretraining, visual discrimination & reversal learning, paired-associates learning, extinction 
learning, the number of trials animals required to reach performance criterion was calculated 
for each mouse and averaged across genotypes. For extinction, it was necessary to exclude 
one mouse from the analysis after acquisition, due to the repeated escapes from the chamber, 
which resulted in WT n=13, Ehmt1+/- n=10 (for acquisition) and n=9 (for extinction). In addition 
to the  ‘trials to criterion’ measure, for the  Reversal learning paradigm the  number of errors 
(incorrect choices on first presentation trials) and correction trials committed were analyzed, 
specifically during the early reversal phase (i.e. on sessions where animals performed below 50% 
correct). This was done to calculate an average “perseveration index” (PI) per animal; the ratio 
of CTs to incorrect responses on first presentation trials (Brigman et al., 2008). For location 
discrimination, the number of trials and errors mice required to reach the overall acquisition 
criterion of Location Discrimination training at intermediate distance were calculated. 
Furthermore, the number of trials mice required to attain within-session acquisition, but not 
reversal, are reported for small and large separation probes. This was done because the within-
session reversal criterion was not reached consistently. In cases where animals had not reached 
the  acquisition criterion, the  total amount of trials performed within that session + 8 was 
used, as this would have been the minimum amount of trials needed to be able to reach that 
criterion. Based on anatomical MRI scans of mice within the cohort of animals that were tested 
in the location discrimination task, performed after the last day of behavioral testing (data not 
shown here), two Ehmt1+/- mice were excluded from location discrimination analysis, as these 
animals showed, bilaterally, greatly enlarged ventricles and reduced hippocampi. In addition, 
two WT mice did not reach the  overall criterion during initial acquisition at intermediate 
distance (after 40 sessions) and were excluded from further analysis, resulting in WT n=17, 
Ehmt1+/- n=8. Finally, for both cohorts, the  average reward collection latency and response 
latency were calculated. 
Proliferation assay. For the  analysis of cell proliferation, we counted the  total number of 
either Ki67+ or BrdU+ cells in the DG per mouse. the number of cells positive for either marker 
was then averaged within the genotype to subsequently perform between genotypes statistical 
comparisons. For EHMT1 intensity analysis density values were then used to calculate the mean 
and standard error mean (SEM), and shown in tables and bar-graphs. 
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All experiments. Data are presented as the  mean±SEM. Where possible, data were 
analyzed using Student’s t-test for independent samples, one-sample t-test and repeated-
measures ANOVA (within-subject factor: session block, between-subject factor: genotype), as 
appropriate. Where the assumption of homogeneity of variance was rejected (Levene’s test), 
an unequal variance t-test was used. Where the assumption of normality was rejected (Shapiro-
Wilk test), attempts were made to normalize the distributions with appropriate transformations, 
but where data could not be normalized with transformations, the  non-parametric Mann-
Whitney U tests was used instead of the  standard t-test. All ANOVA data were subjected to 
Mauchly’s test of sphericity to ensure that the homogeneity of variance assumption was not 
violated. Where it was, the  Huynh-Feldt correction was used. All statistical analyses were 
conducted with a significance level of α=0.05, using SPSS version 17.0. 
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General Discussion
Since the advent of Next Generation Sequencing (NGS), mutations affecting more than 700 genes 
have been shown to be causative for Intellectual Disability (ID) in humans (Vissers et al., 2016). 
Functional genomic studies highlighted that one of the main pathways affected in ID consists of 
genes involved in synaptic function and epigenetic factors (Parikshak et al., 2013; van Bokhoven, 
2011; Vissers et al., 2016). At the  same time, there is a  staggering amount of studies showing 
that epigenetic control of gene expression is pivotal to learning and memory (Benevento et al., 
2015; Barco et al., 2014). However, the molecular mechanisms behind the epigenetic regulation 
of gene expression during synaptic plasticity, learning and memory are far from being clarified. 
During my PhD, I studied in depth the  role of the  epigenetic factor Euchromatic Histone 
Methyltransferase 1 (EHMT1). This gene was described in our department to be causative for KS 
(Kleefstra et al., 2006). Here, I focused my attention in further understanding the function of 
EHMT1 in molecular and cellular processes underlying synaptic plasticity and cognition. 
ehmT1, a Key homeosTaTic Tuner
Neuronal activity-dependent gene regulation is a  prominent mechanism through which 
the  nervous system responds to environmental challenges, like learning & memory, brain 
development and neuronal network formation and maintenance. Contrary to Hebbian-
synapse specific mechanisms, homeostatic synaptic plasticity acts to maintain a fine tuning of 
overall neuronal activity by monitoring and scaling globally all synapses. These global synaptic 
modifications, besides being dynamic, are dependent on epigenetic regulation of gene 
function. I found that EHMT1 is an epigenetic tuner required for homeostatic synaptic scaling. 
This epigenetic factor responds to chronic network deprivation by tuning a gene repression 
program in order to scale up synapses (Figure 5.1). This is achieved through EHMT1-dependent 
dynamic increase in the  di-methylation at lysine 9 (K9) of Histone H3 (H3K9me2). H3K9me2 
levels were bi-directionally altered in response to enduring stimulatory and inhibitory in 
neuronal network activity.
Overall, this finding is very exciting because previously histone methylations were not 
considered as dynamic and only thought to be passively changing through cell divisions 
(Bannister et al., 2002). Therefore, my study contributes to the idea that histone methylations 
have a dynamic nature.
Gene expression analysis before and after induction of homeostatic plasticity on WT and 
neurons lacking EHMT1 I revealed interesting changes in gene expression patterns. Specifically, 
I found that during synaptic scaling up 263 genes were downregulated after TTX treatment. 
However, only a fraction of these genes was downregulated in EHMT1 lacking neurons, which 
fail to exhibit scaling up under the same inhibitory conditions. This suggests a critical role for 
EHMT1 in synaptic scaling, mediated by increased H3K9 dimethylation affecting the expression 
of a subset of genes. Interestingly, little or no changes were observed under basal condition. 
Going more into details to investigate the  individual targets, I found that EHMT1 directly 
regulated Bdnf repression by specifically binding and increasing H3K9me2 levels at the  Bdnf 
promoter IV, both in vitro and in vivo (Figure 5.1). In line with other studies, BDNF repression 
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was shown to be necessary to scale up synapses (Rutherford et al., 1998). Interestingly, BDNF 
regulation is achieved at several levels, including DNA-methylation and histone methylation. 
For instance, Bdnf expression misregulation and impaired synaptic scaling was found in loss-
of-function studies of Mecp2 and Tet3 in primary cortical neurons (Qiu et al., 2012; Blackman 
et al., 2012; Yu et al., 2015). Moreover, downscaling was impeded in Tet3-knock down neurons, 
as the result of the  inability to de-methylate DNA specifically at Bdnf promoter IV (Yu et al., 
2015). BDNF gene is a  key-master regulator that is involved in different neuronal functions, 
like learning and memory, neuronal survival and AMPA receptor trafficking (Cunha et al., 
2010). Therefore, it is not surprising that BDNF gene regulation relies on different fine-tuned 
epigenetic mechanisms that control globally neuronal physiology. It can be hypothesized 
that EHMT1 acts either in parallel or sequentially to other epigenetic regulators to finely tune 
TTX
TTX
LIGHT 
DEPRIVATION
LIGHT 
DEPRIVATION
EHMT
1/2
+
-
Figure legend
DNA
Bdnf-mRNA
EHMT2
-CH3
EHMT1
H3
Transcription starting site
H2A,H2B, H4
H3K9me2
Transcription factor
AMPA receptor
synaptic vescicle
Bdnf-mRNA
figure 5.1. Model depicting the epigenetic synaptic scaling action of EHMT1/2 in repressing Bdnf expression, 
by compacting chromatin locally at Bdnf promoter IV and subsequent increase in AMPA receptors (up 
right insert), in conditions of neuronal network activity deprivation. 
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BDNF expression. For example, EHMT1 through H3K9me2 could function as a permissive tag to 
recruit a machinery that adds more stable repressive markers such as H3K9me3, H3K27me3 and 
DNA methyltransferases through HP1 recruitment (Mozzetta et al., 2014; Rothbart and Strahl, 
2014; Yearim et al., 2015). Taken together a picture is emerging in which H3K9me2 could act as 
an epigenetic mark that represents the activity state of a neuronal network and could serve as 
a general mechanism for poising a state in the genome in a “ready to repress” mode. Histone 
methylations, therefore, represent an important epigenetic component that contributes to 
genomic metaplasticity that tunes gene expression in dynamic states that can be promptly 
reversed in order to serve rapid changes, characteristic of neuronal activity. This hypothesis is 
in line with my data showing that under basal condition we observed few and modest changes 
in gene expression. However, neurons lacking EHMT1 (and having reduced H3K9me2) were 
unable to repress certain genes (including Bdnf), and therefore respond to changes in activity. 
Therefore, H3K9me2 can thus be viewed as a dynamic regulatory histone mark in euchromatic 
regions, as opposed to only a mark for heterochromatin only. 
Growing evidence is correlating strongly the  relation between cognitive disorders and 
impairments in homeostatic synaptic plasticity. Strikingly, a  common denominator between 
KS and other well-known neurodevelopmental disorders are perturbations in the regulation of 
key synaptic regulators like BDNF (reviewed in Dickman and Wondolowski, 2013). Furthermore, 
deficits in homeostatic plasticity have now been described in models for Fragile X syndrome, 
Rett syndrome and Tuberous sclerosis (Lee et al., 2016). Deficits in homeostatic synaptic scaling 
could therefore potentially be used as a biomarker for early diagnosis of neurodevelopmental 
disorders, like Intellectual disability. 
ehmT1, an evoluTionarily conserved epigeneTic 
TranslaTor
The ability to generate human in vitro models to study neurodevelopmental disorders 
represents an enormous biotechnological revolution for studying the molecular and functional 
mechanisms underlying intellectual disabilities and more generally, brain development and 
function. the  results described in chapter 3, contributed to a  project that aimed to induce 
neurons (iN) from human induced pluripotent stem cells (hiPSCs) from human donors. By 
using a modified protocol previously described by Zhang and colleagues (Zhang et al., 2013), 
we have successfully generated hiPSCs-induced neurons (iN-hiPSCs) that formed functional 
synapses and were organized in active neuronal networks. the adapted protocol from Zhang 
et al. (2013) allowed us to obtain a fast and highly efficient differentiation protocol that ensures 
us with the  possibility to derive highly homogenous and synchronized iN-hiPSCs population 
(i.e. cortical upper layer excitatory neurons). This is clearly a  great asset for the  reason that 
it allows us to perform developmental time course studies of neuronal network formation in 
synchronized differentiated iN-hiPSCs populations. 
Besides EHMT1, a  number of other epigenetic regulators have been found to play a  role 
in the  development of KS phenotypic spectrum (KSS). Kleefstra and colleagues (Kleefstra et 
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al., 2012) described four genes which were found to be defective in KSS patients: MBD5, MLL3, 
SMARCB1 and NR1I3. Of these, MBD5, MLL3 and NR1I3 genetically interacted with EHMT1, and 
SMARCB1 influenced EHMT1 through its interaction with MLL3. EHMT1 is thus part of a  larger 
epigenetic module underlying human cognitive disorders. Having iN-hiPSCs production 
optimized, an exciting application is to functionally study iN-hiPSCs neuronal network activity 
by using Multi Electrode Array (MEA) technology. Culturing neurons on MEA plates allows 
recording of neuronal network activity through a  high-dense array of micro-electrodes that 
sense changes in ionic concentrations that are typical of neuronal activity. These signals are 
readily amplified and recorded as single electrode activity. This information integrated with 
other electrodes, provides temporal data of how neurons communicate and form functionally 
mature neuronal networks (Taketani et al., 2006; Frega et al., 2016). By using MEA in high 
throughout-put studies, we can compare the  neuronal network activity and developmental 
profile in iN-hiPSCs from control and KSS related genes (EHMT1, MBD5, NR1/3, SMARCB1, 
MLL3) (Kleefstra et al., 2012). This will allow us to collects signatures of the  temporal and 
neurophysiological activity associated with mutations in these KSS genes, and to establish their 
roles in the maturation of neuronal network activity.
The derivation of iN-hiPSCs represents a breakthrough for research into the molecular and 
cellular mechanisms of disease in human neurodevelopmental (and degenerative) disorders. 
However, there are a number of limitations that still require further advancement. For example, 
although the  cellular homogeneity is considered to be a  desired trait, this also represents 
a  disadvantage, because the  iN-hiPSCs cultures are represented by only excitatory neurons. 
This limits our power to determine in toto the properties of in vivo networks, because the lack 
of inhibitory neurons. Therefore, further efforts should be performed in establishing and 
optimizing protocols for fast and high efficient production of both inhibitory and excitatory 
neuronal populations in iN-hiPSCs cultures.
In the experiments described in chapter 3, we tested whether EHMT1 function in regulating 
homeostatic synaptic scaling up is conserved in humans. In agreement with what I and others 
described previously using rodent in vitro and in vivo models (Benevento et al., 2016; Desai et 
al., 2002; Turrigiano et al., 1998), we are, to the best of our knowledge, the first research group 
showing that iN-hiPSCs from control human donors scaled up synapses in response to chronic 
neuronal activity suppression. Excitingly, we are finding that synaptic scaling up in a  KS iN-
hiPSCs line is blocked after TTX-treatment, suggesting that EHMT1 is required also in humans 
for synaptic scaling up. 
The evolutionarily conserved role of EHMT1 in regulating homeostatic synaptic scaling 
reflects the  importance of this epigenetic factor in determining aspects of central nervous 
system development. the  information provided by evolutionary cross-comparison between 
murine and human in vitro models, like iN-hiPSCs, represents a potent translational interface 
that will be extremely beneficial for further biomedical research. For example, by using 
pharmacological and novel gene editing approaches, like CRISPR-Cas9, directly on iN-hiPSCs 
we could functionally study and hopefully reverse some symptoms associated with cognitive 
disorders and in our case, Kleefstra syndrome.  
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The cogniTive paradox of ehmT1
In chapter four, I focused on the  role of EHMT1 in cognition. I found that Ehmt1+/- mice, 
surprisingly, showed an improvement in pattern separation. Loosely defined, pattern separation 
is the process of making similar patterns or memorized contingencies, different. For example, 
pattern separation refers to the  capacity to remember, every day, where exactly our car is 
parked in our neighborhood. This function depends on the Dentate gyrus function (Leutgeb et 
al., 2007). In parallel to enhanced pattern separation in the Ehmt1+/- mice, I show an increase in 
hippocampal neural stem cell (nsc) proliferation in the adult dentate gyrus. These findings are 
in line with seminal studies showing a direct relation between increases in pattern separation 
ability and nsc proliferation in the  adult hippocampus (Clelland et al., 2009). For example, 
better performances in memory retention and pattern separation abilities were described in 
mice that were subjected to physical exercise or were maintained in enriched environments. 
the  same studies, described that this correlated with an increase in nsc proliferation and 
neuronal differentiation, compared to animals kept in standard environments (Kempermann et 
al., 1997). By analyzing the molecular mechanisms underlying adult hippocampal neurogenesis, 
others highlighted that increases in BDNF expression positively correlated with enhanced nsc 
proliferation, neuronal differentiation and pattern separation, tested with the spatial reversal 
paradigm in the Morris water maze (Bekinschtein et al., 2014). For example, impaired pattern 
separation, a reduction in adult hippocampal nsc proliferation and neurogenesis was reported 
in mouse models in which genes downstream to BDNF activity, like NFATc4, was knocked-down 
(Quadrato et al., 2012). the abnormal increase and lack of regulation of the Bdnf gene I described 
in Ehmt1-KD neurons and in Ehmt1+/- mice, could thus explain the increase in nsc proliferation 
in the adult hippocampus. However, this finding should be corroborated by further quantifying 
which proportion of the nsc proliferating cells effectively differentiates into granular neurons 
in the adult Dentate gyrus of the Ehmt1+/- mice. 
Patients with KS have recognizable physical, developmental and behavioral phenotypes. ID 
is a prominent feature of KS patients, however, comorbidity with other behavioral disturbances, 
like autism spectrum disorder, epilepsy, catatonia during childhood and puberty complicates 
even more the diagnosis and the patient treatment. 
The Ehmt1+/- mice were previously described to manifest ID and autism-like features like, 
reduction in social interaction, lack of interest in exploring novel environments, impairments 
in fear-memory extinction and spatial object recognition. Indicating that this mouse model 
is a  face validated model for KS (Balemans et al., 2010, 2013). Paradoxically to these previous 
results, I found that Ehmt1+/- mice were outperforming WT mice in the location discrimination 
task, showing an increase in pattern separation abilities. An increase in cognitive performance 
in Ehmt1+/- mice has actually already been described by Balemans and collaborators (2013). For 
example, Ehmt1+/- mice showed an increase in fear memory retention in the  contextual fear 
conditioning (CFC) paradigm and a non-significant trend towards an increase in fear memory 
in the  cued-CFC version. the  characteristic of cued-CFC is to use negative reinforcers as 
conditioning stimuli, like foot-shock and loud acoustic pulses. Potentially, these negative-stimuli 
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could be confounding parameters for the interpretation of changes in the freezing scores to 
assess fear-memory retention. Balemans et al, understood the confounding effects of negative 
reinforcers and tested for differences in sensitivity to painful stimuli in the Ehmt1+/- mice. They 
found that the Ehmt1+/- mice have increased startle responses to gradually increased acoustical 
stimuli (Balemans et al., 2013). This correlates well to previous descriptions in which increased 
freezing during CFC were observed in rat models for autism and for post-traumatic stress 
disorders (PTSD) (Markram et al., 2008; Imanaka et al., 2006). Moreover, recently a  study 
reported that peripheral mechanoception is altered in different and well-established autism-
related mouse models (Orefice et al., 2016). This could explain the hypersensitivity and altered 
tactile experiences in patients with KS, who suffer from severe intellectual disability and exhibit 
significant behavioral and psychiatric problems including anxiety and stress to novel contexts 
(personal communication). Integrating these findings could explain why using low aversive 
behavioral tasks such as operant chambers coupled with touch screens (Oomen et al., 2013), 
represent a valuable new behavioral paradigm strategy to assess cognitive abilities in mouse 
models that show hypersensitivity to environmental stressors. Further studies should foster 
the redesign of canonical behavioral paradigms in order to use positive reinforcers and isolate 
stress-related brain function to assess cognition. This may lead to surprising new discoveries 
that could explain paradoxical behaviors in cognitive impairments. Ultimately, these findings 
could be applied to change therapy strategy for treatment of ID and Autism-like patients.
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summary
The findings described in this thesis provided mechanistic insights into the  role of EHMT1 
in synaptic plasticity and in cognition, by using a  mouse model haploinsufficient for Ehmt1 
(Ehmt1+/-) and a  human cellular model for Kleefstra syndrome. Specifically, the  findings 
described in this thesis contribute to increase our understanding of the underlying causes of 
circuit malfunction provoked by EHMT1 haploinsufficiency.
In chapter 2 of this thesis the role of EHMT1 as a key neuronal homeostatic tuner required 
for synaptic scaling is described. First, we report the  histone H3 lysine K9 di-methylation 
(H3K9me2) levels to be dynamically and bidirectionally regulated in function of neuronal 
network chronic manipulations to induce synaptic scaling. Subsequently, through genetic and 
pharmacological manipulations of EHMT1 function, we describe that this epigenetic factor is 
required for the increases in H3K9me2 levels after chronic activity suppression. By performing 
electrophysiological experiments, we give evidence of EHMT1 to be necessary for the increases 
in the  miniature excitatory post-synaptic currents amplitude (mEPSC) and AMPA receptor 
abundance in response to activity deprivation. Mechanistically, via a  series of biochemical 
experiments, we explore how EHMT1 activation is triggered in response to chronic network 
activity deprivation. We describe that EHMT1 and its paralog, EHMT2, increase their interaction 
and augment their catalytic activity by increasing H3K9me2 levels in response to prolonged 
suppression of neuronal firing. Subsequently, through RNA-sequencing experiments, we show 
that EHMT1 participates in the control an epigenetic repressive genetic program required to 
scale up synapses in response to chronic network activity deprivation. This led us to validate 
the dynamics of EHMT1 and EHMT2 gene expression regulation. We report EHMT1 and EHMT2 to 
bind and increase H3K9me2 levels directly at Bdnf promoter IV, leading to Bdnf repression after 
neuronal activity suppression. We conclude chapter 2, by studying whether EHMT1 is required 
for synaptic scaling in vivo. By using a mouse model haploinsufficent for Ehmt1, we indicate that 
EHMT1 function is required for the increase in H3K9me2 levels, in the mEPSC amplitude in layer 
II/III of primary visual cortex after a  light deprivation paradigm. Together the data presented 
in chapter 2 show that EHMT1 and EHMT2 assemble in a repressive epigenetic complex that is 
engaged during synaptic scaling. 
In chapter 3, we describe a  procedure to induce neuronal differentiation from human 
induced pluripotent stem cells (iN-hiPSCs). We first report that the iN-hiPSCs express synaptic 
markers already at early stages of neuronal induction. In a  series of electrophysiological 
experiments, the  iN-hiPSCs are described to elicit action potentials when evoked and to 
spoantaneously organize in active neuronal networks. Having validated the synaptic and active 
properties of the iN-hiPSCs, we use this model to derive iN-hiPSCs from control volunteers and 
Kleefstra syndrome (KS) patients. We, next, test whether human derived neurons from KS were 
defective in expressing synaptic scaling, similar to the experiments we described in chapter 2 of 
this manuscript. We report that synaptic scaling is expressed in human neurons and that EHMT1 
function is required for homeostatic plasticity. Together these results suggest that defects on 
synaptic scaling could be one of the underlying causes of KS. 
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In chapter 4, we study cognition in the  Ehmt1 haploinsufficient mouse model by using 
non-aversive touchscreen-equipped operant chambers. In these series of studies, we report 
the Ehmt1+/- mice to perform similarly to control littermates when tested for visual discrimination, 
object-location paired-associates learning  and extinction learning. Together, these data 
indicate that the  Ehmt1+/- mice are generally unimpaired at learning and memory tasks when 
tested in a low-stress and unaversive environment. When instead testing the Ehmt1+/- mice for 
reversed contingencies by using location discrimination test, a paradigm used to study pattern 
separation, we describe that Ehmt1+/- mice manifested increased performances compared to 
control littermates. To investigate the  cellular correlates, we indicate an increase in neural 
stem cell (nsc) proliferation in the subgranular zone of the dentate gyrus of the Ehmt1+/- mice. 
Together, the data described in chapter 4 suggests that EHMT1 function is required to restrict 
developmental genetic programs for correct nsc proliferation and that Ehmt1+/- mice are 
generally unimpaired at learning and memory tasks when tested in a low-stress and unaversive 
environment.
The findings described in this thesis suggest that EHMT1 functions as an evolutionarily 
conserved epigenetic factor important for synaptic plasticity and cognition.
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lisT of aBBreviaTions
AAV-Cre Adeno-associated virus with Cre recombinase
AMPA  alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ANOVA Analysis of Variance
APV D-(-)-2-Amino-5-phosphonopentanoic acid
ASD Autism spectrum disorders
BAF BRG1 associated factors
BDNF  Brain derived neurotrophic factor
BIX-01924 G9a inhibitor
BrdU Bromo de-oxy Uridine
bp base pairs
C57Bl6/J WT-mouse strain
CA1 Cornu Ammonis 1
CaCl
2
 Calcium Chloride
CANTAB Cambridge Neuropsycological test automated battery
ChIP Chromatin Immunoprecipitation
CNS Central Nervous System
cDNA complementary DNA
CNQX 6-Cyano-7-nitroquinoxaline-2,3-dione (AMPAr antagonist)
CO
2
 Carbon di-oxyde
CsCl Cesium Chloride
CsMeSO
3
 Cesium Metan-sulfonate
DG Dentate gyrus
DIV Days in vitro
Dlg2 Disc large homolog 2 
DMEM Dulbecco modified Eagle medium
DNA Deoxyribonucleic acid
DNMT3A DNA (Cytosine-5)-Methyltransferase 3 Beta
DR Dark reared
Drd1 Dopamine receptor d1 
Drd2 Dopamine receptor d2
DSG Disuccinimidil glutarate
DTT Dithiothreitol
EC Entorhinal cortex
EDTA Ehylenediaminetetraacetic acid
EGTA  Ethylene-glycol-bis(2-aminoehtylether)-N,N,N’,N’-tetraacetic acid
EHMT1 (GLP/KMT1D) Euchromatin histone lysine n-methyltransferase 1
EHMT2 (G9a/KMT1C) Euchromatin histone lysine n-methyltransferase 2
ELISA Enzymatic-linked immunosorbent assay
ERK Extracellular signal-regulated kinase
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EtOH Ethanol
Ezh2 Enhancer of zeste homolog 2
FBS Fetal bovine serum
Gabra1/Gabra2/Gabrb2  Gamma-aminobutyric acid (GABA)A receptor, subunit alpha 1,2/ 
beta 2
(e)GFP (enhanced) Green Fluorescence Protein
GLP G9a-like protein; a histone methyltransferase
GluA1/GluA2 Subunits 1 and 2 of the AMPA receptor
GluN2A/GluN2B Subunits a and B of the NMDA receptor
Grin2B (Nr2B) Glutamate (NMDA) receptor subunit epsilon-2
H2A, 2B, 3, 4 Histone 2A, 2B, 3, 4
H3K4me1 Monomethylated 4th lysine residue of histone H3 
H3K4me3 Trimethylated 4th lysine residue of histone H3 
H3K9me2 Dimethylated 9th lysine residue of histone H3
H3K27me3 Trimethylated 27th lysine residue of histone H3
HAT Histone acetyltransferase
HBSS Hank’s buffered salt solution
HDAC Histone deacetylase
HDM Histone demethylase
HEK293T Human Embryonic Kidney clone 293T cells
hiPSc human induced Pluripotent Stem cells
HMT Histone methyltransferase
HP1 Histone protein 1
h hour/-s
iN(-hiPSCs) induced Neurons-hiPSCs
K Lysine
KCl Potassium Chloride
Ki-67 Marker of proliferation Ki67
KS (9qSTDS) Kleefstra syndrome (9q subtelomeric deletion syndrome)
LA Lateral amygdala
LiCl Lithium Chloride
LSD1 Lysine (K)-specific demethylase 1, also KDM1a
LTM Long-term memory
LTP Long-term potentiation
MAP2 Microtubule associated protein 2
MEA Multi Electrode Array
MeCP2 Methyl-CpG Binding Protein 2
mEPSC Miniature excitatory postsynaptic current
MgCl
2
 Magnesium chloride
min minutes 
mIPSC Miniature inhibitory postsynaptic current
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mRNA Messenger Ribonucleic acid
MS-275  Etinostat (HDAC1 inhibitor)
nAc nucleus Accumbens
NaCl Sodium chloride
NaHCO
3
 Sodium Carbonate
NaHPO
4
 Sodium monohydrogen phosphate
NaH
2
PO
4
 Sodium di-hydrogen phosphate
NDS Normal donkey serum
Ngn2 Neurogenin-2
NGS Normal goat serum
NGS Next generation sequencing
NP-40 (IGEPAL) Octyl phenoxypolyethoxylethano
NR Normal reared
Nsc Neural stem cells
NMDAR N-methyl-D-aspartate receptor
O
2
 Oxigen
PBB Protein binding buffer
PBS Phosphate buffered solution
PCR-(q)-(RT) Polymerase chain reaction-(quantitative)-(Reverse Transcription)
PDL Poli-(D)-lysine
PPIA Peptidylproplyl Isomerase A
PRC2 Polycomb Repressive complex 2
Prnp Prion protein
PSD-95 Post-synaptic density protein 95
PTM Post-translational modification
PTX Picrotoxin
Puro Puromycin
R Arginine
Rab3b Member RAS oncogene family 3b
RNA Ribonucleic acid
rtTA reverse tetracycline-controlle transactivator
s seconds
SDS Sodium-dodecyl sulfate
Setdb1 SET domain bifurcated 1
SEM Standard error mean
SGZ Subgranular zone
shRNA short hairpin RNA
SMARCB1  SWI/SNF-related matrix-associated actin-dependent regulator of 
chromatin subfamily B member 1
STO-609  7-Oxo-7H-benzimidazo[2,1-1]benz[de]isoquinoline-3-carboxylic 
acid acetate
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Suv39 h1 Suppressor of variegation 3-9 homolog 1
SYBR  N’,N’-dimethyl-N[4-[€-(3-methyl-1,3-benzothiazol-2-ylidene)
methyl]-1-phenylquinolin-1-ium-2-y]-N-propylpropane-1,3-diamine
TALE Transcription activator like effector
TB Tris Base
TBS-(T) Tris base solution-(tween or triton)
TrkB-(Fc)-(Ig)  Tyrosine receptor kinase B-(Fragment cristallizable)- (Immunoglobulin)
TTX Tetrodotoxin
VGlut Vescicular Glutamate transporter
VSVG Vescicular Stomatitis virus
VTA Ventral-Tegmental Area
WT Wild type
ZFP Zinc finger protein
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